activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	177453	CHEMBL814625	Inhibition of Tyrosine-protein kinase CSK	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	74.0	CHEMBL2634	Homo sapiens	Activity	%	74.0
	177453	CHEMBL814625	Inhibition of Tyrosine-protein kinase CSK	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	74.0	CHEMBL2634	Homo sapiens	Activity	%	74.0
	178766	CHEMBL814625	Inhibition of Tyrosine-protein kinase CSK	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	89.0	CHEMBL2634	Homo sapiens	Activity	%	89.0
	182513	CHEMBL814625	Inhibition of Tyrosine-protein kinase CSK	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	95.0	CHEMBL2634	Homo sapiens	Activity	%	95.0
	464560	CHEMBL822433	Inhibition of Csk tyrosine kinase	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	IC50	nM	5180.0	CHEMBL2634	Homo sapiens	IC50	uM	5.18
	476109	CHEMBL661282	Inhibition of csk tyrosine kinase	B	COc1cc(Nc2nccc(-c3ccc(NCCN)nc3)n2)cc(OC)c1OC		CHEMBL113185	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	487043	CHEMBL661282	Inhibition of csk tyrosine kinase	B	CC[C@H]1CN(c2ccc(-c3ccnc(Nc4cc(OC)c(OC)c(OC)c4)n3)cn2)CCN1		CHEMBL112346	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	490585	CHEMBL661282	Inhibition of csk tyrosine kinase	B	COc1cc(Nc2nccc(-c3ccc(N4CCNCC4)nc3)n2)cc(OC)c1OC		CHEMBL322066	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	506050	CHEMBL661282	Inhibition of csk tyrosine kinase	B	COc1cc(Nc2nccc(-c3cccnc3)n2)cc(OC)c1OC		CHEMBL112263	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	506164	CHEMBL814629	Inhibition of Tyrosine-protein kinase CSK	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	2100.0	CHEMBL2634	Homo sapiens	IC50	uM	2.1
	616550	CHEMBL814627	Inhibition of Tyrosine-protein kinase CSK at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	104.0	CHEMBL2634	Homo sapiens	Control	%	104.0
	616589	CHEMBL814628	Inhibition of Tyrosine-protein kinase CSK at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	116.0	CHEMBL2634	Homo sapiens	Control	%	116.0
	631768	CHEMBL814632	Selectivity over Protein kinase CSK (100-500)	B	N[C@H]1CC[C@H](Nc2nc(Nc3ccc(P(=O)(O)CP(=O)(O)O)cc3)c3ncn(C4CCCC4)c3n2)CC1		CHEMBL3084838	=	Selectivity		100.0	CHEMBL2634	Homo sapiens	Selectivity		100.0
	675520	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCCN(CCCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL299115	=	Ratio		24.0	CHEMBL2634	Homo sapiens	Ratio		24.0
	675521	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc([N+](=O)[O-])cc1		CHEMBL298809	=	Ratio		5.7	CHEMBL2634	Homo sapiens	Ratio		5.7
	676836	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CHEMBL293731	=	Ratio		200.0	CHEMBL2634	Homo sapiens	Ratio		200.0
	679228	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCc1c[nH]c2ccccc12		CHEMBL58629	=	Ratio		11.6	CHEMBL2634	Homo sapiens	Ratio		11.6
	679229	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)C(F)(F)F		CHEMBL299693	=	Ratio		57.2	CHEMBL2634	Homo sapiens	Ratio		57.2
	682095	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL59201	=	Ratio		7.9	CHEMBL2634	Homo sapiens	Ratio		7.9
	683495	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCCCCCO		CHEMBL417599	=	Ratio		3.6	CHEMBL2634	Homo sapiens	Ratio		3.6
	683496	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCS(C)(=O)=O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL56884	=	Ratio		75.3	CHEMBL2634	Homo sapiens	Ratio		75.3
	684975	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Nc1ccc(N)cc1		CHEMBL56670	=	Ratio		26.9	CHEMBL2634	Homo sapiens	Ratio		26.9
	686193	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCCCCCCO		CHEMBL53225	=	Ratio		2.2	CHEMBL2634	Homo sapiens	Ratio		2.2
	686194	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCc1ccc(O)cc1		CHEMBL292893	=	Ratio		26.7	CHEMBL2634	Homo sapiens	Ratio		26.7
	687534	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCc1c[nH]c2ccccc12		CHEMBL56996	=	Ratio		31.8	CHEMBL2634	Homo sapiens	Ratio		31.8
	687535	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCCc1ccccc1		CHEMBL291906	=	Ratio		27.2	CHEMBL2634	Homo sapiens	Ratio		27.2
	689007	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCC(=O)O)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL301890	=	Ratio		48.0	CHEMBL2634	Homo sapiens	Ratio		48.0
	689008	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCc1cccnc1		CHEMBL59323	=	Ratio		17.7	CHEMBL2634	Homo sapiens	Ratio		17.7
	690307	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1ccccc1		CHEMBL56389	=	Ratio		16.5	CHEMBL2634	Homo sapiens	Ratio		16.5
	690308	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCSC)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL418096	=	Ratio		16.5	CHEMBL2634	Homo sapiens	Ratio		16.5
	692692	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CSCc1ccccc1		CHEMBL301445	=	Ratio		18.9	CHEMBL2634	Homo sapiens	Ratio		18.9
	693940	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCCCCO		CHEMBL55688	=	Ratio		6.4	CHEMBL2634	Homo sapiens	Ratio		6.4
	695326	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CCc1ccccc1		CHEMBL294454	=	Ratio		10.8	CHEMBL2634	Homo sapiens	Ratio		10.8
	696843	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL299477	=	Ratio		1.0	CHEMBL2634	Homo sapiens	Ratio		1.0
	699772	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Nc1ccc([N+](=O)[O-])cc1		CHEMBL56204	=	Ratio		184.4	CHEMBL2634	Homo sapiens	Ratio		184.4
	700960	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCCCCCC(=O)O		CHEMBL59578	=	Ratio		36.7	CHEMBL2634	Homo sapiens	Ratio		36.7
	702232	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCc1c[nH]c2ccc(O)cc12		CHEMBL301439	=	Ratio		31.5	CHEMBL2634	Homo sapiens	Ratio		31.5
	703549	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)COCc1ccccc1		CHEMBL54110	=	Ratio		32.7	CHEMBL2634	Homo sapiens	Ratio		32.7
	704830	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)N(C)CCCc1c(C(N)=O)[nH]c2ccccc12		CHEMBL58630	=	Ratio		9.3	CHEMBL2634	Homo sapiens	Ratio		9.3
	704831	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)O		CHEMBL57363	=	Ratio		606.0	CHEMBL2634	Homo sapiens	Ratio		606.0
	706146	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(C)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL293817	=	Ratio		12.0	CHEMBL2634	Homo sapiens	Ratio		12.0
	706147	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Cc1ccc(CN)cc1		CHEMBL264377	=	Ratio		92.1	CHEMBL2634	Homo sapiens	Ratio		92.1
	706148	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL56432	=	Ratio		16.6	CHEMBL2634	Homo sapiens	Ratio		16.6
	707481	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)OCc1ccccc1		CHEMBL301653	=	Ratio		79.7	CHEMBL2634	Homo sapiens	Ratio		79.7
	707482	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)CSc1ccccc1		CHEMBL300759	=	Ratio		17.7	CHEMBL2634	Homo sapiens	Ratio		17.7
	707483	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CSC)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL55739	=	Ratio		33.1	CHEMBL2634	Homo sapiens	Ratio		33.1
	708751	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCCCN(CCCCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL300802	=	Ratio		327.0	CHEMBL2634	Homo sapiens	Ratio		327.0
	708752	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc(C(F)(F)F)cc1		CHEMBL299535	=	Ratio		25.4	CHEMBL2634	Homo sapiens	Ratio		25.4
	708753	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc(OC)cc1		CHEMBL301414	=	Ratio		7.2	CHEMBL2634	Homo sapiens	Ratio		7.2
	710135	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CSCc1ccccc1)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL300819	=	Ratio		155.4	CHEMBL2634	Homo sapiens	Ratio		155.4
	711388	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	COc1ccc2[nH]cc(CCNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc3ccc(OP(=O)(O)O)cc3)NC(C)=O)c2c1		CHEMBL294045	=	Ratio		29.7	CHEMBL2634	Homo sapiens	Ratio		29.7
	711389	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)Nc1ccc(OC)cc1		CHEMBL56613	=	Ratio		13.5	CHEMBL2634	Homo sapiens	Ratio		13.5
	712751	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCC(=O)OCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL292159	=	Ratio		26.0	CHEMBL2634	Homo sapiens	Ratio		26.0
	712752	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CC(=O)N[C@@H](Cc1ccc(OP(=O)(O)O)cc1)C(=O)N[C@@H](CCC(=O)O)C(=O)NCCCCCCC(N)=O		CHEMBL300568	=	Ratio		115.0	CHEMBL2634	Homo sapiens	Ratio		115.0
	712753	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccccc1		CHEMBL428173	=	Ratio		15.3	CHEMBL2634	Homo sapiens	Ratio		15.3
	713939	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCO)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(C)=O		CHEMBL56187	=	Ratio		16.7	CHEMBL2634	Homo sapiens	Ratio		16.7
	713940	CHEMBL821540	Binding affinity against c-Src tyrosine kinase SH2 domain expressed as ratio of IC50 of test compound over IC50 of AcYEEIE	B	CCCCCN(CCCCC)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(OP(=O)(O)O)cc1)NC(=O)c1ccc(Cl)cc1		CHEMBL57073	=	Ratio		39.0	CHEMBL2634	Homo sapiens	Ratio		39.0
	717185	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CNCCO)c1		CHEMBL176702	=	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	727659	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccccc3)c3ncnc(N)c23)c1		CHEMBL172973	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	727668	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccc(CNCCO)cc1		CHEMBL173453	=	IC50	nM	4300.0	CHEMBL2634	Homo sapiens	IC50	uM	4.3
	729943	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CCN(C)CCO)cc3)c3ncnc(N)c23)c1		CHEMBL105436	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	736003	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CC(=O)NCCO)cc3)c3ncnc(N)c23)c1		CHEMBL175409	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	741245	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	COc1cccc(-c2cn(-c3ccc(CNCCO)cc3)c3ncnc(N)c23)c1		CHEMBL424375	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	742613	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1cccc(CO)c1		CHEMBL173478	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	746482	CHEMBL842141	Tested for inhibition of protein tyrosine kinase Csk phosphorylation in intact cells	B	Nc1ncnc2c1c(-c1ccccc1)cn2-c1ccccc1		CHEMBL169757	>	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	915760	CHEMBL661284	Inhibition of Csk tyrosine kinase at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	84.0	CHEMBL2634	Homo sapiens	Activity	%	84.0
	931221	CHEMBL661284	Inhibition of Csk tyrosine kinase at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	103.0	CHEMBL2634	Homo sapiens	Activity	%	103.0
	1144049	CHEMBL814630	Inhibition of Tyrosine-protein kinase CSK	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	=	IC50	nM	7300.0	CHEMBL2634	Homo sapiens	IC50	uM	7.3
	1152867	CHEMBL814631	Inhibition of Tyrosine-protein kinase CSK	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	IC50	nM	1700.0	CHEMBL2634	Homo sapiens	IC50	uM	1.7
	1173977	CHEMBL660534	Inhibition of Csk tyrosine kinase	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	=	Inhibition	%	87.0	CHEMBL2634	Homo sapiens	Inhibition	%	87.0
	1176721	CHEMBL814631	Inhibition of Tyrosine-protein kinase CSK	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	=	IC50	nM	2000.0	CHEMBL2634	Homo sapiens	IC50	uM	2.0
	1185357	CHEMBL661283	Inhibition of human Csk tyrosine kinase	B	CN1CCN([C@H]2CC[C@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL45177	=	IC50	nM	4270.0	CHEMBL2634	Homo sapiens	IC50	uM	4.27
	1213065	CHEMBL814626	Inhibition of human Tyrosine-protein kinase CSK	B	CN1CCN([C@H]2CC[C@@H](n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL47203	=	IC50	nM	41.0	CHEMBL2634	Homo sapiens	IC50	uM	0.041
Not Active	1650972	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL2634	Homo sapiens	Kd		
	1650973	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2300.0	CHEMBL2634	Homo sapiens	Kd	uM	2.3
Not Active	1650974	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650975	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650976	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650977	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650978	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650979	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1650980	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL2634	Homo sapiens	Kd		
	1651126	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	440.0	CHEMBL2634	Homo sapiens	Kd	uM	0.44
Not Active	1651127	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651128	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651129	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651130	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651131	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651132	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651133	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL2634	Homo sapiens	Kd		
Not Active	1651134	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL2634	Homo sapiens	Kd		
	1651135	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	3700.0	CHEMBL2634	Homo sapiens	Kd	uM	3.7
	1651136	CHEMBL860907	Average Binding Constant for CSK; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2900.0	CHEMBL2634	Homo sapiens	Kd	uM	2.9
Not Active	1658683	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12		CHEMBL188678		Activity			CHEMBL2634	Homo sapiens	Activity		
	1665753	CHEMBL860245	Inhibition of CSK at 10 uM	B	CN1C(=O)C(C(=O)Nc2nncs2)c2cc3occc3cc21		CHEMBL200906	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	Inhibition	%	5.0
	1678203	CHEMBL860873	Inhibitory activity against CSK	B	COc1cc2c(Nc3ncc(CC(=O)Nc4cccc(F)c4)s3)ncnc2cc1OCCCN1CCC(CO)CC1		CHEMBL201307	=	IC50	nM	21000.0	CHEMBL2634	Homo sapiens	IC50	uM	21.0
	1699559	CHEMBL860867	Inhibition of CSK at 10 uM in presence of 100 uM ATP	B	O=C(NC1CCOCC1)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202887	=	Inhibition	%	19.0	CHEMBL2634	Homo sapiens	Inhibition	%	19.0
Not Determined	1728711	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccco3)ccc12		CHEMBL196964		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728754	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(F)cc3)ccc12		CHEMBL197439		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728797	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccsc3)ccc12		CHEMBL196764		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728840	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3oc3ccccc34)ccc12		CHEMBL196759		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728883	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc4ccccc4s3)ccc12		CHEMBL381025		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728936	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Sc3ccccc3S4)ccc12		CHEMBL199216		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1728979	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc12		CHEMBL436767		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729022	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4ccccc34)ccc12		CHEMBL199050		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729065	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(/C=C/c3ccc(Cl)cc3)ccc12		CHEMBL199051		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729108	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4[nH]ccc4c3)ccc12		CHEMBL369969		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729151	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ncccc4c3)ccc12		CHEMBL198740		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729194	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3Oc3ccccc3S4)ccc12		CHEMBL197239		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729237	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	Nc1cc(C(=O)O)cc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL370108		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729280	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccc4c3sc3ccccc34)ccc12		CHEMBL198801		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729326	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1cccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c1		CHEMBL197219		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729369	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=C1c2ccccc2C(=O)N1Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)cc1		CHEMBL197227		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729412	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3cccs3)ccc12		CHEMBL371968		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729455	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc4ccccc4c3)ccc12		CHEMBL200299		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729498	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3csc4ccccc34)ccc12		CHEMBL199416		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729541	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	O=c1cc(N2CCOCC2)oc2cc(-c3ccc(OCc4ccccc4)cc3)ccc12		CHEMBL382501		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729599	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	Cc1ccc(-c2ccc3c(=O)cc(N4CCOCC4)oc3c2)c2ccccc12		CHEMBL200275		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Determined	1729642	CHEMBL860302	Inhibitory activity against CSK at 10 uM	B	COC(=O)/C=C/c1ccccc1-c1ccc2c(=O)cc(N3CCOCC3)oc2c1		CHEMBL199424		Activity			CHEMBL2634	Homo sapiens	Activity		
	1734197	CHEMBL862471	Residual activity at human CSK at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	103.0	CHEMBL2634	Homo sapiens	Activity	%	103.0
	1751457	CHEMBL869154	Inhibition of CSK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3Cl)cn12		CHEMBL215652	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751458	CHEMBL869154	Inhibition of CSK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751459	CHEMBL869154	Inhibition of CSK	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751460	CHEMBL869154	Inhibition of CSK	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751461	CHEMBL869154	Inhibition of CSK	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751462	CHEMBL869154	Inhibition of CSK	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1751642	CHEMBL869154	Inhibition of CSK	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	1769386	CHEMBL910906	Inhibition of CSK	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2634	Homo sapiens	IC50	uM	1.0
	1779354	CHEMBL854964	Inhibition of recombinant CSK by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	=	IC50	nM	270.0	CHEMBL2634	Homo sapiens	IC50	uM	0.27
	1779376	CHEMBL854964	Inhibition of recombinant CSK by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	840.0	CHEMBL2634	Homo sapiens	IC50	uM	0.84
	1790015	CHEMBL854683	Percentage activity of human CSK in the presence of 10uM of compound and 10uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	130.0	CHEMBL2634	Homo sapiens	Activity	%	130.0
	1790332	CHEMBL873771	Percent residual activity, relative to control, of CSK at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	70.0	CHEMBL2634	Homo sapiens	Activity	%	70.0
	1790386	CHEMBL873771	Percent residual activity, relative to control, of CSK at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	48.0	CHEMBL2634	Homo sapiens	Activity	%	48.0
	1790560	CHEMBL856417	Inhibition of human recombinant CSK	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Ki	nM	10000.0	CHEMBL2634	Homo sapiens	Ki	uM	10.0
	1796965	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccccc1I)C(=O)NO		CHEMBL376197	=	IC50	nM	3400.0	CHEMBL2634	Homo sapiens	IC50	uM	3.4
	1796991	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863	=	IC50	nM	9500.0	CHEMBL2634	Homo sapiens	IC50	uM	9.5
	1796992	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	NNC(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL220460	=	IC50	nM	75000.0	CHEMBL2634	Homo sapiens	IC50	uM	75.0
	1796993	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(O)cc1)C(=O)N(O)Cc1ccccc1	Outside typical range	CHEMBL373825	=	IC50	nM	291000.0	CHEMBL2634	Homo sapiens	IC50	uM	291.0
	1796994	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(O)cc1)C(=S)NO		CHEMBL425977	=	IC50	nM	2500.0	CHEMBL2634	Homo sapiens	IC50	uM	2.5
Not Active	1796995	CHEMBL913342	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2 upto 1000 uM	F	CN(O)C(=O)[C@@H](N)Cc1ccc(O)cc1		CHEMBL373848		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	1796996	CHEMBL913342	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2 upto 1000 uM	F	N[C@@H](Cc1ccc(O)cc1)C(=O)O		CHEMBL925		Activity			CHEMBL2634	Homo sapiens	Activity		
	1796997	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(I)cc1)C(=O)NO		CHEMBL219500	=	IC50	nM	3200.0	CHEMBL2634	Homo sapiens	IC50	uM	3.2
	1796998	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(Br)cc1)C(=O)NO		CHEMBL374719	=	IC50	nM	5600.0	CHEMBL2634	Homo sapiens	IC50	uM	5.6
	1796999	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(Cl)cc1)C(=O)NO		CHEMBL220070	=	IC50	nM	6300.0	CHEMBL2634	Homo sapiens	IC50	uM	6.3
	1797000	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(F)c(F)c1)C(=O)NO		CHEMBL373422	=	IC50	nM	18000.0	CHEMBL2634	Homo sapiens	IC50	uM	18.0
	1797001	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(F)cc1)C(=O)NO		CHEMBL385782	=	IC50	nM	11000.0	CHEMBL2634	Homo sapiens	IC50	uM	11.0
	1797002	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(-c2cccc([N+](=O)[O-])c2)cc1)C(=O)NO		CHEMBL219552	=	IC50	nM	6100.0	CHEMBL2634	Homo sapiens	IC50	uM	6.1
	1797003	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(-c2ccc([N+](=O)[O-])cc2)cc1)C(=O)NO		CHEMBL219449	=	IC50	nM	4900.0	CHEMBL2634	Homo sapiens	IC50	uM	4.9
	1797004	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(-c2ccccc2)cc1)C(=O)NO		CHEMBL218769	=	IC50	nM	12000.0	CHEMBL2634	Homo sapiens	IC50	uM	12.0
	1797005	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	CC(C)c1ccc(C[C@H](N)C(=O)NO)cc1		CHEMBL218768	=	IC50	nM	3300.0	CHEMBL2634	Homo sapiens	IC50	uM	3.3
	1797006	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	Cc1ccc(C[C@H](N)C(=O)NO)cc1		CHEMBL218767	=	IC50	nM	9500.0	CHEMBL2634	Homo sapiens	IC50	uM	9.5
	1797007	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccccc1)C(=O)NO		CHEMBL219117	=	IC50	nM	15500.0	CHEMBL2634	Homo sapiens	IC50	uM	15.5
	1797008	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NO		CHEMBL220193	=	IC50	nM	7000.0	CHEMBL2634	Homo sapiens	IC50	uM	7.0
	1797009	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1ccc(B(O)O)cc1)C(=O)NO		CHEMBL219473	=	IC50	nM	34000.0	CHEMBL2634	Homo sapiens	IC50	uM	34.0
	1797010	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	[N-]=[N+]=Nc1ccc(C[C@H](N)C(=O)NO)cc1		CHEMBL219199	=	IC50	nM	21000.0	CHEMBL2634	Homo sapiens	IC50	uM	21.0
	1797011	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N#Cc1ccc(C[C@H](N)C(=O)NO)cc1		CHEMBL555149	=	IC50	nM	28000.0	CHEMBL2634	Homo sapiens	IC50	uM	28.0
	1797012	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	Nc1ccc(C[C@H](N)C(=O)NO)cc1		CHEMBL219917	=	IC50	nM	47000.0	CHEMBL2634	Homo sapiens	IC50	uM	47.0
	1797014	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](CCc1ccc(O)cc1)C(=O)NO		CHEMBL376727	=	IC50	nM	18000.0	CHEMBL2634	Homo sapiens	IC50	uM	18.0
	1797015	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@H](C(=O)NO)c1ccc(O)cc1		CHEMBL220129	=	IC50	nM	57000.0	CHEMBL2634	Homo sapiens	IC50	uM	57.0
	1797016	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	N[C@@H](Cc1cc(I)c(O)c(I)c1)C(=O)NO		CHEMBL220044	=	IC50	nM	3400.0	CHEMBL2634	Homo sapiens	IC50	uM	3.4
	1797017	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	O=C(NO)[C@H](Cc1ccc(O)cc1)c1ccccc1	Outside typical range	CHEMBL218593	=	IC50	nM	290000.0	CHEMBL2634	Homo sapiens	IC50	uM	290.0
	1797018	CHEMBL913341	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2	F	O=C(NO)[C@H](Cc1ccc(O)cc1)NCc1ccccc1		CHEMBL220181	=	IC50	nM	29000.0	CHEMBL2634	Homo sapiens	IC50	uM	29.0
Not Active	1797019	CHEMBL913342	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2 upto 1000 uM	F	O=C(NO)[C@@H](O)Cc1ccc(O)cc1		CHEMBL218648		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	1797020	CHEMBL913342	Inhibition of CSK measured as poly-E4Y phosphorylation by acid precipitation assay in presence of 0.2 mM CoCl2 upto 1000 uM	F	O=C(CCc1ccc(O)cc1)NO		CHEMBL216542		Activity			CHEMBL2634	Homo sapiens	Activity		
	1797021	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	N[C@@H](Cc1cnc[nH]1)C(=O)NO		CHEMBL386198	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797022	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	NCC(=O)NO		CHEMBL216796	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797023	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	CNC(=O)C(N)Cc1ccccc1		CHEMBL216722	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797024	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	N[C@@H](CCC(=O)NO)C(=O)O		CHEMBL63893	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797025	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	NC(CC(=O)NO)C(=O)O		CHEMBL216856	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797026	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	CCCC(N)C(=O)NO		CHEMBL217927	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797027	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	NCCC(=O)NO		CHEMBL218945	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797028	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	CC(C)C[C@H](N)C(=O)NO		CHEMBL303296	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	Inhibition	%	4.0
	1797029	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	NCCCC[C@H](N)C(=O)NO		CHEMBL218019	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	Inhibition	%	3.0
	1797030	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	N=C(N)NCCC[C@H](N)C(=O)NO		CHEMBL376027	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797031	CHEMBL913332	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797032	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	N[C@@H](Cc1cnc[nH]1)C(=O)NO		CHEMBL386198	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	Inhibition	%	2.0
	1797033	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	NCC(=O)NO		CHEMBL216796	=	Inhibition	%	45.0	CHEMBL2634	Homo sapiens	Inhibition	%	45.0
	1797034	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	CNC(=O)C(N)Cc1ccccc1		CHEMBL216722	=	Inhibition	%	77.0	CHEMBL2634	Homo sapiens	Inhibition	%	77.0
	1797035	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	CCCC(N)C(=O)NO		CHEMBL217927	=	Inhibition	%	40.0	CHEMBL2634	Homo sapiens	Inhibition	%	40.0
	1797036	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	NCCC(=O)NO		CHEMBL218945	=	Inhibition	%	7.0	CHEMBL2634	Homo sapiens	Inhibition	%	7.0
	1797037	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	CC(C)C[C@H](N)C(=O)NO		CHEMBL303296	=	Inhibition	%	62.0	CHEMBL2634	Homo sapiens	Inhibition	%	62.0
	1797038	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	NCCCC[C@H](N)C(=O)NO		CHEMBL218019	=	Inhibition	%	26.0	CHEMBL2634	Homo sapiens	Inhibition	%	26.0
	1797039	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	N=C(N)NCCC[C@H](N)C(=O)NO		CHEMBL376027	=	Inhibition	%	36.0	CHEMBL2634	Homo sapiens	Inhibition	%	36.0
	1797040	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863	=	Inhibition	%	83.0	CHEMBL2634	Homo sapiens	Inhibition	%	83.0
	1797041	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	NC(CC(=O)NO)C(=O)O		CHEMBL216856	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797042	CHEMBL913333	Inhibition of CSK at 25 uM in presence of 12 mM MgCl2 and 0.2 mM CoCl2	B	N[C@@H](CCC(=O)NO)C(=O)O		CHEMBL63893	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	Inhibition	%	0.0
	1797043	CHEMBL913338	Inhibition of CSK at 25 uM in presence of 2 mM MnCl2 and 0.2 mM CoCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863	=	Inhibition	%	13.0	CHEMBL2634	Homo sapiens	Inhibition	%	13.0
Not Active	1797044	CHEMBL913335	Inhibition of CSK at 25 mM in presence of 12 mM MgCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	1797045	CHEMBL913336	Inhibition of CSK at 25 mM in presence of 12 mM MgCl2 and 2 mM MnCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	1797046	CHEMBL913337	Inhibition of CSK at 25 mM in presence of 2 mM MnCl2	B	N[C@@H](Cc1ccc(O)cc1)C(=O)NO		CHEMBL217863		Activity			CHEMBL2634	Homo sapiens	Activity		
	1807181	CHEMBL908998	Inhibition of CSK	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	659.0	CHEMBL2634	Homo sapiens	IC50	uM	0.659
	1815210	CHEMBL908519	Inhibition of CSK	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	25000.0	CHEMBL2634	Homo sapiens	IC50	nM	25000.0
	1815346	CHEMBL910179	Inhibition of CSK	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	1800.0	CHEMBL2634	Homo sapiens	IC50	nM	1800.0
	1837968	CHEMBL920479	Inhibition of CSK at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	101.0	CHEMBL2634	Homo sapiens	Inhibition	%	101.0
	1981757	CHEMBL899273	Inhibition of CSK assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	97.0	CHEMBL2634	Homo sapiens	Activity	%	97.0
	1981758	CHEMBL899274	Inhibition of CSK assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	2000771	CHEMBL900480	Inhibition of CSK at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	95.2	CHEMBL2634	Homo sapiens	Inhibition	%	95.2
	2000790	CHEMBL900480	Inhibition of CSK at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	89.3	CHEMBL2634	Homo sapiens	Inhibition	%	89.3
	2025134	CHEMBL886961	Inhibition of human CSK at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	133.0	CHEMBL2634	Homo sapiens	Inhibition	%	133.0
	2025294	CHEMBL886961	Inhibition of human CSK at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	95.0	CHEMBL2634	Homo sapiens	Inhibition	%	95.0
	2025295	CHEMBL886961	Inhibition of human CSK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	129.0	CHEMBL2634	Homo sapiens	Inhibition	%	129.0
	2025296	CHEMBL886961	Inhibition of human CSK at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	125.0	CHEMBL2634	Homo sapiens	Inhibition	%	125.0
	2081783	CHEMBL928806	Inhibition of Csk at 10 uM	B	CC[C@@H](C)Nc1nc2ccc(-c3c(-c4ccccc4F)n[nH]c3N)cc2s1		CHEMBL404115	<=	Inhibition	%	20.0	CHEMBL2634	Homo sapiens	Inhibition	%	20.0
	2099532	CHEMBL949204	Inhibition of CSK at 10 uM	B	CN(C)CCCOc1cc2c(cc1O)c1c3c(c(-c4ccccc4Cl)cc1n2C)C(=O)NC3=O		CHEMBL410261	=	Inhibition	%	43.0	CHEMBL2634	Homo sapiens	Inhibition	%	43.0
	2099656	CHEMBL949204	Inhibition of CSK at 10 uM	B	Cn1c2cc(C(=O)NCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL272267	=	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	Inhibition	%	50.0
	2099657	CHEMBL949204	Inhibition of CSK at 10 uM	B	Cn1c2cc(SCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL404335	=	Inhibition	%	71.0	CHEMBL2634	Homo sapiens	Inhibition	%	71.0
	2099658	CHEMBL949204	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCOCC3)cc2n1CCO		CHEMBL271715	=	Inhibition	%	33.0	CHEMBL2634	Homo sapiens	Inhibition	%	33.0
	2099659	CHEMBL949204	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)c(OCCCN3CCCC3)cc2n1CCO		CHEMBL270021	=	Inhibition	%	39.0	CHEMBL2634	Homo sapiens	Inhibition	%	39.0
	2099660	CHEMBL949204	Inhibition of CSK at 10 uM	B	Cn1c2cc(OCCCN3CCCC3)c(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL255427	=	Inhibition	%	39.0	CHEMBL2634	Homo sapiens	Inhibition	%	39.0
	2137260	CHEMBL937047	Inhibition of cSrc	B	CCN(CC)CCCCNc1ncc2cc(-c3cc(OC)cc(OC)c3)c(NC(=O)NC(C)(C)C)nc2n1		CHEMBL189584	=	IC50	nM	19800.0	CHEMBL2634	Homo sapiens	IC50	nM	19800.0
	2147231	CHEMBL922806	Activity of human CSK kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	105.0	CHEMBL2634	Homo sapiens	Activity	%	105.0
	2167619	CHEMBL932339	Inhibition of CSK	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	10700.0	CHEMBL2634	Homo sapiens	IC50	uM	10.7
	2206876	CHEMBL990550	Inhibition of Csk	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	840.0	CHEMBL2634	Homo sapiens	IC50	nM	840.0
	2239729	CHEMBL996958	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCc1nnn[nH]1		CHEMBL471329	=	Inhibition	%	45.0	CHEMBL2634	Homo sapiens	INH	%	45.0
	2239757	CHEMBL996958	Inhibition of CSK at 10 uM	B	CS(=O)(=O)NC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL460940	=	Inhibition	%	60.0	CHEMBL2634	Homo sapiens	INH	%	60.0
	2239785	CHEMBL996958	Inhibition of CSK at 10 uM	B	CN(C)CCNC(=O)CCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL462011	=	Inhibition	%	92.0	CHEMBL2634	Homo sapiens	INH	%	92.0
	2239813	CHEMBL996958	Inhibition of CSK at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4Cl)cc21)C(=O)NC3=O		CHEMBL508541	=	Inhibition	%	52.0	CHEMBL2634	Homo sapiens	INH	%	52.0
	2239841	CHEMBL996958	Inhibition of CSK at 10 uM	B	CNCCCn1c2ccc(O)cc2c2c3c(c(-c4ccccc4)cc21)C(=O)NC3=O		CHEMBL455192	=	Inhibition	%	82.0	CHEMBL2634	Homo sapiens	INH	%	82.0
	2239869	CHEMBL996958	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1c(Cl)cccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL471163	=	Inhibition	%	12.0	CHEMBL2634	Homo sapiens	INH	%	12.0
	2239896	CHEMBL996958	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1c2c2cc(O)ccc2n1CCCO		CHEMBL411662	=	Inhibition	%	28.0	CHEMBL2634	Homo sapiens	INH	%	28.0
	2239924	CHEMBL996958	Inhibition of CSK at 10 uM	B	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	=	Inhibition	%	33.0	CHEMBL2634	Homo sapiens	INH	%	33.0
	2279719	CHEMBL960133	Inhibition of CSK at 10 uM	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
Not Active	2298977	CHEMBL1020731	Inhibition of human CSK at 10 umol/L	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	2302169	CHEMBL950838	Inhibition of CSK at 10 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	2418046	CHEMBL1019610	Inhibition of CSK at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	2449126	CHEMBL985579	Inhibition of CSK	B	COc1ccc2c(Oc3ccc(NC(=O)c4c(C)n(CC(C)(C)O)n(-c5ccccc5)c4=O)nc3)ccnc2c1		CHEMBL460472	=	IC50	nM	165.0	CHEMBL2634	Homo sapiens	IC50	nM	165.0
	2470135	CHEMBL1033255	Inhibition of CSK at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2634	Homo sapiens	INH	%	10.0
	2476617	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	8.0	CHEMBL2634	Homo sapiens	Activity	%	8.0
Not Evaluated	2476820	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2478659	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2478862	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL2634	Homo sapiens	Activity		
	2479536	CHEMBL988930	Binding affinity to human CSK	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Kd	nM	28.0	CHEMBL2634	Homo sapiens	Kd	nM	28.0
Not Evaluated	2479717	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL2634	Homo sapiens	Activity		
Active	2480716	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL2634	Homo sapiens	Activity		
	2482697	CHEMBL987148	Inhibition of CSK	B	Nc1ccc(N)c2c1C(=O)c1ccccc1C2=O		CHEMBL86771	>	IC50	nM	40000.0	CHEMBL2634	Homo sapiens	IC50	uM	40.0
	2506941	CHEMBL942610	Inhibition of CSK at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	2506942	CHEMBL942610	Inhibition of CSK at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	2507165	CHEMBL947783	Inhibition of Csk	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	>	IC50	nM	30000.0	CHEMBL2634	Homo sapiens	IC50	uM	30.0
	2511958	CHEMBL969672	Inhibition of human CSK at 1 uM assessed as residual enzyme activity	B	O=C(Nc1ccccc1Cl)c1ccc(Nc2nc(Nc3ccc(O)cc3)ncc2F)cc1		CHEMBL521949	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	2527194	CHEMBL984175	Inhibition of CSK at 3 uM	B	COc1c(NC(=O)Nc2ccc(-c3ccc(CN4CCOCC4)nc3)c3ccccc23)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL451523	=	Inhibition	%	62.0	CHEMBL2634	Homo sapiens	INH	%	62.0
Not Evaluated	2577338	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2577541	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL2634	Homo sapiens	Activity		
	2583231	CHEMBL1009269	Inhibition of Csk	B	CNC(=O)c1ccc(Nc2nccc(-c3cnc(C)n3C(C)C)n2)cc1F		CHEMBL455428	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
Not Evaluated	2593543	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL2634	Homo sapiens	Activity		
Active	2593746	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL2634	Homo sapiens	Activity		
	2594012	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.2	CHEMBL2634	Homo sapiens	Activity	%	0.2
Not Evaluated	2594955	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2595158	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL2634	Homo sapiens	Activity		
	2595224	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	30.0	CHEMBL2634	Homo sapiens	Activity	%	30.0
Not Evaluated	2596355	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2597624	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Evaluated	2597827	CHEMBL1035881	Binding affinity to human CSK at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL2634	Homo sapiens	Activity		
	2613345	CHEMBL1015231	Inhibition of CSK	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	2626895	CHEMBL999779	Binding affinity to human CSK at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(Nc3ncnc4ccc(N)cc34)cc2)c1		CHEMBL497033	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	2626922	CHEMBL999779	Binding affinity to human CSK at 5 uM	B	Cc1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc(Nc3ncnc4ccc(N)cc34)c2)c1		CHEMBL497615	=	Activity	%	21.0	CHEMBL2634	Homo sapiens	Activity	%	21.0
	2635927	CHEMBL1000661	Inhibition of CSK at 1 uM relative to control	B	CSc1cc(Oc2ccnc3[nH]c(=O)[nH]c23)ccc1NC(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL496009	<	Residual_activity	%	25.0	CHEMBL2634	Homo sapiens	Residual_activity	%	25.0
	2635995	CHEMBL1000661	Inhibition of CSK at 1 uM relative to control	B	O=C(Nc1cc(C(F)(F)F)ccc1F)Nc1ccc(Oc2ccnc3[nH]c(=O)[nH]c23)c2ccccc12		CHEMBL498112	<	Residual_activity	%	25.0	CHEMBL2634	Homo sapiens	Residual_activity	%	25.0
	2636063	CHEMBL1000661	Inhibition of CSK at 1 uM relative to control	B	CC(C)(C)c1cccc(NC(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c3ccccc23)c1		CHEMBL496073	=	Residual_activity	%	50.0	CHEMBL2634	Homo sapiens	Residual_activity	%	50.0
	2721582	CHEMBL1060990	Inhibition of CSK at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	2892233	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892234	CHEMBL1037547	Binding constant for full-length CSK	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892235	CHEMBL1037547	Binding constant for full-length CSK	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2300.0	CHEMBL2634	Homo sapiens	Kd	nM	2300.0
	2892236	CHEMBL1037547	Binding constant for full-length CSK	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892237	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892238	CHEMBL1037547	Binding constant for full-length CSK	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892239	CHEMBL1037547	Binding constant for full-length CSK	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892240	CHEMBL1037547	Binding constant for full-length CSK	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892241	CHEMBL1037547	Binding constant for full-length CSK	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	6100.0	CHEMBL2634	Homo sapiens	Kd	nM	6100.0
	2892242	CHEMBL1037547	Binding constant for full-length CSK	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892243	CHEMBL1037547	Binding constant for full-length CSK	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892244	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1.0	CHEMBL2634	Homo sapiens	Kd	nM	1.0
	2892245	CHEMBL1037547	Binding constant for full-length CSK	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	3400.0	CHEMBL2634	Homo sapiens	Kd	nM	3400.0
	2892246	CHEMBL1037547	Binding constant for full-length CSK	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892247	CHEMBL1037547	Binding constant for full-length CSK	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892248	CHEMBL1037547	Binding constant for full-length CSK	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892249	CHEMBL1037547	Binding constant for full-length CSK	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892250	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892251	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892252	CHEMBL1037547	Binding constant for full-length CSK	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892253	CHEMBL1037547	Binding constant for full-length CSK	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892254	CHEMBL1037547	Binding constant for full-length CSK	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892255	CHEMBL1037547	Binding constant for full-length CSK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892256	CHEMBL1037547	Binding constant for full-length CSK	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	9000.0	CHEMBL2634	Homo sapiens	Kd	nM	9000.0
	2892257	CHEMBL1037547	Binding constant for full-length CSK	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892258	CHEMBL1037547	Binding constant for full-length CSK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	8700.0	CHEMBL2634	Homo sapiens	Kd	nM	8700.0
	2892259	CHEMBL1037547	Binding constant for full-length CSK	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892260	CHEMBL1037547	Binding constant for full-length CSK	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892261	CHEMBL1037547	Binding constant for full-length CSK	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892262	CHEMBL1037547	Binding constant for full-length CSK	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892263	CHEMBL1037547	Binding constant for full-length CSK	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892264	CHEMBL1037547	Binding constant for full-length CSK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892265	CHEMBL1037547	Binding constant for full-length CSK	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	330.0	CHEMBL2634	Homo sapiens	Kd	nM	330.0
	2892266	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892267	CHEMBL1037547	Binding constant for full-length CSK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892268	CHEMBL1037547	Binding constant for full-length CSK	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4800.0	CHEMBL2634	Homo sapiens	Kd	nM	4800.0
	2892269	CHEMBL1037547	Binding constant for full-length CSK	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	2892270	CHEMBL1037547	Binding constant for full-length CSK	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2500.0	CHEMBL2634	Homo sapiens	Kd	nM	2500.0
	2897228	CHEMBL1061124	Percent residual CSK activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2897229	CHEMBL1061124	Percent residual CSK activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	2897230	CHEMBL1061124	Percent residual CSK activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	109.0	CHEMBL2634	Homo sapiens	Activity	%	109.0
Antagonist	2897288	CHEMBL1061991	Inhibition of CSK in the presence of 20uM ATP	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	IC50	nM	1970.0	CHEMBL2634	Homo sapiens	IC50	uM	1.97
Antagonist	2897289	CHEMBL1061991	Inhibition of CSK in the presence of 20uM ATP	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	IC50	nM	510.0	CHEMBL2634	Homo sapiens	IC50	uM	0.51
Antagonist	2897290	CHEMBL1061991	Inhibition of CSK in the presence of 20uM ATP	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	IC50	nM	640.0	CHEMBL2634	Homo sapiens	IC50	uM	0.64
	2900775	CHEMBL1062801	Percentage CSK activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	114.0	CHEMBL2634	Homo sapiens	Activity	%	114.0
	2900776	CHEMBL1062801	Percentage CSK activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	99.0	CHEMBL2634	Homo sapiens	Activity	%	99.0
	2900777	CHEMBL1062801	Percentage CSK activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	80.0	CHEMBL2634	Homo sapiens	Activity	%	80.0
	2900778	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	99.0	CHEMBL2634	Homo sapiens	Activity	%	99.0
	2900779	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	101.0	CHEMBL2634	Homo sapiens	Activity	%	101.0
	2900780	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	93.0	CHEMBL2634	Homo sapiens	Activity	%	93.0
	2900781	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2900782	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	2900783	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	75.0	CHEMBL2634	Homo sapiens	Activity	%	75.0
	2900784	CHEMBL1063742	Percentage CSK activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	78.0	CHEMBL2634	Homo sapiens	Activity	%	78.0
	2900785	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	2900786	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	117.0	CHEMBL2634	Homo sapiens	Activity	%	117.0
	2900787	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2900788	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	67.0	CHEMBL2634	Homo sapiens	Activity	%	67.0
	2900789	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	2900790	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	80.0	CHEMBL2634	Homo sapiens	Activity	%	80.0
	2900791	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	104.0	CHEMBL2634	Homo sapiens	Activity	%	104.0
	2900792	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	2900793	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	87.0	CHEMBL2634	Homo sapiens	Activity	%	87.0
	2900794	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	85.0	CHEMBL2634	Homo sapiens	Activity	%	85.0
	2900795	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	89.0	CHEMBL2634	Homo sapiens	Activity	%	89.0
	2900796	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	76.0	CHEMBL2634	Homo sapiens	Activity	%	76.0
	2900797	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	72.0	CHEMBL2634	Homo sapiens	Activity	%	72.0
	2900798	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	70.0	CHEMBL2634	Homo sapiens	Activity	%	70.0
	2900799	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
Antagonist	2900800	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	6.0	CHEMBL2634	Homo sapiens	Activity	%	6.0
Antagonist	2900801	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	6.0	CHEMBL2634	Homo sapiens	Activity	%	6.0
	2900802	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	68.0	CHEMBL2634	Homo sapiens	Activity	%	68.0
	2900803	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	63.0	CHEMBL2634	Homo sapiens	Activity	%	63.0
	2900804	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	105.0	CHEMBL2634	Homo sapiens	Activity	%	105.0
	2900805	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	83.0	CHEMBL2634	Homo sapiens	Activity	%	83.0
	2900806	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2900807	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	88.0	CHEMBL2634	Homo sapiens	Activity	%	88.0
	2900808	CHEMBL1062002	Percentage CSK activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	103.0	CHEMBL2634	Homo sapiens	Activity	%	103.0
	2900809	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	70.0	CHEMBL2634	Homo sapiens	Activity	%	70.0
	2900810	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	66.0	CHEMBL2634	Homo sapiens	Activity	%	66.0
	2900811	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2900812	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	93.0	CHEMBL2634	Homo sapiens	Activity	%	93.0
	2900813	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	71.0	CHEMBL2634	Homo sapiens	Activity	%	71.0
	2900814	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	93.0	CHEMBL2634	Homo sapiens	Activity	%	93.0
	2900815	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	67.0	CHEMBL2634	Homo sapiens	Activity	%	67.0
	2900816	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	69.0	CHEMBL2634	Homo sapiens	Activity	%	69.0
	2900817	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	70.0	CHEMBL2634	Homo sapiens	Activity	%	70.0
	2900818	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	73.0	CHEMBL2634	Homo sapiens	Activity	%	73.0
	2900819	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	88.0	CHEMBL2634	Homo sapiens	Activity	%	88.0
	2900820	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	83.0	CHEMBL2634	Homo sapiens	Activity	%	83.0
	2900821	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	2900822	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	2900823	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	65.0	CHEMBL2634	Homo sapiens	Activity	%	65.0
	2900824	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	98.0	CHEMBL2634	Homo sapiens	Activity	%	98.0
	2900825	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	86.0	CHEMBL2634	Homo sapiens	Activity	%	86.0
	2900826	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	84.0	CHEMBL2634	Homo sapiens	Activity	%	84.0
	2900827	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	2900828	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	2900829	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	92.0	CHEMBL2634	Homo sapiens	Activity	%	92.0
	2900830	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	89.0	CHEMBL2634	Homo sapiens	Activity	%	89.0
	2900831	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	86.0	CHEMBL2634	Homo sapiens	Activity	%	86.0
	2900832	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	69.0	CHEMBL2634	Homo sapiens	Activity	%	69.0
Antagonist	2900833	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	32.0	CHEMBL2634	Homo sapiens	Activity	%	32.0
Antagonist	2900834	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	26.0	CHEMBL2634	Homo sapiens	Activity	%	26.0
Antagonist	2900835	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	36.0	CHEMBL2634	Homo sapiens	Activity	%	36.0
	2900836	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	83.0	CHEMBL2634	Homo sapiens	Activity	%	83.0
	2900837	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	85.0	CHEMBL2634	Homo sapiens	Activity	%	85.0
	2900838	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	94.0	CHEMBL2634	Homo sapiens	Activity	%	94.0
Antagonist	2900839	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	12.0	CHEMBL2634	Homo sapiens	Activity	%	12.0
	2900840	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	87.0	CHEMBL2634	Homo sapiens	Activity	%	87.0
Antagonist	2900841	CHEMBL1061954	Percentage CSK activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	39.0	CHEMBL2634	Homo sapiens	Activity	%	39.0
	2900842	CHEMBL1062003	Percentage CSK activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	2900843	CHEMBL1062003	Percentage CSK activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	79.0	CHEMBL2634	Homo sapiens	Activity	%	79.0
	2900844	CHEMBL1062004	Percentage CSK activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	88.0	CHEMBL2634	Homo sapiens	Activity	%	88.0
	2900845	CHEMBL1051375	Percentage CSK activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	55.0	CHEMBL2634	Homo sapiens	Activity	%	55.0
	2921393	CHEMBL1052899	Inhibition of CSK assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	2926249	CHEMBL1056922	Inhibition of CSK assessed as remaining enzyme activity at 3 uM relative to DMSO	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	Activity	%	72.0	CHEMBL2634	Homo sapiens	Activity	%	72.0
	2926651	CHEMBL1051390	Inhibition of CSK assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	72.0	CHEMBL2634	Homo sapiens	Activity	%	72.0
	2926652	CHEMBL1051390	Inhibition of CSK assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	98.0	CHEMBL2634	Homo sapiens	Activity	%	98.0
	2926653	CHEMBL1051390	Inhibition of CSK assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	87.0	CHEMBL2634	Homo sapiens	Activity	%	87.0
	2926654	CHEMBL1051390	Inhibition of CSK assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	74.0	CHEMBL2634	Homo sapiens	Activity	%	74.0
	2928435	CHEMBL1055346	Inhibition of CSK assessed as remaining enzyme activity at 1 uM relative to DMSO	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	31.0	CHEMBL2634	Homo sapiens	Activity	%	31.0
	2938516	CHEMBL1041349	Inhibition of CSK at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	2938517	CHEMBL1041348	Inhibition of CSK at 2 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	2944866	CHEMBL1049989	Inhibition of CSK at 2 uM	B	c1cncc(CN2CCC(n3ncc4c(N5CCOCC5)nc(-c5ccc6[nH]ccc6c5)nc43)CC2)c1		CHEMBL583194	=	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	2946933	CHEMBL1054421	Inhibition of CSK at 2 uM	B	c1ccc2c(c1)CC(Nc1nc(Nc3ccncc3)nc(N3CCNCC3)n1)C2		CHEMBL575741	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	2999047	CHEMBL1044623	Inhibition of CSK assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1onc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL220227	=	Activity	%	87.0	CHEMBL2634	Homo sapiens	Activity	%	87.0
	2999837	CHEMBL1044623	Inhibition of CSK assessed as residual activity at 10 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	CC(C)c1noc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL375428	=	Activity	%	95.0	CHEMBL2634	Homo sapiens	Activity	%	95.0
	2999908	CHEMBL1050750	Inhibition of CSK assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c(SC)nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL569114	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	2999984	CHEMBL1050750	Inhibition of CSK assessed as residual activity at 0.1 uM by Cherenkov counting relative to control in presence of 20 uM ATP	B	COc1ccc(/C=C/C(=O)Nc2cc(-c3[nH]c([S+](C)[O-])nc3-c3ccc(F)cc3)ccn2)c(OC)c1		CHEMBL572006	=	Activity	%	79.0	CHEMBL2634	Homo sapiens	Activity	%	79.0
Not Active	3005056	CHEMBL1047315	Inhibition of CSK at 10 uM	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	3005057	CHEMBL1047315	Inhibition of CSK at 10 uM	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	3005058	CHEMBL1047315	Inhibition of CSK at 10 uM	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887		Activity			CHEMBL2634	Homo sapiens	Activity		
Not Active	3005059	CHEMBL1047315	Inhibition of CSK at 10 uM	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989		Activity			CHEMBL2634	Homo sapiens	Activity		
	3052575	CHEMBL1037116	Residual activity of CSK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	76.0	CHEMBL2634	Homo sapiens	Residual activity	%	76.0
	3053884	CHEMBL1044284	Residual activity of CSK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	3.0	CHEMBL2634	Homo sapiens	Residual activity	%	3.0
	3054136	CHEMBL1040240	Residual activity of CSK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	120.0	CHEMBL2634	Homo sapiens	Residual activity	%	120.0
	3055423	CHEMBL1037116	Residual activity of CSK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	82.0	CHEMBL2634	Homo sapiens	Residual activity	%	82.0
	3055675	CHEMBL1044284	Residual activity of CSK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	18.0	CHEMBL2634	Homo sapiens	Residual activity	%	18.0
	3056980	CHEMBL1040240	Residual activity of CSK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	111.0	CHEMBL2634	Homo sapiens	Residual activity	%	111.0
	3058300	CHEMBL1037116	Residual activity of CSK at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	97.0	CHEMBL2634	Homo sapiens	Residual activity	%	97.0
	3058552	CHEMBL1044284	Residual activity of CSK at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	17.0	CHEMBL2634	Homo sapiens	Residual activity	%	17.0
	3072898	CHEMBL1040240	Residual activity of CSK at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	104.0	CHEMBL2634	Homo sapiens	Residual activity	%	104.0
	3088554	CHEMBL1049479	Inhibition of Csk	B	CN(C)CCOc1ccc2c(c1)CCn1nc(-c3ccc(Oc4ccccc4)cc3)c(C(N)=O)c1N2		CHEMBL591325	=	IC50	nM	1.7	CHEMBL2634	Homo sapiens	IC50	nM	1.7
	3088618	CHEMBL1049492	Inhibition of Csk	B	NC(=O)c1c(-c2ccc(Oc3ccccc3)cc2)[nH]c(C(=O)c2c(F)cccc2F)c1N		CHEMBL589630	=	IC50	nM	4.5	CHEMBL2634	Homo sapiens	IC50	nM	4.5
	3130824	CHEMBL1066179	Inhibition of CSK at 3 to 6 uM relative to control	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3131750	CHEMBL1065755	Inhibition of CSK at 3 uM relative to control	B	NC(=O)c1ccc(NC(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1		CHEMBL600852	>	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3213787	CHEMBL1107591	Inhibition of CSK at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	98.0	CHEMBL2634	Homo sapiens	INH	%	98.0
	3224785	CHEMBL1102779	Inhibition of CSK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3225035	CHEMBL1102779	Inhibition of CSK at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3260071	CHEMBL1104320	Inhibition of CSK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2nccc(Nc3cccc(Br)c3)c2c1		CHEMBL1089524	=	Activity	%	73.0	CHEMBL2634	Homo sapiens	Activity	%	73.0
	3261402	CHEMBL1104320	Inhibition of CSK at 10 uM assessed as residual activity by [33P]ATP radioactive filter binding assay relative to control	B	CN(C)CCCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL1088901	=	Activity	%	63.0	CHEMBL2634	Homo sapiens	Activity	%	63.0
	3306927	CHEMBL1117952	Inhibition of CSK at 3 uM	B	O=C(Nc1cc2cc[nH]c(=O)c2cc1Cl)C(NC1CC1)c1ccccc1		CHEMBL1084106	=	Inhibition	%	94.0	CHEMBL2634	Homo sapiens	INH	%	94.0
	3316529	CHEMBL1117893	Inhibition of CSK	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	IC50	nM	840.0	CHEMBL2634	Homo sapiens	IC50	nM	840.0
	3331878	CHEMBL1168837	Inhibition of CSK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3333293	CHEMBL1168837	Inhibition of CSK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3334698	CHEMBL1168837	Inhibition of CSK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3336118	CHEMBL1168837	Inhibition of CSK at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3337485	CHEMBL1168837	Inhibition of CSK at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3337733	CHEMBL1168837	Inhibition of CSK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3339065	CHEMBL1168837	Inhibition of CSK at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3340367	CHEMBL1168837	Inhibition of CSK at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3340646	CHEMBL1168837	Inhibition of CSK at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3342062	CHEMBL1168837	Inhibition of CSK at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	3357889	CHEMBL1175455	Inhibition of CSK at 10 uM	B	NC(=O)c1c(Br)n(O[C@H]2O[C@@H](CO)[C@@H](O)[C@@H]2O)c2ncncc12		CHEMBL1170818	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	3358510	CHEMBL1174182	Inhibition of CSK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.15	CHEMBL2634	Homo sapiens	INH	%	0.15
	3358952	CHEMBL1174182	Inhibition of CSK at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.1	CHEMBL2634	Homo sapiens	INH	%	0.1
	3400014	CHEMBL1217211	Inhibition of human CSK at 10 uM	B	Cc1ccc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc2C)C3)cn1		CHEMBL1214141	=	Inhibition	%	100.0	CHEMBL2634	Homo sapiens	INH	%	100.0
	3419121	CHEMBL1228789	Inhibition of CSK at 100 uM relative to control	B	NC(=O)c1sc2c([N+](=O)[O-])cc(C(F)(F)F)cc2[n+]1[O-]		CHEMBL476124	=	Inhibition	%	45.0	CHEMBL2634	Homo sapiens	INH	%	45.0
	3443364	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	75.0	CHEMBL2634	Homo sapiens	INH	%	75.0
	3443581	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	39.0	CHEMBL2634	Homo sapiens	INH	%	39.0
	3444736	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	32.0	CHEMBL2634	Homo sapiens	INH	%	32.0
	3445072	CHEMBL1244775	Binding affinity to CSK	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	260.0	CHEMBL2634	Homo sapiens	Kd	nM	260.0
	3445360	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	29.0	CHEMBL2634	Homo sapiens	INH	%	29.0
	3445577	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	16.0	CHEMBL2634	Homo sapiens	INH	%	16.0
	3445789	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	68.0	CHEMBL2634	Homo sapiens	INH	%	68.0
	3445979	CHEMBL1244397	Inhibition of CSK at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	34.0	CHEMBL2634	Homo sapiens	INH	%	34.0
	3446202	CHEMBL1244342	Inhibition of CSK	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	63.0	CHEMBL2634	Homo sapiens	IC50	nM	63.0
	3447998	CHEMBL1249774	Inhibition of human CSK activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	3448074	CHEMBL1249774	Inhibition of human CSK activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	INH	%	2.0
	3448383	CHEMBL1244775	Binding affinity to CSK	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	3448900	CHEMBL1244775	Binding affinity to CSK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	8700.0	CHEMBL2634	Homo sapiens	Kd	nM	8700.0
	3449535	CHEMBL1244775	Binding affinity to CSK	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	2900.0	CHEMBL2634	Homo sapiens	Kd	nM	2900.0
	3449610	CHEMBL1244775	Binding affinity to CSK	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	3450310	CHEMBL1244775	Binding affinity to CSK	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	3450951	CHEMBL1244775	Binding affinity to CSK	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	uM	10.0
	3463197	CHEMBL1252285	Inhibition of CSK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-1.0	CHEMBL2634	Homo sapiens	INH	%	-1.0
	3463416	CHEMBL1252285	Inhibition of CSK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	3463960	CHEMBL1252285	Inhibition of CSK at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
Not Active	3499123	CHEMBL1259867	Inhibition of CSK at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	3525152	CHEMBL1274120	Inhibition of CSK at 1 uM	B	CCN(C)C(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL496862	=	Inhibition	%	72.0	CHEMBL2634	Homo sapiens	INH	%	72.0
	3525182	CHEMBL1274120	Inhibition of CSK at 1 uM	B	O=C1Nc2ccccc2/C1=C(/Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL500435	=	Inhibition	%	32.0	CHEMBL2634	Homo sapiens	INH	%	32.0
	3525212	CHEMBL1274120	Inhibition of CSK at 1 uM	B	CN(C)C(=O)c1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL1272078	=	Inhibition	%	74.0	CHEMBL2634	Homo sapiens	INH	%	74.0
	3525242	CHEMBL1274120	Inhibition of CSK at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL1272128	=	Inhibition	%	83.0	CHEMBL2634	Homo sapiens	INH	%	83.0
	3525272	CHEMBL1274120	Inhibition of CSK at 1 uM	B	CCNC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL1272289	=	Inhibition	%	96.0	CHEMBL2634	Homo sapiens	INH	%	96.0
	3525302	CHEMBL1274120	Inhibition of CSK at 1 uM	B	CCNCc1ccc(N/C(=C2\C(=O)Nc3cc(C(=O)N(C)CC)ccc32)c2ccccc2)cc1		CHEMBL1271471	=	Inhibition	%	78.0	CHEMBL2634	Homo sapiens	INH	%	78.0
	3556517	CHEMBL1285578	Inhibition of CSK at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	19.0	CHEMBL2634	Homo sapiens	INH	%	19.0
	5120318	CHEMBL1648380	Inhibition of human CSK at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	100.0	CHEMBL2634	Homo sapiens	INH	%	100.0
	5133685	CHEMBL1648727	Inhibition of CSK assessed as residual activity at 10 uM	B	CN(C)C/C=C/C(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641990	=	Activity	%	85.0	CHEMBL2634	Homo sapiens	Activity	%	85.0
	5133780	CHEMBL1648727	Inhibition of CSK assessed as residual activity at 10 uM	B	CN(C)CCCC(=O)Nc1ccc2c(C#N)cnc(Nc3cccc(Br)c3)c2c1		CHEMBL1641989	=	Activity	%	89.0	CHEMBL2634	Homo sapiens	Activity	%	89.0
	5133891	CHEMBL1648727	Inhibition of CSK assessed as residual activity at 10 uM	B	CN1CCN(CCC(=O)Nc2ccc3c(C#N)cnc(Nc4cccc(Br)c4)c3c2)CC1		CHEMBL1641992	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	5191451	CHEMBL1664082	Inhibition of CSK at 1 uM	B	COc1cc2nc(-c3cc(F)ccc3O)nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC		CHEMBL1236782	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	5191452	CHEMBL1664082	Inhibition of CSK at 1 uM	B	CC(C)(O)[C@@H]1CNC[C@H]1Nc1nc(-c2cc(-c3cc[nH]n3)ccc2O)nc2ccccc12		CHEMBL1650131	=	Inhibition	%	70.0	CHEMBL2634	Homo sapiens	INH	%	70.0
	5242956	CHEMBL1685650	Inhibition of CSK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	105.0	CHEMBL2634	Homo sapiens	INH	%	105.0
	5243795	CHEMBL1685899	Inhibition of CSK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	95.0	CHEMBL2634	Homo sapiens	INH	%	95.0
	5243908	CHEMBL1685650	Inhibition of CSK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	107.0	CHEMBL2634	Homo sapiens	INH	%	107.0
	5244016	CHEMBL1685899	Inhibition of CSK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	56.0	CHEMBL2634	Homo sapiens	INH	%	56.0
	5244889	CHEMBL1685650	Inhibition of CSK at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	140.0	CHEMBL2634	Homo sapiens	INH	%	140.0
	5244997	CHEMBL1685899	Inhibition of CSK at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	128.0	CHEMBL2634	Homo sapiens	INH	%	128.0
	5245148	CHEMBL1685650	Inhibition of CSK at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	106.0	CHEMBL2634	Homo sapiens	INH	%	106.0
	5245978	CHEMBL1685899	Inhibition of CSK at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	100.0	CHEMBL2634	Homo sapiens	INH	%	100.0
	6151041	CHEMBL1763675	Inhibition of CSK at 10 uM	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	Inhibition	%	80.0	CHEMBL2634	Homo sapiens	INH	%	80.0
	6152362	CHEMBL1763678	Inhibition of CSK	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	IC50	nM	80.0	CHEMBL2634	Homo sapiens	IC50	uM	0.08
	6167013	CHEMBL1768899	Inhibition of CSK	B	CNc1cncc(-c2c[nH]c(=O)c(NC(=O)c3ccc(N4CCC[C@H]4CN4CCCC4)cc3)c2)n1		CHEMBL1765781	>	Ki	nM	1000.0	CHEMBL2634	Homo sapiens	Ki	uM	1.0
	6210067	CHEMBL1781030	Inhibition of CSK at 4 uM by mobility shift assay	B	Cc1cc(-c2cccc(N)c2)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL1778718	=	Inhibition	%	-6.5	CHEMBL2634	Homo sapiens	INH	%	-6.5
	6273813	CHEMBL1806264	Inhibition of CSK assessed as residual enzyme activity at 10 uM	B	CC(C)c1cnn2c(NCc3ccccc3)cc(N[C@@H](CO)[C@H](O)CO)nc12		CHEMBL1234833	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	6341033	CHEMBL1827763	Activity of CSK kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	6352200	CHEMBL1825737	Inhibition of CSK assessed as residual activity at 10 uM by radioactivity assay in presence of 20 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	105.0	CHEMBL2634	Homo sapiens	Activity	%	105.0
	6385793	CHEMBL1838326	Inhibition of human CSK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	6385794	CHEMBL1838326	Inhibition of human CSK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	6385795	CHEMBL1838326	Inhibition of human CSK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	6385796	CHEMBL1838326	Inhibition of human CSK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	6385797	CHEMBL1838326	Inhibition of human CSK in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	6386348	CHEMBL1839867	Inhibition of recombinant CSK	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	7567346	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7567805	CHEMBL1908645	Binding constant for CSK kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7568302	CHEMBL1908645	Binding constant for CSK kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	60.0	CHEMBL2634	Homo sapiens	Kd	nM	60.0
	7568734	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7569319	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7569809	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7570272	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7570699	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7571295	CHEMBL1908645	Binding constant for CSK kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7571310	CHEMBL1908645	Binding constant for CSK kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7571786	CHEMBL1908645	Binding constant for CSK kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7572249	CHEMBL1908645	Binding constant for CSK kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7572665	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	1800.0	CHEMBL2634	Homo sapiens	Kd	nM	1800.0
	7573291	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	1.0	CHEMBL2634	Homo sapiens	Kd	nM	1.0
	7573767	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7574236	CHEMBL1908645	Binding constant for CSK kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	8700.0	CHEMBL2634	Homo sapiens	Kd	nM	8700.0
	7574644	CHEMBL1908645	Binding constant for CSK kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7574812	CHEMBL1908645	Binding constant for CSK kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7575273	CHEMBL1908645	Binding constant for CSK kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	9600.0	CHEMBL2634	Homo sapiens	Kd	nM	9600.0
	7575744	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	2500.0	CHEMBL2634	Homo sapiens	Kd	nM	2500.0
	7576209	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2200.0	CHEMBL2634	Homo sapiens	Kd	nM	2200.0
	7576617	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	5900.0	CHEMBL2634	Homo sapiens	Kd	nM	5900.0
	7576786	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7577245	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	120.0	CHEMBL2634	Homo sapiens	Kd	nM	120.0
	7577723	CHEMBL1908645	Binding constant for CSK kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	4400.0	CHEMBL2634	Homo sapiens	Kd	nM	4400.0
	7578193	CHEMBL1908645	Binding constant for CSK kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	2000.0	CHEMBL2634	Homo sapiens	Kd	nM	2000.0
	7578598	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2500.0	CHEMBL2634	Homo sapiens	Kd	nM	2500.0
	7578794	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7579168	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7579618	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7580092	CHEMBL1908645	Binding constant for CSK kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7581152	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7581537	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7581982	CHEMBL1908645	Binding constant for CSK kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7582475	CHEMBL1908645	Binding constant for CSK kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7582875	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	4800.0	CHEMBL2634	Homo sapiens	Kd	nM	4800.0
	7583498	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7583895	CHEMBL1908645	Binding constant for CSK kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7584340	CHEMBL1908645	Binding constant for CSK kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7584369	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7584831	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	160.0	CHEMBL2634	Homo sapiens	Kd	nM	160.0
	7585235	CHEMBL1908645	Binding constant for CSK kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7585828	CHEMBL1908645	Binding constant for CSK kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7586236	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7586711	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7587165	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7587789	CHEMBL1908645	Binding constant for CSK kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	1100.0	CHEMBL2634	Homo sapiens	Kd	nM	1100.0
	7588219	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7588690	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7589141	CHEMBL1908645	Binding constant for CSK kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7589736	CHEMBL1908645	Binding constant for CSK kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	260.0	CHEMBL2634	Homo sapiens	Kd	nM	260.0
	7590203	CHEMBL1908645	Binding constant for CSK kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7590677	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7591128	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7591285	CHEMBL1908645	Binding constant for CSK kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7591707	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7592179	CHEMBL1908645	Binding constant for CSK kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7592652	CHEMBL1908645	Binding constant for CSK kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	9000.0	CHEMBL2634	Homo sapiens	Kd	nM	9000.0
	7593105	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	32.0	CHEMBL2634	Homo sapiens	Kd	nM	32.0
	7593252	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	2300.0	CHEMBL2634	Homo sapiens	Kd	nM	2300.0
	7593687	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7594159	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7594632	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	2400.0	CHEMBL2634	Homo sapiens	Kd	nM	2400.0
	7595220	CHEMBL1908645	Binding constant for CSK kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7595664	CHEMBL1908645	Binding constant for CSK kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	6100.0	CHEMBL2634	Homo sapiens	Kd	nM	6100.0
	7596138	CHEMBL1908645	Binding constant for CSK kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7596614	CHEMBL1908645	Binding constant for CSK kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7597192	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	3800.0	CHEMBL2634	Homo sapiens	Kd	nM	3800.0
	7597645	CHEMBL1908645	Binding constant for CSK kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7598118	CHEMBL1908645	Binding constant for CSK kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	=	Kd	nM	550.0	CHEMBL2634	Homo sapiens	Kd	nM	550.0
	7598146	CHEMBL1908645	Binding constant for CSK kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2634	Homo sapiens	Kd	nM	10000.0
	7598588	CHEMBL1908645	Binding constant for CSK kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	330.0	CHEMBL2634	Homo sapiens	Kd	nM	330.0
	7922740	CHEMBL1919421	Inhibition of human recombinant CSK at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12	Outside typical range	CHEMBL1915438	=	Inhibition	%	-16.0	CHEMBL2634	Homo sapiens	INH	%	-16.0
	7931076	CHEMBL1919255	Inhibition of CSK relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	15.0	CHEMBL2634	Homo sapiens	INH	%	15.0
	7956230	CHEMBL1924893	Inhibition of N-terminus flag-tagged CSK expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	=	IC50	nM	4700.0	CHEMBL2634	Homo sapiens	IC50	nM	4700.0
	7959723	CHEMBL1932836	Inhibition of CSK	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL2634	Homo sapiens	IC50	uM	30.0
	7959724	CHEMBL1932836	Inhibition of CSK	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	IC50	nM	30000.0	CHEMBL2634	Homo sapiens	IC50	uM	30.0
	7969707	CHEMBL1930963	Inhibition of CSK assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	35.0	CHEMBL2634	Homo sapiens	Activity	%	35.0
	8004380	CHEMBL1943337	Inhibition of human CSK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940980	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	8004381	CHEMBL1943337	Inhibition of human CSK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCn3cccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940981	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	8004382	CHEMBL1943337	Inhibition of human CSK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1940987	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	8004383	CHEMBL1943337	Inhibition of human CSK in HL-60 cells lysate assessed as reduction of labeling of acyl-phosphate ATP probe at 100 nM	B	C[C@H]1COc2c(NCCCc3ccccn3)c(F)c(N)c3c(=O)c(C#N)cn1c23		CHEMBL1940990	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
Not Active	8012219	CHEMBL1941636	Inhibition of CSK at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
Not Active	8012220	CHEMBL1941636	Inhibition of CSK at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
Not Active	8012221	CHEMBL1941636	Inhibition of CSK at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
Not Active	8012222	CHEMBL1941636	Inhibition of CSK at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	8013060	CHEMBL1947847	Inhibition of CSK using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	8017863	CHEMBL1948821	Inhibition of CSK assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	8017864	CHEMBL1948821	Inhibition of CSK assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	86.0	CHEMBL2634	Homo sapiens	Activity	%	86.0
	8017865	CHEMBL1948821	Inhibition of CSK assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	90.0	CHEMBL2634	Homo sapiens	Activity	%	90.0
	8047096	CHEMBL1958835	Inhibition of CSK at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	8061361	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	-0.21	CHEMBL2634	Homo sapiens	Inhibition	%	-0.21
	8061538	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.56	CHEMBL2634	Homo sapiens	Inhibition	%	2.56
	8061869	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	6.08	CHEMBL2634	Homo sapiens	Inhibition	%	6.08
	8062060	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.5	CHEMBL2634	Homo sapiens	Inhibition	%	1.5
	8062400	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.1	CHEMBL2634	Homo sapiens	Inhibition	%	3.1
	8062562	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	7.63	CHEMBL2634	Homo sapiens	Inhibition	%	7.63
	8062884	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-5.08	CHEMBL2634	Homo sapiens	Inhibition	%	-5.08
	8063240	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	7.83	CHEMBL2634	Homo sapiens	Inhibition	%	7.83
	8063407	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.37	CHEMBL2634	Homo sapiens	Inhibition	%	-0.37
	8063739	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	5.75	CHEMBL2634	Homo sapiens	Inhibition	%	5.75
	8063921	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	-0.79	CHEMBL2634	Homo sapiens	Inhibition	%	-0.79
	8064260	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	-0.66	CHEMBL2634	Homo sapiens	Inhibition	%	-0.66
	8064470	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.53	CHEMBL2634	Homo sapiens	Inhibition	%	-1.53
	8064832	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	1.21	CHEMBL2634	Homo sapiens	Inhibition	%	1.21
	8064998	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	5.3	CHEMBL2634	Homo sapiens	Inhibition	%	5.3
	8065338	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	6.81	CHEMBL2634	Homo sapiens	Inhibition	%	6.81
	8065513	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	5.73	CHEMBL2634	Homo sapiens	Inhibition	%	5.73
	8065737	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.25	CHEMBL2634	Homo sapiens	Inhibition	%	4.25
	8065852	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.19	CHEMBL2634	Homo sapiens	Inhibition	%	2.19
	8066062	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-1.42	CHEMBL2634	Homo sapiens	Inhibition	%	-1.42
	8066286	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.3	CHEMBL2634	Homo sapiens	Inhibition	%	1.3
	8066422	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	-1.08	CHEMBL2634	Homo sapiens	Inhibition	%	-1.08
	8066588	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.42	CHEMBL2634	Homo sapiens	Inhibition	%	0.42
	8066812	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	4.87	CHEMBL2634	Homo sapiens	Inhibition	%	4.87
	8066936	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	7.57	CHEMBL2634	Homo sapiens	Inhibition	%	7.57
	8067335	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.8	CHEMBL2634	Homo sapiens	Inhibition	%	2.8
	8067456	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.54	CHEMBL2634	Homo sapiens	Inhibition	%	-0.54
	8067680	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	-0.04	CHEMBL2634	Homo sapiens	Inhibition	%	-0.04
	8067890	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-3.01	CHEMBL2634	Homo sapiens	Inhibition	%	-3.01
	8068025	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.91	CHEMBL2634	Homo sapiens	Inhibition	%	2.91
	8068413	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.15	CHEMBL2634	Homo sapiens	Inhibition	%	2.15
	8068538	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.27	CHEMBL2634	Homo sapiens	Inhibition	%	3.27
	8068762	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.81	CHEMBL2634	Homo sapiens	Inhibition	%	1.81
	8068936	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-1.83	CHEMBL2634	Homo sapiens	Inhibition	%	-1.83
	8069285	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.22	CHEMBL2634	Homo sapiens	Inhibition	%	2.22
	8069356	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	12.1	CHEMBL2634	Homo sapiens	Inhibition	%	12.1
	8069580	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.76	CHEMBL2634	Homo sapiens	Inhibition	%	2.76
	8069741	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	5.14	CHEMBL2634	Homo sapiens	Inhibition	%	5.14
	8070091	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.65	CHEMBL2634	Homo sapiens	Inhibition	%	0.65
	8070263	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.52	CHEMBL2634	Homo sapiens	Inhibition	%	1.52
	8070612	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.02	CHEMBL2634	Homo sapiens	Inhibition	%	1.02
	8070910	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	7.32	CHEMBL2634	Homo sapiens	Inhibition	%	7.32
	8071067	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.78	CHEMBL2634	Homo sapiens	Inhibition	%	-0.78
	8071417	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-1.25	CHEMBL2634	Homo sapiens	Inhibition	%	-1.25
	8071590	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-2.89	CHEMBL2634	Homo sapiens	Inhibition	%	-2.89
	8071814	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	6.94	CHEMBL2634	Homo sapiens	Inhibition	%	6.94
	8071939	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-3.97	CHEMBL2634	Homo sapiens	Inhibition	%	-3.97
	8072253	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-2.03	CHEMBL2634	Homo sapiens	Inhibition	%	-2.03
	8072410	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	3.65	CHEMBL2634	Homo sapiens	Inhibition	%	3.65
	8072634	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	4.95	CHEMBL2634	Homo sapiens	Inhibition	%	4.95
	8072759	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.97	CHEMBL2634	Homo sapiens	Inhibition	%	0.97
	8073150	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.14	CHEMBL2634	Homo sapiens	Inhibition	%	4.14
	8073275	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	4.36	CHEMBL2634	Homo sapiens	Inhibition	%	4.36
	8073618	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-2.97	CHEMBL2634	Homo sapiens	Inhibition	%	-2.97
	8073851	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.36	CHEMBL2634	Homo sapiens	Inhibition	%	2.36
	8074227	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.41	CHEMBL2634	Homo sapiens	Inhibition	%	1.41
	8074357	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.4	CHEMBL2634	Homo sapiens	Inhibition	%	-1.4
	8074738	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.51	CHEMBL2634	Homo sapiens	Inhibition	%	0.51
	8074865	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	33.41	CHEMBL2634	Homo sapiens	Inhibition	%	33.41
	8075089	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-1.28	CHEMBL2634	Homo sapiens	Inhibition	%	-1.28
	8075200	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	-6.97	CHEMBL2634	Homo sapiens	Inhibition	%	-6.97
	8075437	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.07	CHEMBL2634	Homo sapiens	Inhibition	%	-0.07
	8075661	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-4.12	CHEMBL2634	Homo sapiens	Inhibition	%	-4.12
	8075802	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.29	CHEMBL2634	Homo sapiens	Inhibition	%	1.29
	8075944	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.02	CHEMBL2634	Homo sapiens	Inhibition	%	0.02
	8076168	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.23	CHEMBL2634	Homo sapiens	Inhibition	%	-1.23
	8076316	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.29	CHEMBL2634	Homo sapiens	Inhibition	%	0.29
	8076674	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-2.41	CHEMBL2634	Homo sapiens	Inhibition	%	-2.41
	8076776	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.06	CHEMBL2634	Homo sapiens	Inhibition	%	-2.06
	8077000	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-6.18	CHEMBL2634	Homo sapiens	Inhibition	%	-6.18
	8077247	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-5.0	CHEMBL2634	Homo sapiens	Inhibition	%	-5.0
	8077375	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.91	CHEMBL2634	Homo sapiens	Inhibition	%	1.91
	8077750	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.18	CHEMBL2634	Homo sapiens	Inhibition	%	-2.18
	8077893	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.97	CHEMBL2634	Homo sapiens	Inhibition	%	2.97
	8078256	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-8.87	CHEMBL2634	Homo sapiens	Inhibition	%	-8.87
	8078582	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-4.87	CHEMBL2634	Homo sapiens	Inhibition	%	-4.87
	8078832	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-5.08	CHEMBL2634	Homo sapiens	Inhibition	%	-5.08
	8078948	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.99	CHEMBL2634	Homo sapiens	Inhibition	%	0.99
	8079172	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	6.38	CHEMBL2634	Homo sapiens	Inhibition	%	6.38
	8079330	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.73	CHEMBL2634	Homo sapiens	Inhibition	%	-0.73
	8079472	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.94	CHEMBL2634	Homo sapiens	Inhibition	%	2.94
	8079696	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.39	CHEMBL2634	Homo sapiens	Inhibition	%	3.39
	8079835	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-6.35	CHEMBL2634	Homo sapiens	Inhibition	%	-6.35
	8080164	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-6.96	CHEMBL2634	Homo sapiens	Inhibition	%	-6.96
	8080416	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-2.24	CHEMBL2634	Homo sapiens	Inhibition	%	-2.24
	8080755	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.5	CHEMBL2634	Homo sapiens	Inhibition	%	2.5
	8080919	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.52	CHEMBL2634	Homo sapiens	Inhibition	%	-0.52
	8081278	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-3.52	CHEMBL2634	Homo sapiens	Inhibition	%	-3.52
	8081422	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	1.38	CHEMBL2634	Homo sapiens	Inhibition	%	1.38
	8081749	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.82	CHEMBL2634	Homo sapiens	Inhibition	%	0.82
	8082001	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.85	CHEMBL2634	Homo sapiens	Inhibition	%	-1.85
	8082338	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	8.35	CHEMBL2634	Homo sapiens	Inhibition	%	8.35
	8082511	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-4.42	CHEMBL2634	Homo sapiens	Inhibition	%	-4.42
	8082858	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.66	CHEMBL2634	Homo sapiens	Inhibition	%	-0.66
	8083014	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	6.03	CHEMBL2634	Homo sapiens	Inhibition	%	6.03
	8083238	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	2.76	CHEMBL2634	Homo sapiens	Inhibition	%	2.76
	8083337	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-5.59	CHEMBL2634	Homo sapiens	Inhibition	%	-5.59
	8083591	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.78	CHEMBL2634	Homo sapiens	Inhibition	%	-1.78
	8083815	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-6.81	CHEMBL2634	Homo sapiens	Inhibition	%	-6.81
	8083925	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	7.73	CHEMBL2634	Homo sapiens	Inhibition	%	7.73
	8084110	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.76	CHEMBL2634	Homo sapiens	Inhibition	%	-3.76
	8084334	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	1.66	CHEMBL2634	Homo sapiens	Inhibition	%	1.66
	8084452	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.62	CHEMBL2634	Homo sapiens	Inhibition	%	0.62
	8084837	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	6.51	CHEMBL2634	Homo sapiens	Inhibition	%	6.51
	8084935	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.14	CHEMBL2634	Homo sapiens	Inhibition	%	-2.14
	8085159	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.39	CHEMBL2634	Homo sapiens	Inhibition	%	-2.39
	8085415	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-6.66	CHEMBL2634	Homo sapiens	Inhibition	%	-6.66
	8085523	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.95	CHEMBL2634	Homo sapiens	Inhibition	%	1.95
	8085747	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	5.97	CHEMBL2634	Homo sapiens	Inhibition	%	5.97
	8085936	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	9.03	CHEMBL2634	Homo sapiens	Inhibition	%	9.03
	8086051	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	6.06	CHEMBL2634	Homo sapiens	Inhibition	%	6.06
	8086275	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	27.62	CHEMBL2634	Homo sapiens	Inhibition	%	27.62
	8086437	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1	Outside typical range	CHEMBL261129	=	Inhibition	%	-13.75	CHEMBL2634	Homo sapiens	Inhibition	%	-13.75
	8086760	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-1.68	CHEMBL2634	Homo sapiens	Inhibition	%	-1.68
	8086971	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.49	CHEMBL2634	Homo sapiens	Inhibition	%	0.49
	8087353	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.98	CHEMBL2634	Homo sapiens	Inhibition	%	2.98
	8087467	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	15.16	CHEMBL2634	Homo sapiens	Inhibition	%	15.16
	8087829	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	12.58	CHEMBL2634	Homo sapiens	Inhibition	%	12.58
	8087971	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.39	CHEMBL2634	Homo sapiens	Inhibition	%	4.39
	8088195	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	4.45	CHEMBL2634	Homo sapiens	Inhibition	%	4.45
	8088343	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.18	CHEMBL2634	Homo sapiens	Inhibition	%	1.18
	8088695	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.7	CHEMBL2634	Homo sapiens	Inhibition	%	1.7
	8088788	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.25	CHEMBL2634	Homo sapiens	Inhibition	%	2.25
	8089012	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	-0.41	CHEMBL2634	Homo sapiens	Inhibition	%	-0.41
	8089140	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.02	CHEMBL2634	Homo sapiens	Inhibition	%	-0.02
	8089512	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	0.6	CHEMBL2634	Homo sapiens	Inhibition	%	0.6
	8089632	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.4	CHEMBL2634	Homo sapiens	Inhibition	%	1.4
	8089856	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.15	CHEMBL2634	Homo sapiens	Inhibition	%	1.15
	8090036	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.17	CHEMBL2634	Homo sapiens	Inhibition	%	1.17
	8090201	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.06	CHEMBL2634	Homo sapiens	Inhibition	%	-1.06
	8090592	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-0.24	CHEMBL2634	Homo sapiens	Inhibition	%	-0.24
	8090731	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.6	CHEMBL2634	Homo sapiens	Inhibition	%	1.6
	8090955	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	3.6	CHEMBL2634	Homo sapiens	Inhibition	%	3.6
	8091160	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	5.85	CHEMBL2634	Homo sapiens	Inhibition	%	5.85
	8091297	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	10.57	CHEMBL2634	Homo sapiens	Inhibition	%	10.57
	8091676	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.34	CHEMBL2634	Homo sapiens	Inhibition	%	4.34
	8091792	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.72	CHEMBL2634	Homo sapiens	Inhibition	%	2.72
	8092016	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	3.11	CHEMBL2634	Homo sapiens	Inhibition	%	3.11
	8092153	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.9	CHEMBL2634	Homo sapiens	Inhibition	%	1.9
	8092528	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	1.58	CHEMBL2634	Homo sapiens	Inhibition	%	1.58
	8092676	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.29	CHEMBL2634	Homo sapiens	Inhibition	%	1.29
	8093029	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	5.68	CHEMBL2634	Homo sapiens	Inhibition	%	5.68
	8093341	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	4.06	CHEMBL2634	Homo sapiens	Inhibition	%	4.06
	8093481	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.71	CHEMBL2634	Homo sapiens	Inhibition	%	0.71
	8093844	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.41	CHEMBL2634	Homo sapiens	Inhibition	%	1.41
	8094188	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.96	CHEMBL2634	Homo sapiens	Inhibition	%	1.96
	8094368	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.88	CHEMBL2634	Homo sapiens	Inhibition	%	0.88
	8094543	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-3.02	CHEMBL2634	Homo sapiens	Inhibition	%	-3.02
	8094767	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.42	CHEMBL2634	Homo sapiens	Inhibition	%	1.42
	8094923	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.69	CHEMBL2634	Homo sapiens	Inhibition	%	1.69
	8095287	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	29.38	CHEMBL2634	Homo sapiens	Inhibition	%	29.38
	8095490	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	9.28	CHEMBL2634	Homo sapiens	Inhibition	%	9.28
	8095631	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-1.32	CHEMBL2634	Homo sapiens	Inhibition	%	-1.32
	8095855	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	1.79	CHEMBL2634	Homo sapiens	Inhibition	%	1.79
	8096003	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	11.07	CHEMBL2634	Homo sapiens	Inhibition	%	11.07
	8096344	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.43	CHEMBL2634	Homo sapiens	Inhibition	%	5.43
	8096483	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	3.34	CHEMBL2634	Homo sapiens	Inhibition	%	3.34
	8096707	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.03	CHEMBL2634	Homo sapiens	Inhibition	%	-0.03
	8096863	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	4.58	CHEMBL2634	Homo sapiens	Inhibition	%	4.58
	8097010	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	2.73	CHEMBL2634	Homo sapiens	Inhibition	%	2.73
	8097234	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.11	CHEMBL2634	Homo sapiens	Inhibition	%	3.11
	8097321	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.14	CHEMBL2634	Homo sapiens	Inhibition	%	4.14
	8097541	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.58	CHEMBL2634	Homo sapiens	Inhibition	%	1.58
	8097691	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-1.24	CHEMBL2634	Homo sapiens	Inhibition	%	-1.24
	8097915	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.13	CHEMBL2634	Homo sapiens	Inhibition	%	-2.13
	8098048	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.42	CHEMBL2634	Homo sapiens	Inhibition	%	2.42
	8098392	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-1.48	CHEMBL2634	Homo sapiens	Inhibition	%	-1.48
	8098572	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	3.48	CHEMBL2634	Homo sapiens	Inhibition	%	3.48
	8098981	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.44	CHEMBL2634	Homo sapiens	Inhibition	%	0.44
	8099125	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	0.42	CHEMBL2634	Homo sapiens	Inhibition	%	0.42
	8099491	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.53	CHEMBL2634	Homo sapiens	Inhibition	%	0.53
	8099685	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.65	CHEMBL2634	Homo sapiens	Inhibition	%	1.65
	8100056	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	2.91	CHEMBL2634	Homo sapiens	Inhibition	%	2.91
	8100202	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	58.21	CHEMBL2634	Homo sapiens	Inhibition	%	58.21
	8100542	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	5.55	CHEMBL2634	Homo sapiens	Inhibition	%	5.55
	8100906	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.54	CHEMBL2634	Homo sapiens	Inhibition	%	1.54
	8101066	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.75	CHEMBL2634	Homo sapiens	Inhibition	%	2.75
	8101432	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-1.07	CHEMBL2634	Homo sapiens	Inhibition	%	-1.07
	8101617	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	4.64	CHEMBL2634	Homo sapiens	Inhibition	%	4.64
	8101870	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	4.78	CHEMBL2634	Homo sapiens	Inhibition	%	4.78
	8102249	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-2.2	CHEMBL2634	Homo sapiens	Inhibition	%	-2.2
	8102380	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl	Outside typical range	CHEMBL1909373	=	Inhibition	%	-42.48	CHEMBL2634	Homo sapiens	Inhibition	%	-42.48
	8102604	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.59	CHEMBL2634	Homo sapiens	Inhibition	%	1.59
	8102724	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.56	CHEMBL2634	Homo sapiens	Inhibition	%	0.56
	8102902	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.39	CHEMBL2634	Homo sapiens	Inhibition	%	0.39
	8103126	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.89	CHEMBL2634	Homo sapiens	Inhibition	%	1.89
	8103322	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	-1.53	CHEMBL2634	Homo sapiens	Inhibition	%	-1.53
	8103460	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	5.24	CHEMBL2634	Homo sapiens	Inhibition	%	5.24
	8103684	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.49	CHEMBL2634	Homo sapiens	Inhibition	%	0.49
	8103834	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.13	CHEMBL2634	Homo sapiens	Inhibition	%	3.13
	8104019	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.45	CHEMBL2634	Homo sapiens	Inhibition	%	3.45
	8104243	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.23	CHEMBL2634	Homo sapiens	Inhibition	%	1.23
	8104391	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	8.35	CHEMBL2634	Homo sapiens	Inhibition	%	8.35
	8104537	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.16	CHEMBL2634	Homo sapiens	Inhibition	%	2.16
	8104761	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.17	CHEMBL2634	Homo sapiens	Inhibition	%	4.17
	8104875	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.79	CHEMBL2634	Homo sapiens	Inhibition	%	0.79
	8105239	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.72	CHEMBL2634	Homo sapiens	Inhibition	%	0.72
	8105405	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.12	CHEMBL2634	Homo sapiens	Inhibition	%	2.12
	8105767	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.86	CHEMBL2634	Homo sapiens	Inhibition	%	-0.86
	8106047	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.08	CHEMBL2634	Homo sapiens	Inhibition	%	5.08
	8106212	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	17.28	CHEMBL2634	Homo sapiens	Inhibition	%	17.28
	8106436	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.44	CHEMBL2634	Homo sapiens	Inhibition	%	2.44
	8106592	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	26.53	CHEMBL2634	Homo sapiens	Inhibition	%	26.53
	8106945	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	5.35	CHEMBL2634	Homo sapiens	Inhibition	%	5.35
	8107066	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.47	CHEMBL2634	Homo sapiens	Inhibition	%	-0.47
	8107462	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-3.78	CHEMBL2634	Homo sapiens	Inhibition	%	-3.78
	8107663	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	2.13	CHEMBL2634	Homo sapiens	Inhibition	%	2.13
	8108022	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	9.32	CHEMBL2634	Homo sapiens	Inhibition	%	9.32
	8108180	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	3.42	CHEMBL2634	Homo sapiens	Inhibition	%	3.42
	8108579	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	5.95	CHEMBL2634	Homo sapiens	Inhibition	%	5.95
	8108726	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.15	CHEMBL2634	Homo sapiens	Inhibition	%	5.15
	8109092	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.76	CHEMBL2634	Homo sapiens	Inhibition	%	1.76
	8109206	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.87	CHEMBL2634	Homo sapiens	Inhibition	%	0.87
	8109430	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.25	CHEMBL2634	Homo sapiens	Inhibition	%	-0.25
	8109560	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.81	CHEMBL2634	Homo sapiens	Inhibition	%	-0.81
	8109731	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.4	CHEMBL2634	Homo sapiens	Inhibition	%	2.4
	8109955	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	5.07	CHEMBL2634	Homo sapiens	Inhibition	%	5.07
	8110087	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	3.66	CHEMBL2634	Homo sapiens	Inhibition	%	3.66
	8110366	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	-1.85	CHEMBL2634	Homo sapiens	Inhibition	%	-1.85
	8110756	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.64	CHEMBL2634	Homo sapiens	Inhibition	%	-0.64
	8110914	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-0.42	CHEMBL2634	Homo sapiens	Inhibition	%	-0.42
	8111261	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	4.01	CHEMBL2634	Homo sapiens	Inhibition	%	4.01
	8111388	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.9	CHEMBL2634	Homo sapiens	Inhibition	%	2.9
	8111612	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.37	CHEMBL2634	Homo sapiens	Inhibition	%	-1.37
	8111778	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-1.04	CHEMBL2634	Homo sapiens	Inhibition	%	-1.04
	8111983	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.12	CHEMBL2634	Homo sapiens	Inhibition	%	1.12
	8112344	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.83	CHEMBL2634	Homo sapiens	Inhibition	%	-0.83
	8112512	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	7.18	CHEMBL2634	Homo sapiens	Inhibition	%	7.18
	8112736	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	23.14	CHEMBL2634	Homo sapiens	Inhibition	%	23.14
	8112908	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.96	CHEMBL2634	Homo sapiens	Inhibition	%	2.96
	8113060	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.59	CHEMBL2634	Homo sapiens	Inhibition	%	3.59
	8113284	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.36	CHEMBL2634	Homo sapiens	Inhibition	%	1.36
	8113420	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.36	CHEMBL2634	Homo sapiens	Inhibition	%	1.36
	8113768	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.22	CHEMBL2634	Homo sapiens	Inhibition	%	2.22
	8113884	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.65	CHEMBL2634	Homo sapiens	Inhibition	%	-0.65
	8114284	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.05	CHEMBL2634	Homo sapiens	Inhibition	%	2.05
	8114416	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.79	CHEMBL2634	Homo sapiens	Inhibition	%	4.79
	8114640	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.1	CHEMBL2634	Homo sapiens	Inhibition	%	-0.1
	8114692	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.72	CHEMBL2634	Homo sapiens	Inhibition	%	2.72
	8114916	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.73	CHEMBL2634	Homo sapiens	Inhibition	%	1.73
	8115082	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	6.39	CHEMBL2634	Homo sapiens	Inhibition	%	6.39
	8115247	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	2.55	CHEMBL2634	Homo sapiens	Inhibition	%	2.55
	8115471	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.09	CHEMBL2634	Homo sapiens	Inhibition	%	-1.09
	8115591	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.75	CHEMBL2634	Homo sapiens	Inhibition	%	3.75
	8115948	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.82	CHEMBL2634	Homo sapiens	Inhibition	%	-0.82
	8116107	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.77	CHEMBL2634	Homo sapiens	Inhibition	%	0.77
	8116310	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	0.89	CHEMBL2634	Homo sapiens	Inhibition	%	0.89
	8116534	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.49	CHEMBL2634	Homo sapiens	Inhibition	%	3.49
	8116668	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.42	CHEMBL2634	Homo sapiens	Inhibition	%	0.42
	8117064	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	73.32	CHEMBL2634	Homo sapiens	Inhibition	%	73.32
	8117235	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	4.64	CHEMBL2634	Homo sapiens	Inhibition	%	4.64
	8117617	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.91	CHEMBL2634	Homo sapiens	Inhibition	%	5.91
	8117747	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.67	CHEMBL2634	Homo sapiens	Inhibition	%	0.67
	8118109	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.54	CHEMBL2634	Homo sapiens	Inhibition	%	2.54
	8118225	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.23	CHEMBL2634	Homo sapiens	Inhibition	%	-3.23
	8118449	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.55	CHEMBL2634	Homo sapiens	Inhibition	%	3.55
	8118621	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	3.02	CHEMBL2634	Homo sapiens	Inhibition	%	3.02
	8118981	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.56	CHEMBL2634	Homo sapiens	Inhibition	%	2.56
	8119252	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.05	CHEMBL2634	Homo sapiens	Inhibition	%	1.05
	8119411	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	40.95	CHEMBL2634	Homo sapiens	Inhibition	%	40.95
	8119802	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	3.91	CHEMBL2634	Homo sapiens	Inhibition	%	3.91
	8119921	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.86	CHEMBL2634	Homo sapiens	Inhibition	%	2.86
	8120284	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-2.99	CHEMBL2634	Homo sapiens	Inhibition	%	-2.99
	8120444	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.3	CHEMBL2634	Homo sapiens	Inhibition	%	-0.3
	8120668	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.39	CHEMBL2634	Homo sapiens	Inhibition	%	-1.39
	8120869	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.26	CHEMBL2634	Homo sapiens	Inhibition	%	1.26
	8120997	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.01	CHEMBL2634	Homo sapiens	Inhibition	%	-1.01
	8121221	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.99	CHEMBL2634	Homo sapiens	Inhibition	%	0.99
	8121393	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.2	CHEMBL2634	Homo sapiens	Inhibition	%	-1.2
	8121560	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.04	CHEMBL2634	Homo sapiens	Inhibition	%	1.04
	8121947	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.13	CHEMBL2634	Homo sapiens	Inhibition	%	1.13
	8122068	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	5.6	CHEMBL2634	Homo sapiens	Inhibition	%	5.6
	8122292	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.36	CHEMBL2634	Homo sapiens	Inhibition	%	0.36
	8122430	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	2.38	CHEMBL2634	Homo sapiens	Inhibition	%	2.38
	8122774	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	4.45	CHEMBL2634	Homo sapiens	Inhibition	%	4.45
	8122941	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.11	CHEMBL2634	Homo sapiens	Inhibition	%	1.11
	8123307	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.11	CHEMBL2634	Homo sapiens	Inhibition	%	3.11
	8123585	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	-0.35	CHEMBL2634	Homo sapiens	Inhibition	%	-0.35
	8123735	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.22	CHEMBL2634	Homo sapiens	Inhibition	%	4.22
	8124126	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.91	CHEMBL2634	Homo sapiens	Inhibition	%	1.91
	8124245	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	5.64	CHEMBL2634	Homo sapiens	Inhibition	%	5.64
	8124469	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.74	CHEMBL2634	Homo sapiens	Inhibition	%	4.74
	8124608	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.48	CHEMBL2634	Homo sapiens	Inhibition	%	0.48
	8124997	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	4.15	CHEMBL2634	Homo sapiens	Inhibition	%	4.15
	8125198	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	-0.21	CHEMBL2634	Homo sapiens	Inhibition	%	-0.21
	8125552	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.49	CHEMBL2634	Homo sapiens	Inhibition	%	-1.49
	8125720	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.39	CHEMBL2634	Homo sapiens	Inhibition	%	2.39
	8125884	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.36	CHEMBL2634	Homo sapiens	Inhibition	%	0.36
	8126108	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.49	CHEMBL2634	Homo sapiens	Inhibition	%	2.49
	8126272	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.18	CHEMBL2634	Homo sapiens	Inhibition	%	2.18
	8126611	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	18.63	CHEMBL2634	Homo sapiens	Inhibition	%	18.63
	8126747	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.61	CHEMBL2634	Homo sapiens	Inhibition	%	1.61
	8127093	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.47	CHEMBL2634	Homo sapiens	Inhibition	%	0.47
	8127260	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	4.32	CHEMBL2634	Homo sapiens	Inhibition	%	4.32
	8127484	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	7.64	CHEMBL2634	Homo sapiens	Inhibition	%	7.64
	8127626	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	9.28	CHEMBL2634	Homo sapiens	Inhibition	%	9.28
	8127914	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	4.01	CHEMBL2634	Homo sapiens	Inhibition	%	4.01
	8128066	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	5.56	CHEMBL2634	Homo sapiens	Inhibition	%	5.56
	8128290	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.08	CHEMBL2634	Homo sapiens	Inhibition	%	4.08
	8128457	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	7.17	CHEMBL2634	Homo sapiens	Inhibition	%	7.17
	8128800	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	11.79	CHEMBL2634	Homo sapiens	Inhibition	%	11.79
	8128937	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.51	CHEMBL2634	Homo sapiens	Inhibition	%	0.51
	8129161	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.7	CHEMBL2634	Homo sapiens	Inhibition	%	0.7
	8129332	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-2.53	CHEMBL2634	Homo sapiens	Inhibition	%	-2.53
	8129521	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	10.28	CHEMBL2634	Homo sapiens	Inhibition	%	10.28
	8129884	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-1.56	CHEMBL2634	Homo sapiens	Inhibition	%	-1.56
	8130045	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.81	CHEMBL2634	Homo sapiens	Inhibition	%	2.81
	8130441	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.26	CHEMBL2634	Homo sapiens	Inhibition	%	-0.26
	8130601	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.79	CHEMBL2634	Homo sapiens	Inhibition	%	1.79
	8130941	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.29	CHEMBL2634	Homo sapiens	Inhibition	%	-0.29
	8131080	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	3.86	CHEMBL2634	Homo sapiens	Inhibition	%	3.86
	8131304	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.89	CHEMBL2634	Homo sapiens	Inhibition	%	3.89
	8131424	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.28	CHEMBL2634	Homo sapiens	Inhibition	%	3.28
	8131815	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	17.89	CHEMBL2634	Homo sapiens	Inhibition	%	17.89
	8131956	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	7.62	CHEMBL2634	Homo sapiens	Inhibition	%	7.62
	8132242	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.83	CHEMBL2634	Homo sapiens	Inhibition	%	0.83
	8132613	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.46	CHEMBL2634	Homo sapiens	Inhibition	%	7.46
	8132781	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.04	CHEMBL2634	Homo sapiens	Inhibition	%	0.04
	8133126	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.92	CHEMBL2634	Homo sapiens	Inhibition	%	3.92
	8133488	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-1.69	CHEMBL2634	Homo sapiens	Inhibition	%	-1.69
	8133660	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.46	CHEMBL2634	Homo sapiens	Inhibition	%	-1.46
	8133840	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	-1.19	CHEMBL2634	Homo sapiens	Inhibition	%	-1.19
	8134064	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	12.64	CHEMBL2634	Homo sapiens	Inhibition	%	12.64
	8134212	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.51	CHEMBL2634	Homo sapiens	Inhibition	%	-1.51
	8134372	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.56	CHEMBL2634	Homo sapiens	Inhibition	%	0.56
	8134596	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.61	CHEMBL2634	Homo sapiens	Inhibition	%	1.61
	8134780	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-9.22	CHEMBL2634	Homo sapiens	Inhibition	%	-9.22
	8134940	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	8.18	CHEMBL2634	Homo sapiens	Inhibition	%	8.18
	8135164	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.73	CHEMBL2634	Homo sapiens	Inhibition	%	1.73
	8135279	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.01	CHEMBL2634	Homo sapiens	Inhibition	%	2.01
	8135644	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.61	CHEMBL2634	Homo sapiens	Inhibition	%	3.61
	8135765	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.71	CHEMBL2634	Homo sapiens	Inhibition	%	1.71
	8135989	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	Inhibition	%	3.0
	8136157	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	2.79	CHEMBL2634	Homo sapiens	Inhibition	%	2.79
	8136301	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	44.37	CHEMBL2634	Homo sapiens	Inhibition	%	44.37
	8136525	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.85	CHEMBL2634	Homo sapiens	Inhibition	%	3.85
	8136591	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.1	CHEMBL2634	Homo sapiens	Inhibition	%	1.1
	8136815	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-1.53	CHEMBL2634	Homo sapiens	Inhibition	%	-1.53
	8136950	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.65	CHEMBL2634	Homo sapiens	Inhibition	%	1.65
	8137113	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	6.0	CHEMBL2634	Homo sapiens	Inhibition	%	6.0
	8137337	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.59	CHEMBL2634	Homo sapiens	Inhibition	%	2.59
	8137457	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.58	CHEMBL2634	Homo sapiens	Inhibition	%	2.58
	8137829	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	4.47	CHEMBL2634	Homo sapiens	Inhibition	%	4.47
	8137995	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.65	CHEMBL2634	Homo sapiens	Inhibition	%	-1.65
	8138398	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	3.59	CHEMBL2634	Homo sapiens	Inhibition	%	3.59
	8138546	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.98	CHEMBL2634	Homo sapiens	Inhibition	%	-0.98
	8138928	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.18	CHEMBL2634	Homo sapiens	Inhibition	%	0.18
	8139113	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-6.43	CHEMBL2634	Homo sapiens	Inhibition	%	-6.43
	8139496	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	20.18	CHEMBL2634	Homo sapiens	Inhibition	%	20.18
	8139610	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.54	CHEMBL2634	Homo sapiens	Inhibition	%	0.54
	8139834	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.7	CHEMBL2634	Homo sapiens	Inhibition	%	3.7
	8139975	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	6.74	CHEMBL2634	Homo sapiens	Inhibition	%	6.74
	8140322	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.4	CHEMBL2634	Homo sapiens	Inhibition	%	0.4
	8140481	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.91	CHEMBL2634	Homo sapiens	Inhibition	%	3.91
	8140848	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	6.08	CHEMBL2634	Homo sapiens	Inhibition	%	6.08
	8141150	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	3.07	CHEMBL2634	Homo sapiens	Inhibition	%	3.07
	8141280	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.23	CHEMBL2634	Homo sapiens	Inhibition	%	4.23
	8141664	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	12.07	CHEMBL2634	Homo sapiens	Inhibition	%	12.07
	8141783	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	5.83	CHEMBL2634	Homo sapiens	Inhibition	%	5.83
	8142007	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	24.64	CHEMBL2634	Homo sapiens	Inhibition	%	24.64
	8142168	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.27	CHEMBL2634	Homo sapiens	Inhibition	%	-0.27
	8142336	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-5.02	CHEMBL2634	Homo sapiens	Inhibition	%	-5.02
	8142560	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-4.98	CHEMBL2634	Homo sapiens	Inhibition	%	-4.98
	8142736	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.7	CHEMBL2634	Homo sapiens	Inhibition	%	2.7
	8142885	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-7.18	CHEMBL2634	Homo sapiens	Inhibition	%	-7.18
	8143109	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1	Outside typical range	CHEMBL477979	=	Inhibition	%	-10.06	CHEMBL2634	Homo sapiens	Inhibition	%	-10.06
	8143264	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-1.23	CHEMBL2634	Homo sapiens	Inhibition	%	-1.23
	8143451	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-2.19	CHEMBL2634	Homo sapiens	Inhibition	%	-2.19
	8143675	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.94	CHEMBL2634	Homo sapiens	Inhibition	%	4.94
	8143834	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	4.63	CHEMBL2634	Homo sapiens	Inhibition	%	4.63
	8144172	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	0.44	CHEMBL2634	Homo sapiens	Inhibition	%	0.44
	8144311	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	5.15	CHEMBL2634	Homo sapiens	Inhibition	%	5.15
	8144665	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.23	CHEMBL2634	Homo sapiens	Inhibition	%	3.23
	8144818	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.99	CHEMBL2634	Homo sapiens	Inhibition	%	-0.99
	8145042	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.28	CHEMBL2634	Homo sapiens	Inhibition	%	2.28
	8145179	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	7.31	CHEMBL2634	Homo sapiens	Inhibition	%	7.31
	8145492	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.41	CHEMBL2634	Homo sapiens	Inhibition	%	0.41
	8145616	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.84	CHEMBL2634	Homo sapiens	Inhibition	%	0.84
	8145840	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.82	CHEMBL2634	Homo sapiens	Inhibition	%	4.82
	8146001	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.55	CHEMBL2634	Homo sapiens	Inhibition	%	10.55
	8146345	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.7	CHEMBL2634	Homo sapiens	Inhibition	%	1.7
	8146505	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.25	CHEMBL2634	Homo sapiens	Inhibition	%	2.25
	8146896	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.36	CHEMBL2634	Homo sapiens	Inhibition	%	-1.36
	8147065	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	-0.63	CHEMBL2634	Homo sapiens	Inhibition	%	-0.63
	8147431	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.19	CHEMBL2634	Homo sapiens	Inhibition	%	4.19
	8147584	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	4.88	CHEMBL2634	Homo sapiens	Inhibition	%	4.88
	8147995	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.27	CHEMBL2634	Homo sapiens	Inhibition	%	-0.27
	8148153	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	11.42	CHEMBL2634	Homo sapiens	Inhibition	%	11.42
	8148491	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	4.59	CHEMBL2634	Homo sapiens	Inhibition	%	4.59
	8148630	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.73	CHEMBL2634	Homo sapiens	Inhibition	%	2.73
	8148854	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.93	CHEMBL2634	Homo sapiens	Inhibition	%	2.93
	8148992	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.03	CHEMBL2634	Homo sapiens	Inhibition	%	3.03
	8149375	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.24	CHEMBL2634	Homo sapiens	Inhibition	%	3.24
	8149509	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	6.6	CHEMBL2634	Homo sapiens	Inhibition	%	6.6
	8149831	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	7.8	CHEMBL2634	Homo sapiens	Inhibition	%	7.8
	8150180	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.94	CHEMBL2634	Homo sapiens	Inhibition	%	2.94
	8150340	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	19.48	CHEMBL2634	Homo sapiens	Inhibition	%	19.48
	8150684	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	7.52	CHEMBL2634	Homo sapiens	Inhibition	%	7.52
	8150849	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-7.26	CHEMBL2634	Homo sapiens	Inhibition	%	-7.26
	8151073	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-4.71	CHEMBL2634	Homo sapiens	Inhibition	%	-4.71
	8151236	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1	Outside typical range	CHEMBL495902	=	Inhibition	%	-11.2	CHEMBL2634	Homo sapiens	Inhibition	%	-11.2
	8151413	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.28	CHEMBL2634	Homo sapiens	Inhibition	%	4.28
	8151775	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.44	CHEMBL2634	Homo sapiens	Inhibition	%	1.44
	8151929	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	2.1	CHEMBL2634	Homo sapiens	Inhibition	%	2.1
	8152153	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	7.02	CHEMBL2634	Homo sapiens	Inhibition	%	7.02
	8152341	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	5.89	CHEMBL2634	Homo sapiens	Inhibition	%	5.89
	8152499	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.22	CHEMBL2634	Homo sapiens	Inhibition	%	4.22
	8152723	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.75	CHEMBL2634	Homo sapiens	Inhibition	%	3.75
	8152837	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	1.43	CHEMBL2634	Homo sapiens	Inhibition	%	1.43
	8153200	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.47	CHEMBL2634	Homo sapiens	Inhibition	%	2.47
	8153337	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	4.26	CHEMBL2634	Homo sapiens	Inhibition	%	4.26
	8153718	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	4.77	CHEMBL2634	Homo sapiens	Inhibition	%	4.77
	8153851	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.43	CHEMBL2634	Homo sapiens	Inhibition	%	3.43
	8154075	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.95	CHEMBL2634	Homo sapiens	Inhibition	%	4.95
	8154172	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	23.03	CHEMBL2634	Homo sapiens	Inhibition	%	23.03
	8154522	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	35.26	CHEMBL2634	Homo sapiens	Inhibition	%	35.26
	8154681	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.96	CHEMBL2634	Homo sapiens	Inhibition	%	1.96
	8154905	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	3.24	CHEMBL2634	Homo sapiens	Inhibition	%	3.24
	8155025	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.03	CHEMBL2634	Homo sapiens	Inhibition	%	1.03
	8155425	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.9	CHEMBL2634	Homo sapiens	Inhibition	%	-0.9
	8155586	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1	Outside typical range	CHEMBL495902	=	Inhibition	%	-13.28	CHEMBL2634	Homo sapiens	Inhibition	%	-13.28
	8155764	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.85	CHEMBL2634	Homo sapiens	Inhibition	%	0.85
	8155988	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.97	CHEMBL2634	Homo sapiens	Inhibition	%	1.97
	8156126	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.57	CHEMBL2634	Homo sapiens	Inhibition	%	1.57
	8156338	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.09	CHEMBL2634	Homo sapiens	Inhibition	%	3.09
	8156562	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.33	CHEMBL2634	Homo sapiens	Inhibition	%	2.33
	8156712	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	10.12	CHEMBL2634	Homo sapiens	Inhibition	%	10.12
	8156855	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	6.51	CHEMBL2634	Homo sapiens	Inhibition	%	6.51
	8157079	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	5.89	CHEMBL2634	Homo sapiens	Inhibition	%	5.89
	8157199	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.88	CHEMBL2634	Homo sapiens	Inhibition	%	1.88
	8157564	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	4.48	CHEMBL2634	Homo sapiens	Inhibition	%	4.48
	8157694	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	11.72	CHEMBL2634	Homo sapiens	Inhibition	%	11.72
	8157918	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.93	CHEMBL2634	Homo sapiens	Inhibition	%	3.93
	8158079	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-3.17	CHEMBL2634	Homo sapiens	Inhibition	%	-3.17
	8158329	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	7.9	CHEMBL2634	Homo sapiens	Inhibition	%	7.9
	8158711	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.29	CHEMBL2634	Homo sapiens	Inhibition	%	-0.29
	8158880	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	3.87	CHEMBL2634	Homo sapiens	Inhibition	%	3.87
	8159239	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.67	CHEMBL2634	Homo sapiens	Inhibition	%	7.67
	8159359	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	2.47	CHEMBL2634	Homo sapiens	Inhibition	%	2.47
	8159583	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	3.65	CHEMBL2634	Homo sapiens	Inhibition	%	3.65
	8159714	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.32	CHEMBL2634	Homo sapiens	Inhibition	%	5.32
	8160079	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.76	CHEMBL2634	Homo sapiens	Inhibition	%	1.76
	8160216	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	6.19	CHEMBL2634	Homo sapiens	Inhibition	%	6.19
	8160590	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-1.06	CHEMBL2634	Homo sapiens	Inhibition	%	-1.06
	8160884	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.78	CHEMBL2634	Homo sapiens	Inhibition	%	2.78
	8161034	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.59	CHEMBL2634	Homo sapiens	Inhibition	%	3.59
	8161401	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.46	CHEMBL2634	Homo sapiens	Inhibition	%	4.46
	8161526	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.65	CHEMBL2634	Homo sapiens	Inhibition	%	5.65
	8161750	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.31	CHEMBL2634	Homo sapiens	Inhibition	%	1.31
	8161888	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	12.93	CHEMBL2634	Homo sapiens	Inhibition	%	12.93
	8162242	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.49	CHEMBL2634	Homo sapiens	Inhibition	%	5.49
	8162402	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.95	CHEMBL2634	Homo sapiens	Inhibition	%	-0.95
	8162655	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.91	CHEMBL2634	Homo sapiens	Inhibition	%	5.91
	8163027	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	2.77	CHEMBL2634	Homo sapiens	Inhibition	%	2.77
	8163196	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.29	CHEMBL2634	Homo sapiens	Inhibition	%	2.29
	8163554	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	7.44	CHEMBL2634	Homo sapiens	Inhibition	%	7.44
	8163901	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	5.05	CHEMBL2634	Homo sapiens	Inhibition	%	5.05
	8164035	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.66	CHEMBL2634	Homo sapiens	Inhibition	%	2.66
	8164399	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.2	CHEMBL2634	Homo sapiens	Inhibition	%	-0.2
	8164554	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.68	CHEMBL2634	Homo sapiens	Inhibition	%	3.68
	8164778	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.02	CHEMBL2634	Homo sapiens	Inhibition	%	5.02
	8164922	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.86	CHEMBL2634	Homo sapiens	Inhibition	%	-0.86
	8165216	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.99	CHEMBL2634	Homo sapiens	Inhibition	%	2.99
	8165357	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	13.06	CHEMBL2634	Homo sapiens	Inhibition	%	13.06
	8165581	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.73	CHEMBL2634	Homo sapiens	Inhibition	%	7.73
	8165724	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	14.9	CHEMBL2634	Homo sapiens	Inhibition	%	14.9
	8166074	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.08	CHEMBL2634	Homo sapiens	Inhibition	%	3.08
	8166212	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.6	CHEMBL2634	Homo sapiens	Inhibition	%	4.6
	8166566	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.74	CHEMBL2634	Homo sapiens	Inhibition	%	6.74
	8166891	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	67.92	CHEMBL2634	Homo sapiens	Inhibition	%	67.92
	8166979	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.06	CHEMBL2634	Homo sapiens	Inhibition	%	5.06
	8167203	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.95	CHEMBL2634	Homo sapiens	Inhibition	%	2.95
	8167344	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	3.77	CHEMBL2634	Homo sapiens	Inhibition	%	3.77
	8167508	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.06	CHEMBL2634	Homo sapiens	Inhibition	%	0.06
	8167732	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.21	CHEMBL2634	Homo sapiens	Inhibition	%	0.21
	8167865	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	5.53	CHEMBL2634	Homo sapiens	Inhibition	%	5.53
	8168213	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.78	CHEMBL2634	Homo sapiens	Inhibition	%	0.78
	8168354	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.58	CHEMBL2634	Homo sapiens	Inhibition	%	4.58
	8168578	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	6.17	CHEMBL2634	Homo sapiens	Inhibition	%	6.17
	8168714	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-2.23	CHEMBL2634	Homo sapiens	Inhibition	%	-2.23
	8169102	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	13.39	CHEMBL2634	Homo sapiens	Inhibition	%	13.39
	8169244	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.59	CHEMBL2634	Homo sapiens	Inhibition	%	3.59
	8169548	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.18	CHEMBL2634	Homo sapiens	Inhibition	%	2.18
	8169906	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	11.51	CHEMBL2634	Homo sapiens	Inhibition	%	11.51
	8170051	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.53	CHEMBL2634	Homo sapiens	Inhibition	%	3.53
	8170400	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	3.78	CHEMBL2634	Homo sapiens	Inhibition	%	3.78
	8170540	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	6.86	CHEMBL2634	Homo sapiens	Inhibition	%	6.86
	8170764	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.4	CHEMBL2634	Homo sapiens	Inhibition	%	5.4
	8170899	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	16.52	CHEMBL2634	Homo sapiens	Inhibition	%	16.52
	8171096	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-3.31	CHEMBL2634	Homo sapiens	Inhibition	%	-3.31
	8171320	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	21.04	CHEMBL2634	Homo sapiens	Inhibition	%	21.04
	8171537	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.94	CHEMBL2634	Homo sapiens	Inhibition	%	2.94
	8171678	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.59	CHEMBL2634	Homo sapiens	Inhibition	%	2.59
	8172055	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.19	CHEMBL2634	Homo sapiens	Inhibition	%	1.19
	8172187	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	8.91	CHEMBL2634	Homo sapiens	Inhibition	%	8.91
	8172411	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.52	CHEMBL2634	Homo sapiens	Inhibition	%	6.52
	8172539	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	1.35	CHEMBL2634	Homo sapiens	Inhibition	%	1.35
	8172905	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	7.7	CHEMBL2634	Homo sapiens	Inhibition	%	7.7
	8173041	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-7.29	CHEMBL2634	Homo sapiens	Inhibition	%	-7.29
	8173430	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	5.5	CHEMBL2634	Homo sapiens	Inhibition	%	5.5
	8173571	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.41	CHEMBL2634	Homo sapiens	Inhibition	%	0.41
	8173795	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	4.14	CHEMBL2634	Homo sapiens	Inhibition	%	4.14
	8173882	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	8.17	CHEMBL2634	Homo sapiens	Inhibition	%	8.17
	8174238	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	4.04	CHEMBL2634	Homo sapiens	Inhibition	%	4.04
	8174386	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	20.57	CHEMBL2634	Homo sapiens	Inhibition	%	20.57
	8174610	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.29	CHEMBL2634	Homo sapiens	Inhibition	%	1.29
	8174732	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	4.79	CHEMBL2634	Homo sapiens	Inhibition	%	4.79
	8175099	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	3.99	CHEMBL2634	Homo sapiens	Inhibition	%	3.99
	8175235	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.27	CHEMBL2634	Homo sapiens	Inhibition	%	4.27
	8175459	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	6.02	CHEMBL2634	Homo sapiens	Inhibition	%	6.02
	8175491	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.03	CHEMBL2634	Homo sapiens	Inhibition	%	3.03
	8175715	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	7.33	CHEMBL2634	Homo sapiens	Inhibition	%	7.33
	8175878	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	5.24	CHEMBL2634	Homo sapiens	Inhibition	%	5.24
	8176031	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	0.65	CHEMBL2634	Homo sapiens	Inhibition	%	0.65
	8176255	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	3.09	CHEMBL2634	Homo sapiens	Inhibition	%	3.09
	8176404	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	4.81	CHEMBL2634	Homo sapiens	Inhibition	%	4.81
	8176760	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.18	CHEMBL2634	Homo sapiens	Inhibition	%	9.18
	8176890	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.0	CHEMBL2634	Homo sapiens	Inhibition	%	1.0
	8177256	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	8.08	CHEMBL2634	Homo sapiens	Inhibition	%	8.08
	8177394	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-3.46	CHEMBL2634	Homo sapiens	Inhibition	%	-3.46
	8177618	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.3	CHEMBL2634	Homo sapiens	Inhibition	%	4.3
	8177782	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	16.81	CHEMBL2634	Homo sapiens	Inhibition	%	16.81
	8178146	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	-1.69	CHEMBL2634	Homo sapiens	Inhibition	%	-1.69
	8178234	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	9.56	CHEMBL2634	Homo sapiens	Inhibition	%	9.56
	8178458	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.6	CHEMBL2634	Homo sapiens	Inhibition	%	0.6
	8178585	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	24.82	CHEMBL2634	Homo sapiens	Inhibition	%	24.82
	8178958	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-3.57	CHEMBL2634	Homo sapiens	Inhibition	%	-3.57
	8179081	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.58	CHEMBL2634	Homo sapiens	Inhibition	%	5.58
	8179305	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	7.41	CHEMBL2634	Homo sapiens	Inhibition	%	7.41
	8179449	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.94	CHEMBL2634	Homo sapiens	Inhibition	%	2.94
	8179810	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.98	CHEMBL2634	Homo sapiens	Inhibition	%	1.98
	8180067	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.02	CHEMBL2634	Homo sapiens	Inhibition	%	4.02
	8180221	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	22.37	CHEMBL2634	Homo sapiens	Inhibition	%	22.37
	8180601	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.46	CHEMBL2634	Homo sapiens	Inhibition	%	1.46
	8180749	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.3	CHEMBL2634	Homo sapiens	Inhibition	%	2.3
	8181106	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	70.29	CHEMBL2634	Homo sapiens	Inhibition	%	70.29
	8181237	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.94	CHEMBL2634	Homo sapiens	Inhibition	%	1.94
	8181461	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-5.47	CHEMBL2634	Homo sapiens	Inhibition	%	-5.47
	8181601	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	43.39	CHEMBL2634	Homo sapiens	Inhibition	%	43.39
	8181964	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	9.75	CHEMBL2634	Homo sapiens	Inhibition	%	9.75
	8182127	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.94	CHEMBL2634	Homo sapiens	Inhibition	%	5.94
	8182491	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.84	CHEMBL2634	Homo sapiens	Inhibition	%	1.84
	8182807	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.76	CHEMBL2634	Homo sapiens	Inhibition	%	2.76
	8182929	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.3	CHEMBL2634	Homo sapiens	Inhibition	%	3.3
	8183153	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	11.4	CHEMBL2634	Homo sapiens	Inhibition	%	11.4
	8183302	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.51	CHEMBL2634	Homo sapiens	Inhibition	%	-0.51
	8183655	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.13	CHEMBL2634	Homo sapiens	Inhibition	%	-0.13
	8183797	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	7.78	CHEMBL2634	Homo sapiens	Inhibition	%	7.78
	8184157	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	5.5	CHEMBL2634	Homo sapiens	Inhibition	%	5.5
	8184423	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	6.5	CHEMBL2634	Homo sapiens	Inhibition	%	6.5
	8184570	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.68	CHEMBL2634	Homo sapiens	Inhibition	%	2.68
	8184794	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.12	CHEMBL2634	Homo sapiens	Inhibition	%	1.12
	8184951	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	3.81	CHEMBL2634	Homo sapiens	Inhibition	%	3.81
	8185100	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	0.76	CHEMBL2634	Homo sapiens	Inhibition	%	0.76
	8185324	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.86	CHEMBL2634	Homo sapiens	Inhibition	%	-0.86
	8185455	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	94.23	CHEMBL2634	Homo sapiens	Inhibition	%	94.23
	8185810	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-4.0	CHEMBL2634	Homo sapiens	Inhibition	%	-4.0
	8185949	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.97	CHEMBL2634	Homo sapiens	Inhibition	%	2.97
	8186173	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.74	CHEMBL2634	Homo sapiens	Inhibition	%	4.74
	8186314	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	4.89	CHEMBL2634	Homo sapiens	Inhibition	%	4.89
	8186478	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.38	CHEMBL2634	Homo sapiens	Inhibition	%	5.38
	8186702	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.99	CHEMBL2634	Homo sapiens	Inhibition	%	7.99
	8186841	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.02	CHEMBL2634	Homo sapiens	Inhibition	%	0.02
	8187163	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.27	CHEMBL2634	Homo sapiens	Inhibition	%	4.27
	8187511	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	8.18	CHEMBL2634	Homo sapiens	Inhibition	%	8.18
	8187659	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	10.58	CHEMBL2634	Homo sapiens	Inhibition	%	10.58
	8188012	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	6.46	CHEMBL2634	Homo sapiens	Inhibition	%	6.46
	8188155	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.9	CHEMBL2634	Homo sapiens	Inhibition	%	4.9
	8188379	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	7.01	CHEMBL2634	Homo sapiens	Inhibition	%	7.01
	8188514	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	5.8	CHEMBL2634	Homo sapiens	Inhibition	%	5.8
	8188788	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	5.63	CHEMBL2634	Homo sapiens	Inhibition	%	5.63
	8189160	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	0.38	CHEMBL2634	Homo sapiens	Inhibition	%	0.38
	8189316	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	12.45	CHEMBL2634	Homo sapiens	Inhibition	%	12.45
	8189689	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-2.55	CHEMBL2634	Homo sapiens	Inhibition	%	-2.55
	8189821	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.24	CHEMBL2634	Homo sapiens	Inhibition	%	3.24
	8190045	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	8.24	CHEMBL2634	Homo sapiens	Inhibition	%	8.24
	8190177	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.21	CHEMBL2634	Homo sapiens	Inhibition	%	3.21
	8190541	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.98	CHEMBL2634	Homo sapiens	Inhibition	%	5.98
	8190678	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	8.37	CHEMBL2634	Homo sapiens	Inhibition	%	8.37
	8191066	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	9.3	CHEMBL2634	Homo sapiens	Inhibition	%	9.3
	8191204	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.68	CHEMBL2634	Homo sapiens	Inhibition	%	3.68
	8191428	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.47	CHEMBL2634	Homo sapiens	Inhibition	%	1.47
	8191524	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	25.53	CHEMBL2634	Homo sapiens	Inhibition	%	25.53
	8191870	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	12.22	CHEMBL2634	Homo sapiens	Inhibition	%	12.22
	8192019	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.29	CHEMBL2634	Homo sapiens	Inhibition	%	1.29
	8192243	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.54	CHEMBL2634	Homo sapiens	Inhibition	%	0.54
	8192372	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.65	CHEMBL2634	Homo sapiens	Inhibition	%	3.65
	8192740	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	4.87	CHEMBL2634	Homo sapiens	Inhibition	%	4.87
	8192876	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	18.19	CHEMBL2634	Homo sapiens	Inhibition	%	18.19
	8193148	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	17.68	CHEMBL2634	Homo sapiens	Inhibition	%	17.68
	8193517	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-1.57	CHEMBL2634	Homo sapiens	Inhibition	%	-1.57
	8193674	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.86	CHEMBL2634	Homo sapiens	Inhibition	%	3.86
	8193898	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	-0.23	CHEMBL2634	Homo sapiens	Inhibition	%	-0.23
	8194047	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-7.4	CHEMBL2634	Homo sapiens	Inhibition	%	-7.4
	8194402	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	5.1	CHEMBL2634	Homo sapiens	Inhibition	%	5.1
	8194533	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.65	CHEMBL2634	Homo sapiens	Inhibition	%	3.65
	8194900	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	16.1	CHEMBL2634	Homo sapiens	Inhibition	%	16.1
	8195033	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	7.33	CHEMBL2634	Homo sapiens	Inhibition	%	7.33
	8195257	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.66	CHEMBL2634	Homo sapiens	Inhibition	%	8.66
	8195421	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	6.31	CHEMBL2634	Homo sapiens	Inhibition	%	6.31
	8195784	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.92	CHEMBL2634	Homo sapiens	Inhibition	%	3.92
	8195882	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.42	CHEMBL2634	Homo sapiens	Inhibition	%	1.42
	8196106	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	6.65	CHEMBL2634	Homo sapiens	Inhibition	%	6.65
	8196223	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.17	CHEMBL2634	Homo sapiens	Inhibition	%	8.17
	8196597	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	3.99	CHEMBL2634	Homo sapiens	Inhibition	%	3.99
	8196725	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	6.32	CHEMBL2634	Homo sapiens	Inhibition	%	6.32
	8197090	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.89	CHEMBL2634	Homo sapiens	Inhibition	%	9.89
	8197227	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	-0.12	CHEMBL2634	Homo sapiens	Inhibition	%	-0.12
	8197451	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.11	CHEMBL2634	Homo sapiens	Inhibition	%	0.11
	8197502	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.77	CHEMBL2634	Homo sapiens	Inhibition	%	0.77
	8197726	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.4	CHEMBL2634	Homo sapiens	Inhibition	%	5.4
	8197866	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.5	CHEMBL2634	Homo sapiens	Inhibition	%	0.5
	8198247	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	7.37	CHEMBL2634	Homo sapiens	Inhibition	%	7.37
	8198385	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.39	CHEMBL2634	Homo sapiens	Inhibition	%	-3.39
	8198739	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	16.83	CHEMBL2634	Homo sapiens	Inhibition	%	16.83
	8198870	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.38	CHEMBL2634	Homo sapiens	Inhibition	%	3.38
	8199094	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.75	CHEMBL2634	Homo sapiens	Inhibition	%	0.75
	8199242	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	17.45	CHEMBL2634	Homo sapiens	Inhibition	%	17.45
	8199600	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.79	CHEMBL2634	Homo sapiens	Inhibition	%	2.79
	8199763	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	7.85	CHEMBL2634	Homo sapiens	Inhibition	%	7.85
	8200125	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.94	CHEMBL2634	Homo sapiens	Inhibition	%	3.94
	8200453	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.47	CHEMBL2634	Homo sapiens	Inhibition	%	0.47
	8200568	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	30.9	CHEMBL2634	Homo sapiens	Inhibition	%	30.9
	8200942	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	14.46	CHEMBL2634	Homo sapiens	Inhibition	%	14.46
	8201072	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	4.25	CHEMBL2634	Homo sapiens	Inhibition	%	4.25
	8201296	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	9.5	CHEMBL2634	Homo sapiens	Inhibition	%	9.5
	8201431	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.58	CHEMBL2634	Homo sapiens	Inhibition	%	4.58
	8201788	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.71	CHEMBL2634	Homo sapiens	Inhibition	%	-0.71
	8202067	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.85	CHEMBL2634	Homo sapiens	Inhibition	%	2.85
	8202207	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	4.61	CHEMBL2634	Homo sapiens	Inhibition	%	4.61
	8202598	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.61	CHEMBL2634	Homo sapiens	Inhibition	%	4.61
	8202723	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	5.1	CHEMBL2634	Homo sapiens	Inhibition	%	5.1
	8202947	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	6.45	CHEMBL2634	Homo sapiens	Inhibition	%	6.45
	8203077	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	6.16	CHEMBL2634	Homo sapiens	Inhibition	%	6.16
	8203432	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	5.79	CHEMBL2634	Homo sapiens	Inhibition	%	5.79
	8203578	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	55.27	CHEMBL2634	Homo sapiens	Inhibition	%	55.27
	8203936	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	6.87	CHEMBL2634	Homo sapiens	Inhibition	%	6.87
	8204102	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	7.62	CHEMBL2634	Homo sapiens	Inhibition	%	7.62
	8204326	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	32.91	CHEMBL2634	Homo sapiens	Inhibition	%	32.91
	8204463	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	14.52	CHEMBL2634	Homo sapiens	Inhibition	%	14.52
	8204792	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	5.89	CHEMBL2634	Homo sapiens	Inhibition	%	5.89
	8204907	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	7.17	CHEMBL2634	Homo sapiens	Inhibition	%	7.17
	8205131	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	24.9	CHEMBL2634	Homo sapiens	Inhibition	%	24.9
	8205280	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.84	CHEMBL2634	Homo sapiens	Inhibition	%	10.84
	8205640	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.08	CHEMBL2634	Homo sapiens	Inhibition	%	3.08
	8205779	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	5.2	CHEMBL2634	Homo sapiens	Inhibition	%	5.2
	8206135	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-1.23	CHEMBL2634	Homo sapiens	Inhibition	%	-1.23
	8206411	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.03	CHEMBL2634	Homo sapiens	Inhibition	%	2.03
	8206554	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-4.69	CHEMBL2634	Homo sapiens	Inhibition	%	-4.69
	8206778	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-6.6	CHEMBL2634	Homo sapiens	Inhibition	%	-6.6
	8206958	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.79	CHEMBL2634	Homo sapiens	Inhibition	%	1.79
	8207308	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.57	CHEMBL2634	Homo sapiens	Inhibition	%	5.57
	8207438	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.51	CHEMBL2634	Homo sapiens	Inhibition	%	3.51
	8207794	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	19.0	CHEMBL2634	Homo sapiens	Inhibition	%	19.0
	8207939	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	5.75	CHEMBL2634	Homo sapiens	Inhibition	%	5.75
	8208163	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.9	CHEMBL2634	Homo sapiens	Inhibition	%	1.9
	8208295	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	7.77	CHEMBL2634	Homo sapiens	Inhibition	%	7.77
	8208685	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.44	CHEMBL2634	Homo sapiens	Inhibition	%	4.44
	8208818	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	57.07	CHEMBL2634	Homo sapiens	Inhibition	%	57.07
	8209147	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.57	CHEMBL2634	Homo sapiens	Inhibition	%	0.57
	8209487	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	9.09	CHEMBL2634	Homo sapiens	Inhibition	%	9.09
	8209637	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.31	CHEMBL2634	Homo sapiens	Inhibition	%	5.31
	8209997	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	7.45	CHEMBL2634	Homo sapiens	Inhibition	%	7.45
	8210138	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	4.41	CHEMBL2634	Homo sapiens	Inhibition	%	4.41
	8210362	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.95	CHEMBL2634	Homo sapiens	Inhibition	%	5.95
	8210498	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%		CHEMBL2634	Homo sapiens	Inhibition	%	
	8210757	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	3.38	CHEMBL2634	Homo sapiens	Inhibition	%	3.38
	8211125	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.76	CHEMBL2634	Homo sapiens	Inhibition	%	1.76
	8211295	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.67	CHEMBL2634	Homo sapiens	Inhibition	%	1.67
	8211642	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	6.75	CHEMBL2634	Homo sapiens	Inhibition	%	6.75
	8211771	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	8.35	CHEMBL2634	Homo sapiens	Inhibition	%	8.35
	8211995	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	10.89	CHEMBL2634	Homo sapiens	Inhibition	%	10.89
	8212127	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.62	CHEMBL2634	Homo sapiens	Inhibition	%	5.62
	8212492	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.39	CHEMBL2634	Homo sapiens	Inhibition	%	3.39
	8212625	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	10.28	CHEMBL2634	Homo sapiens	Inhibition	%	10.28
	8212849	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.99	CHEMBL2634	Homo sapiens	Inhibition	%	7.99
	8213019	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	8.49	CHEMBL2634	Homo sapiens	Inhibition	%	8.49
	8213148	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.81	CHEMBL2634	Homo sapiens	Inhibition	%	3.81
	8213372	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.08	CHEMBL2634	Homo sapiens	Inhibition	%	2.08
	8213476	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	4.82	CHEMBL2634	Homo sapiens	Inhibition	%	4.82
	8213813	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	4.7	CHEMBL2634	Homo sapiens	Inhibition	%	4.7
	8213960	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	6.64	CHEMBL2634	Homo sapiens	Inhibition	%	6.64
	8214184	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.04	CHEMBL2634	Homo sapiens	Inhibition	%	2.04
	8214321	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.29	CHEMBL2634	Homo sapiens	Inhibition	%	4.29
	8214679	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	10.78	CHEMBL2634	Homo sapiens	Inhibition	%	10.78
	8214831	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-4.84	CHEMBL2634	Homo sapiens	Inhibition	%	-4.84
	8215082	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	5.62	CHEMBL2634	Homo sapiens	Inhibition	%	5.62
	8215306	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.1	CHEMBL2634	Homo sapiens	Inhibition	%	2.1
	8215459	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	0.42	CHEMBL2634	Homo sapiens	Inhibition	%	0.42
	8215623	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.21	CHEMBL2634	Homo sapiens	Inhibition	%	3.21
	8215847	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.68	CHEMBL2634	Homo sapiens	Inhibition	%	2.68
	8215966	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	5.74	CHEMBL2634	Homo sapiens	Inhibition	%	5.74
	8216309	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.79	CHEMBL2634	Homo sapiens	Inhibition	%	4.79
	8216445	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	4.74	CHEMBL2634	Homo sapiens	Inhibition	%	4.74
	8216669	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.49	CHEMBL2634	Homo sapiens	Inhibition	%	5.49
	8216807	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	5.61	CHEMBL2634	Homo sapiens	Inhibition	%	5.61
	8217165	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	7.37	CHEMBL2634	Homo sapiens	Inhibition	%	7.37
	8217339	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.92	CHEMBL2634	Homo sapiens	Inhibition	%	4.92
	8217694	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	7.28	CHEMBL2634	Homo sapiens	Inhibition	%	7.28
	8217795	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-3.37	CHEMBL2634	Homo sapiens	Inhibition	%	-3.37
	8218019	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-4.62	CHEMBL2634	Homo sapiens	Inhibition	%	-4.62
	8218134	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	6.25	CHEMBL2634	Homo sapiens	Inhibition	%	6.25
	8218485	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	3.74	CHEMBL2634	Homo sapiens	Inhibition	%	3.74
	8218628	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	10.12	CHEMBL2634	Homo sapiens	Inhibition	%	10.12
	8218852	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	10.92	CHEMBL2634	Homo sapiens	Inhibition	%	10.92
	8218983	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	35.43	CHEMBL2634	Homo sapiens	Inhibition	%	35.43
	8219143	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-3.84	CHEMBL2634	Homo sapiens	Inhibition	%	-3.84
	8219367	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-4.36	CHEMBL2634	Homo sapiens	Inhibition	%	-4.36
	8219617	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.85	CHEMBL2634	Homo sapiens	Inhibition	%	2.85
	8219778	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.45	CHEMBL2634	Homo sapiens	Inhibition	%	2.45
	8220171	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.33	CHEMBL2634	Homo sapiens	Inhibition	%	3.33
	8220300	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	6.92	CHEMBL2634	Homo sapiens	Inhibition	%	6.92
	8220638	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.85	CHEMBL2634	Homo sapiens	Inhibition	%	4.85
	8221000	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	4.47	CHEMBL2634	Homo sapiens	Inhibition	%	4.47
	8221136	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.48	CHEMBL2634	Homo sapiens	Inhibition	%	3.48
	8221493	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.06	CHEMBL2634	Homo sapiens	Inhibition	%	5.06
	8221658	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.07	CHEMBL2634	Homo sapiens	Inhibition	%	1.07
	8222013	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.26	CHEMBL2634	Homo sapiens	Inhibition	%	4.26
	8222335	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.68	CHEMBL2634	Homo sapiens	Inhibition	%	2.68
	8222469	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.75	CHEMBL2634	Homo sapiens	Inhibition	%	2.75
	8222811	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	22.03	CHEMBL2634	Homo sapiens	Inhibition	%	22.03
	8223179	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	60.97	CHEMBL2634	Homo sapiens	Inhibition	%	60.97
	8223308	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.64	CHEMBL2634	Homo sapiens	Inhibition	%	2.64
	8223693	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.54	CHEMBL2634	Homo sapiens	Inhibition	%	0.54
	8223943	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	3.76	CHEMBL2634	Homo sapiens	Inhibition	%	3.76
	8224105	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.88	CHEMBL2634	Homo sapiens	Inhibition	%	0.88
	8224329	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.53	CHEMBL2634	Homo sapiens	Inhibition	%	2.53
	8224499	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.27	CHEMBL2634	Homo sapiens	Inhibition	%	3.27
	8224634	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.69	CHEMBL2634	Homo sapiens	Inhibition	%	4.69
	8224858	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	8.34	CHEMBL2634	Homo sapiens	Inhibition	%	8.34
	8224972	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.43	CHEMBL2634	Homo sapiens	Inhibition	%	4.43
	8225330	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.63	CHEMBL2634	Homo sapiens	Inhibition	%	4.63
	8225468	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.45	CHEMBL2634	Homo sapiens	Inhibition	%	1.45
	8225692	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.01	CHEMBL2634	Homo sapiens	Inhibition	%	1.01
	8225827	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	7.02	CHEMBL2634	Homo sapiens	Inhibition	%	7.02
	8225985	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.09	CHEMBL2634	Homo sapiens	Inhibition	%	4.09
	8226209	CHEMBL1962255	GSK_PKIS: CSK mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.13	CHEMBL2634	Homo sapiens	Inhibition	%	3.13
	8226334	CHEMBL1962254	GSK_PKIS: CSK mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	10.2	CHEMBL2634	Homo sapiens	Inhibition	%	10.2
	10838557	CHEMBL2014130	Inhibition of CSK at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	10839601	CHEMBL2015001	Inhibition of CSK assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	33.0	CHEMBL2634	Homo sapiens	Activity	%	33.0
	10839674	CHEMBL2015845	Inhibition of CSK assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	10949780	CHEMBL2050662	Inhibition of CSK using ATP preincubated with compound for 5 mins measured after 10 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	=	IC50	nM	3900.0	CHEMBL2634	Homo sapiens	IC50	nM	3900.0
Not Active	10986944	CHEMBL2072248	Inhibition of CSK at 10 uM	B	NS(=O)(=O)c1cc(-c2nc3ccccc3s2)cs1		CHEMBL2069711		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	10991141	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	COc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070045	=	IC50	nM	2600.0	CHEMBL2634	Homo sapiens	IC50	uM	2.6
	10991142	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	COc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070047	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	10991143	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070048	=	IC50	nM	3100.0	CHEMBL2634	Homo sapiens	IC50	uM	3.1
	10991144	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070050	=	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	10991145	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2n1.Cl		CHEMBL2070051	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	10991146	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(C4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070075	=	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	10991147	CHEMBL2072948	Inhibition of human CSK using Ac-KKKKEEIYFFF-OH as substrate after 180 mins	B	CCOc1ccc2cc(-c3nn(CC4CCN(C)CC4)c4ncnc(N)c34)ccc2c1.Cl		CHEMBL2070081	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	12036420	CHEMBL2150256	Inhibition of CSK after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	=	IC50	nM	5100.0	CHEMBL2634	Homo sapiens	IC50	nM	5100.0
	12046278	CHEMBL2156515	Inhibition of CSK at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	3.5	CHEMBL2634	Homo sapiens	INH	%	3.5
	12074626	CHEMBL2161023	Inhibition of Csk at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	12074675	CHEMBL2161396	Inhibition of CSK at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	12170826	CHEMBL2212693	Inhibition of CSK assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	104.0	CHEMBL2634	Homo sapiens	Activity	%	104.0
	12172127	CHEMBL2213952	Inhibition of CSK assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	114.0	CHEMBL2634	Homo sapiens	Activity	%	114.0
	12173680	CHEMBL2209316	Inhibition of CSK assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	12183903	CHEMBL2211481	Inhibition of CSK	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	pIC50		5.0
	12227560	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227561	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227562	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	114.0	CHEMBL2634	Homo sapiens	Residual Activity	%	114.0
	12227563	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227564	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227565	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227566	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	114.0	CHEMBL2634	Homo sapiens	Residual Activity	%	114.0
	12227567	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227568	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	110.0	CHEMBL2634	Homo sapiens	Residual Activity	%	110.0
	12227569	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227570	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227571	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227572	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227573	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	82.0	CHEMBL2634	Homo sapiens	Residual Activity	%	82.0
	12227574	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	117.0	CHEMBL2634	Homo sapiens	Residual Activity	%	117.0
	12227575	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227576	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227577	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12227578	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227579	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12227580	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227581	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12227582	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	112.0	CHEMBL2634	Homo sapiens	Residual Activity	%	112.0
	12227583	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227584	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227585	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227586	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227587	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12227588	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227589	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227590	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	121.0	CHEMBL2634	Homo sapiens	Residual Activity	%	121.0
	12227591	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	72.0	CHEMBL2634	Homo sapiens	Residual Activity	%	72.0
	12227592	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	112.0	CHEMBL2634	Homo sapiens	Residual Activity	%	112.0
	12227593	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227594	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227595	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227596	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	80.0	CHEMBL2634	Homo sapiens	Residual Activity	%	80.0
	12227597	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL2634	Homo sapiens	Residual Activity	%	112.0
	12227598	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	112.0	CHEMBL2634	Homo sapiens	Residual Activity	%	112.0
	12227599	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227600	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	113.0	CHEMBL2634	Homo sapiens	Residual Activity	%	113.0
	12227601	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	120.0	CHEMBL2634	Homo sapiens	Residual Activity	%	120.0
	12227602	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227603	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12227604	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227605	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	114.0	CHEMBL2634	Homo sapiens	Residual Activity	%	114.0
	12227606	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227607	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	121.0	CHEMBL2634	Homo sapiens	Residual Activity	%	121.0
	12227608	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	123.0	CHEMBL2634	Homo sapiens	Residual Activity	%	123.0
	12227609	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	127.0	CHEMBL2634	Homo sapiens	Residual Activity	%	127.0
	12227610	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227611	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL2634	Homo sapiens	Residual Activity	%	0.0
	12227612	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227613	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	112.0	CHEMBL2634	Homo sapiens	Residual Activity	%	112.0
	12227614	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227615	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	117.0	CHEMBL2634	Homo sapiens	Residual Activity	%	117.0
	12227616	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12227617	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	120.0	CHEMBL2634	Homo sapiens	Residual Activity	%	120.0
	12227618	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227619	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227620	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227621	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	82.0	CHEMBL2634	Homo sapiens	Residual Activity	%	82.0
	12227622	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227623	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227624	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	114.0	CHEMBL2634	Homo sapiens	Residual Activity	%	114.0
	12227625	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	116.0	CHEMBL2634	Homo sapiens	Residual Activity	%	116.0
	12227626	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12227627	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	121.0	CHEMBL2634	Homo sapiens	Residual Activity	%	121.0
	12227628	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227629	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	12.0	CHEMBL2634	Homo sapiens	Residual Activity	%	12.0
	12227630	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	123.0	CHEMBL2634	Homo sapiens	Residual Activity	%	123.0
	12227631	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12227632	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	122.0	CHEMBL2634	Homo sapiens	Residual Activity	%	122.0
	12227633	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12227634	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	117.0	CHEMBL2634	Homo sapiens	Residual Activity	%	117.0
	12227635	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	119.0	CHEMBL2634	Homo sapiens	Residual Activity	%	119.0
	12227636	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	121.0	CHEMBL2634	Homo sapiens	Residual Activity	%	121.0
	12227637	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12227638	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227639	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	29.0	CHEMBL2634	Homo sapiens	Residual Activity	%	29.0
	12227640	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227641	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12227642	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227643	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227644	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227645	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227646	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227647	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227648	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227649	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227650	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227651	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227652	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227653	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227654	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227655	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227656	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227657	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	116.0	CHEMBL2634	Homo sapiens	Residual Activity	%	116.0
	12227658	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12227659	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12227660	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	97.0	CHEMBL2634	Homo sapiens	Residual Activity	%	97.0
	12227661	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	71.0	CHEMBL2634	Homo sapiens	Residual Activity	%	71.0
	12227662	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227663	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227664	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227665	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227666	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227667	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	86.0	CHEMBL2634	Homo sapiens	Residual Activity	%	86.0
	12227668	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	113.0	CHEMBL2634	Homo sapiens	Residual Activity	%	113.0
	12227669	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227670	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12227671	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12227672	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227673	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	110.0	CHEMBL2634	Homo sapiens	Residual Activity	%	110.0
	12227674	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227675	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12227676	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12227677	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12227678	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	114.0	CHEMBL2634	Homo sapiens	Residual Activity	%	114.0
	12227679	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227680	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227681	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227682	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227683	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227684	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227685	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	110.0	CHEMBL2634	Homo sapiens	Residual Activity	%	110.0
	12227686	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12227687	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12227688	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12227689	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227690	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227691	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	81.0	CHEMBL2634	Homo sapiens	Residual Activity	%	81.0
	12227692	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227693	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227694	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	79.0	CHEMBL2634	Homo sapiens	Residual Activity	%	79.0
	12227695	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12227696	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	123.0	CHEMBL2634	Homo sapiens	Residual Activity	%	123.0
	12227697	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227698	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	94.0	CHEMBL2634	Homo sapiens	Residual Activity	%	94.0
	12227699	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227700	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12227701	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227702	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227703	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227704	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	119.0	CHEMBL2634	Homo sapiens	Residual Activity	%	119.0
	12227705	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	123.0	CHEMBL2634	Homo sapiens	Residual Activity	%	123.0
	12227706	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12227707	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12227708	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12227709	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	123.0	CHEMBL2634	Homo sapiens	Residual Activity	%	123.0
	12227710	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	110.0	CHEMBL2634	Homo sapiens	Residual Activity	%	110.0
	12227711	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	121.0	CHEMBL2634	Homo sapiens	Residual Activity	%	121.0
	12227712	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	122.0	CHEMBL2634	Homo sapiens	Residual Activity	%	122.0
	12227713	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227714	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	120.0	CHEMBL2634	Homo sapiens	Residual Activity	%	120.0
	12227715	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227716	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	126.0	CHEMBL2634	Homo sapiens	Residual Activity	%	126.0
	12227717	CHEMBL2219006	Millipore: Percentage of residual kinase activity of CSK at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12227718	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227719	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227720	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227721	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	83.0	CHEMBL2634	Homo sapiens	Residual Activity	%	83.0
	12227722	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12227723	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12227724	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12227725	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	80.0	CHEMBL2634	Homo sapiens	Residual Activity	%	80.0
	12227726	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227727	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	97.0	CHEMBL2634	Homo sapiens	Residual Activity	%	97.0
	12227728	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12227729	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227730	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12227731	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	20.0	CHEMBL2634	Homo sapiens	Residual Activity	%	20.0
	12227732	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	83.0	CHEMBL2634	Homo sapiens	Residual Activity	%	83.0
	12227733	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	109.0	CHEMBL2634	Homo sapiens	Residual Activity	%	109.0
	12227734	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227735	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227736	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12227737	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12227738	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227739	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12227740	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12227741	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	91.0	CHEMBL2634	Homo sapiens	Residual Activity	%	91.0
	12227742	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	91.0	CHEMBL2634	Homo sapiens	Residual Activity	%	91.0
	12227743	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	66.0	CHEMBL2634	Homo sapiens	Residual Activity	%	66.0
	12227744	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	89.0	CHEMBL2634	Homo sapiens	Residual Activity	%	89.0
	12227745	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	76.0	CHEMBL2634	Homo sapiens	Residual Activity	%	76.0
	12227746	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	113.0	CHEMBL2634	Homo sapiens	Residual Activity	%	113.0
	12227747	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	78.0	CHEMBL2634	Homo sapiens	Residual Activity	%	78.0
	12227748	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12227749	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	35.0	CHEMBL2634	Homo sapiens	Residual Activity	%	35.0
	12227750	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	89.0	CHEMBL2634	Homo sapiens	Residual Activity	%	89.0
	12227751	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	120.0	CHEMBL2634	Homo sapiens	Residual Activity	%	120.0
	12227752	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12227753	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12227754	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	29.0	CHEMBL2634	Homo sapiens	Residual Activity	%	29.0
	12227755	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12227756	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12227757	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227758	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227759	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12227760	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12227761	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	73.0	CHEMBL2634	Homo sapiens	Residual Activity	%	73.0
	12227762	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	69.0	CHEMBL2634	Homo sapiens	Residual Activity	%	69.0
	12227763	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12227764	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12227765	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	97.0	CHEMBL2634	Homo sapiens	Residual Activity	%	97.0
	12230295	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL2634	Homo sapiens	Residual Activity	%	115.0
	12230296	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12230297	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	83.0	CHEMBL2634	Homo sapiens	Residual Activity	%	83.0
	12230298	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	-1.0	CHEMBL2634	Homo sapiens	Residual Activity	%	-1.0
	12230299	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230300	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12230301	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230302	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12230303	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12230304	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12230305	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230306	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12230307	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	108.0	CHEMBL2634	Homo sapiens	Residual Activity	%	108.0
	12230308	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	78.0	CHEMBL2634	Homo sapiens	Residual Activity	%	78.0
	12230309	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230310	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230311	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	113.0	CHEMBL2634	Homo sapiens	Residual Activity	%	113.0
	12230312	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	119.0	CHEMBL2634	Homo sapiens	Residual Activity	%	119.0
	12230313	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	118.0	CHEMBL2634	Homo sapiens	Residual Activity	%	118.0
	12230314	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	117.0	CHEMBL2634	Homo sapiens	Residual Activity	%	117.0
	12230315	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230316	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	3.0	CHEMBL2634	Homo sapiens	Residual Activity	%	3.0
	12230317	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12230318	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230319	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230320	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	62.0	CHEMBL2634	Homo sapiens	Residual Activity	%	62.0
	12230321	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12230322	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	127.0	CHEMBL2634	Homo sapiens	Residual Activity	%	127.0
	12230323	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	117.0	CHEMBL2634	Homo sapiens	Residual Activity	%	117.0
	12230324	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230325	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	94.0	CHEMBL2634	Homo sapiens	Residual Activity	%	94.0
	12230326	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	4.0	CHEMBL2634	Homo sapiens	Residual Activity	%	4.0
	12230327	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230328	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230329	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230330	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12230331	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	94.0	CHEMBL2634	Homo sapiens	Residual Activity	%	94.0
	12230332	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL2634	Homo sapiens	Residual Activity	%	107.0
	12230333	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230334	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	98.0	CHEMBL2634	Homo sapiens	Residual Activity	%	98.0
	12230335	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230336	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	78.0	CHEMBL2634	Homo sapiens	Residual Activity	%	78.0
	12230337	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12230338	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12230339	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	83.0	CHEMBL2634	Homo sapiens	Residual Activity	%	83.0
	12230340	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230341	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	97.0	CHEMBL2634	Homo sapiens	Residual Activity	%	97.0
	12230342	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230343	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12230344	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12230345	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12230346	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230347	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	58.0	CHEMBL2634	Homo sapiens	Residual Activity	%	58.0
	12230348	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	18.0	CHEMBL2634	Homo sapiens	Residual Activity	%	18.0
	12230349	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	111.0	CHEMBL2634	Homo sapiens	Residual Activity	%	111.0
	12230350	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230351	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12230352	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230353	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL2634	Homo sapiens	Residual Activity	%	89.0
	12230354	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	88.0	CHEMBL2634	Homo sapiens	Residual Activity	%	88.0
	12230355	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230356	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	81.0	CHEMBL2634	Homo sapiens	Residual Activity	%	81.0
	12230357	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	105.0	CHEMBL2634	Homo sapiens	Residual Activity	%	105.0
	12230358	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12230359	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12230360	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230361	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230362	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12230363	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	56.0	CHEMBL2634	Homo sapiens	Residual Activity	%	56.0
	12230364	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	84.0	CHEMBL2634	Homo sapiens	Residual Activity	%	84.0
	12230365	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	94.0	CHEMBL2634	Homo sapiens	Residual Activity	%	94.0
	12230366	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	101.0	CHEMBL2634	Homo sapiens	Residual Activity	%	101.0
	12230367	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230368	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	69.0	CHEMBL2634	Homo sapiens	Residual Activity	%	69.0
	12230369	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	88.0	CHEMBL2634	Homo sapiens	Residual Activity	%	88.0
	12230370	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	94.0	CHEMBL2634	Homo sapiens	Residual Activity	%	94.0
	12230371	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	92.0	CHEMBL2634	Homo sapiens	Residual Activity	%	92.0
	12230372	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	88.0	CHEMBL2634	Homo sapiens	Residual Activity	%	88.0
	12230373	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	65.0	CHEMBL2634	Homo sapiens	Residual Activity	%	65.0
	12230374	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL2634	Homo sapiens	Residual Activity	%	113.0
	12230375	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	95.0	CHEMBL2634	Homo sapiens	Residual Activity	%	95.0
	12230376	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230377	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230378	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	74.0	CHEMBL2634	Homo sapiens	Residual Activity	%	74.0
	12230379	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	93.0	CHEMBL2634	Homo sapiens	Residual Activity	%	93.0
	12230380	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL2634	Homo sapiens	Residual Activity	%	96.0
	12230381	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	21.0	CHEMBL2634	Homo sapiens	Residual Activity	%	21.0
	12230382	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	73.0	CHEMBL2634	Homo sapiens	Residual Activity	%	73.0
	12230383	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230384	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	44.0	CHEMBL2634	Homo sapiens	Residual Activity	%	44.0
	12230385	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	89.0	CHEMBL2634	Homo sapiens	Residual Activity	%	89.0
	12230386	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12230387	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL2634	Homo sapiens	Residual Activity	%	87.0
	12230388	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	86.0	CHEMBL2634	Homo sapiens	Residual Activity	%	86.0
	12230389	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	88.0	CHEMBL2634	Homo sapiens	Residual Activity	%	88.0
	12230390	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	64.0	CHEMBL2634	Homo sapiens	Residual Activity	%	64.0
	12230391	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	91.0	CHEMBL2634	Homo sapiens	Residual Activity	%	91.0
	12230392	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	106.0	CHEMBL2634	Homo sapiens	Residual Activity	%	106.0
	12230393	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	86.0	CHEMBL2634	Homo sapiens	Residual Activity	%	86.0
	12230394	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	90.0	CHEMBL2634	Homo sapiens	Residual Activity	%	90.0
	12230395	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	65.0	CHEMBL2634	Homo sapiens	Residual Activity	%	65.0
	12230396	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230397	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	103.0	CHEMBL2634	Homo sapiens	Residual Activity	%	103.0
	12230398	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL2634	Homo sapiens	Residual Activity	%	102.0
	12230399	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	100.0	CHEMBL2634	Homo sapiens	Residual Activity	%	100.0
	12230400	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	97.0	CHEMBL2634	Homo sapiens	Residual Activity	%	97.0
	12230401	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	99.0	CHEMBL2634	Homo sapiens	Residual Activity	%	99.0
	12230402	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	91.0	CHEMBL2634	Homo sapiens	Residual Activity	%	91.0
	12230403	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	104.0	CHEMBL2634	Homo sapiens	Residual Activity	%	104.0
	12230404	CHEMBL2219007	Millipore: Percentage of residual kinase activity of CSK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	75.0	CHEMBL2634	Homo sapiens	Residual Activity	%	75.0
	12673073	CHEMBL2345622	Inhibition of recombinant CSK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	59.0	CHEMBL2634	Homo sapiens	Activity	%	59.0
	12673074	CHEMBL2345622	Inhibition of recombinant CSK (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	58.0	CHEMBL2634	Homo sapiens	Activity	%	58.0
	12674226	CHEMBL2344628	Inhibition of human CSK using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	57.0	CHEMBL2634	Homo sapiens	Activity	%	57.0
	12693242	CHEMBL2343927	Inhibition of CSK (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	12728081	CHEMBL2351296	Inhibition of CSK (unknown origin) incubated for 5 mins prior to ATP addition measured after 10 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	12728866	CHEMBL2353150	Inhibition of CSK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	97.0	CHEMBL2634	Homo sapiens	Activity	%	97.0
	12730008	CHEMBL2353651	Inhibition of CSK (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	12730256	CHEMBL2353150	Inhibition of CSK (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	102.0	CHEMBL2634	Homo sapiens	Activity	%	102.0
	12730883	CHEMBL2352482	Inhibition of CSK (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	99.0	CHEMBL2634	Homo sapiens	Activity	%	99.0
	13302656	CHEMBL2382640	Ratio of Kcat to Km for GST-fused Csk (unknown origin) expressed in Escherichia coli at 1 uM (Rvb = 1.91 no unit)	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	Kcat/Km	/min/microM	1.34	CHEMBL2634	Homo sapiens	Kcat/Km	/min/microM	1.34
	13302658	CHEMBL2382642	Ratio of Kcat to Km for GST-fused Csk (unknown origin) expressed in Escherichia coli at 0.5 uM (Rvb = 1.91 no unit)	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	Kcat/Km	/min/microM	1.44	CHEMBL2634	Homo sapiens	Kcat/Km	/min/microM	1.44
	13302663	CHEMBL2382770	Inhibition of GST-fused Csk (unknown origin) expressed in Escherichia coli using polyE4Y as substrate after 20 mins by scintillation counting analysis in presence of [gamma-32P]-ATP	B	N=C(N)NCCC[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC1=O		CHEMBL2382016	=	IC50	nM	800.0	CHEMBL2634	Homo sapiens	IC50	uM	0.8
	13351584	CHEMBL2399992	Inhibition of human CSK at 10 uM relative to control	B	Cl.O=c1[nH]nc2c(NCCCc3ccncc3)cc(Cl)cn12	Outside typical range	CHEMBL2397859	=	Inhibition	%	-29.0	CHEMBL2634	Homo sapiens	INH	%	-29.0
	13375907	CHEMBL2405315	Inhibition of CSK (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	13438128	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438129	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438130	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438131	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438132	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438133	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438134	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438135	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438136	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438137	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438138	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13438139	CHEMBL2422444	Inhibition of CSK in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	13440865	CHEMBL2429608	Inhibition of CSK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc4c(N)ncnc43)cc2)cc1	Outside typical range	CHEMBL2425144	=	Inhibition	%	-66.0	CHEMBL2634	Homo sapiens	INH	%	-66.0
	13442382	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13445517	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13448572	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13448708	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13451503	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13453043	CHEMBL2429608	Inhibition of CSK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-c3cccnc3)cc2)cc1	Outside typical range	CHEMBL2425156	=	Inhibition	%	-26.0	CHEMBL2634	Homo sapiens	INH	%	-26.0
	13453091	CHEMBL2429608	Inhibition of CSK (unknown origin) at 1 uM by [33P]-ATP filter-binding assay	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3cnc(C)c3)cc2)cc1		CHEMBL2425145	=	Inhibition	%	-4.0	CHEMBL2634	Homo sapiens	INH	%	-4.0
	13454688	CHEMBL2428003	Competitive binding affinity to CSK (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	13465476	CHEMBL2434228	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	91.0	CHEMBL2634	Homo sapiens	Activity	%	91.0
	13465502	CHEMBL2434615	Inhibition of human CSK assessed as residual activity at 10 uM relative to control	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Activity	%	80.0	CHEMBL2634	Homo sapiens	Activity	%	80.0
	13465526	CHEMBL2434201	Inhibition of human CSK assessed as residual activity at 25 uM relative to control	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	13465549	CHEMBL2434615	Inhibition of human CSK assessed as residual activity at 10 uM relative to control	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	13466477	CHEMBL2434228	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	93.38	CHEMBL2634	Homo sapiens	Activity	%	93.38
	13466504	CHEMBL2434615	Inhibition of human CSK assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1nccc(-c2c(-c3ccccc3)noc2C)n1		CHEMBL2430324	=	Activity	%	103.93	CHEMBL2634	Homo sapiens	Activity	%	103.93
	13466531	CHEMBL2434228	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	95.26	CHEMBL2634	Homo sapiens	Activity	%	95.26
	13466558	CHEMBL2434615	Inhibition of human CSK assessed as residual activity at 10 uM relative to control	B	CC(=O)Nc1cccc(-c2cnc3[nH]nc(C)c3c2)c1		CHEMBL2430323	=	Activity	%	47.98	CHEMBL2634	Homo sapiens	Activity	%	47.98
Active	13488403	CHEMBL2439418	Inhibition of human CSK at 1 uM	B	Clc1ccc2ncc(Br)n2n1		CHEMBL2436439		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	13872174	CHEMBL3101927	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	122.0	CHEMBL2634	Homo sapiens	Activity	%	122.0
	13906468	CHEMBL3117704	Inhibition of CSK (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	50.6	CHEMBL2634	Homo sapiens	INH	%	50.6
	14582471	CHEMBL3240431	Inhibition of human CSK assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	111.0	CHEMBL2634	Homo sapiens	Activity	%	111.0
	14648160	CHEMBL3267037	Inhibition of human CSK at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	14648161	CHEMBL3267037	Inhibition of human CSK at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	14659349	CHEMBL3267563	Inhibition of CSK (unknown origin) at 1 uM	B	CCOP(=O)(CC)Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1		CHEMBL3264107	=	Inhibition	%	24.0	CHEMBL2634	Homo sapiens	INH	%	24.0
	14659350	CHEMBL3267563	Inhibition of CSK (unknown origin) at 1 uM	B	CCCP(=O)(Cc1cccc(Nc2cc(-c3ccccc3OC)ncn2)c1)OCC		CHEMBL3264108	=	Inhibition	%	14.0	CHEMBL2634	Homo sapiens	INH	%	14.0
Active	14730443	CHEMBL3292734	Inhibition of CSK (unknown origin) at 0.5 uM by [33P]-ATP filter binding assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	15007997	CHEMBL3367994	Inhibition of human CSK at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	INH	%	2.0
	15007998	CHEMBL3367994	Inhibition of human CSK at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	INH	%	2.0
	15007999	CHEMBL3367994	Inhibition of human CSK at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	-3.0	CHEMBL2634	Homo sapiens	INH	%	-3.0
	15018570	CHEMBL3361884	Inhibition of CSK (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	3.5	CHEMBL2634	Homo sapiens	INH	%	3.5
	15019175	CHEMBL3364368	Inhibition of CSK (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
Not Active	15062576	CHEMBL3370289	Inhibition of human CSK by Off-chip mobility shift assay	B	O=C(Cc1c(F)cccc1Cl)Nc1onc(-c2ccc(F)cc2)c1-c1ccncn1		CHEMBL3310142		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	15072591	CHEMBL3382651	Inhibition of CSK (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	109.0	CHEMBL2634	Homo sapiens	Activity	%	109.0
	15122482	CHEMBL3367684	Inhibition of human CSK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	15126955	CHEMBL3367684	Inhibition of human CSK assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	54.0	CHEMBL2634	Homo sapiens	Activity	%	54.0
	15126987	CHEMBL3367684	Inhibition of human CSK assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	116.0	CHEMBL2634	Homo sapiens	Activity	%	116.0
	15149943	CHEMBL3395920	Inhibition of CSK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	15149944	CHEMBL3395920	Inhibition of CSK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	15149945	CHEMBL3395920	Inhibition of CSK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	15149946	CHEMBL3395920	Inhibition of CSK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	15149947	CHEMBL3395920	Inhibition of CSK (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	15249276	CHEMBL3428306	Inhibition of human CSK using poly[Glu:Tyr] (4:1) peptide substrate at 1 uM by 33P Hotspot assay	B	CN1CCN(c2ccc(Nc3ncc(Cl)c(NC[C@H]4CCCO4)n3)cc2)CC1		CHEMBL3426891	=	Inhibition	%	26.3	CHEMBL2634	Homo sapiens	INH	%	26.3
	15251816	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	93.0	CHEMBL2634	Homo sapiens	Activity	%	93.0
	15251981	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	54.0	CHEMBL2634	Homo sapiens	Activity	%	54.0
	15252083	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	76.0	CHEMBL2634	Homo sapiens	Activity	%	76.0
	15252728	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	102.0	CHEMBL2634	Homo sapiens	Activity	%	102.0
	15252830	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	86.0	CHEMBL2634	Homo sapiens	Activity	%	86.0
	15253504	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	114.0	CHEMBL2634	Homo sapiens	Activity	%	114.0
	15253606	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	82.0	CHEMBL2634	Homo sapiens	Activity	%	82.0
	15253708	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	90.0	CHEMBL2634	Homo sapiens	Activity	%	90.0
	15254374	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	94.0	CHEMBL2634	Homo sapiens	Activity	%	94.0
	15254476	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	97.0	CHEMBL2634	Homo sapiens	Activity	%	97.0
	15254578	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	90.0	CHEMBL2634	Homo sapiens	Activity	%	90.0
	15255268	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	90.0	CHEMBL2634	Homo sapiens	Activity	%	90.0
	15255371	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	99.0	CHEMBL2634	Homo sapiens	Activity	%	99.0
	15255473	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	81.0	CHEMBL2634	Homo sapiens	Activity	%	81.0
	15256205	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	15256307	CHEMBL3428404	Inhibition of CSK (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	80.0	CHEMBL2634	Homo sapiens	Activity	%	80.0
	15605124	CHEMBL3578505	Competitive binding affinity to CSK in human A375 cells after 15 mins in presence of ATP analogue	B	CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1		CHEMBL3577124	=	IC50	nM	290.0	CHEMBL2634	Homo sapiens	IC50	nM	290.0
	15649100	CHEMBL3595085	Inhibition of CSK (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL2634	Homo sapiens	IC50	nM	1000.0
	15650152	CHEMBL3595418	Inhibition of human CSK at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	23.0	CHEMBL2634	Homo sapiens	INH	%	23.0
	15756046	CHEMBL3632427	Inhibition of CSK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	100.29	CHEMBL2634	Homo sapiens	INH	%	100.29
	15757013	CHEMBL3632427	Inhibition of CSK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	78.39	CHEMBL2634	Homo sapiens	INH	%	78.39
	15758676	CHEMBL3632427	Inhibition of CSK (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	15.63	CHEMBL2634	Homo sapiens	INH	%	15.63
	16370661	CHEMBL3734198	Inhibition of Csk (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(Cl)c(C(=O)Nc2ccc(NC(C)=O)nc2)c1F		CHEMBL3732214	<=	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	16379603	CHEMBL3738400	Inhibition of CSK (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-5.8	CHEMBL2634	Homo sapiens	INH	%	-5.8
	16379604	CHEMBL3738400	Inhibition of CSK (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	0.9	CHEMBL2634	Homo sapiens	INH	%	0.9
	16417133	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(C)(=O)=O)CC3)nc21		CHEMBL3747699	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	16417134	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCC(O)CC4)cc3)nc21		CHEMBL3746959	=	Inhibition	%	34.0	CHEMBL2634	Homo sapiens	INH	%	34.0
	16417135	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	CN1CCN(CCCNc2ncc3cc(Oc4ccc(F)cc4F)c(=O)n(C)c3n2)CC1		CHEMBL3746022	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	16417136	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5ccc(F)cc5F)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3745734	=	Inhibition	%	20.0	CHEMBL2634	Homo sapiens	INH	%	20.0
	16417137	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2c(Cl)cccc2Cl)cc2cnc(NC3CCOCC3)nc21		CHEMBL3747351	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	16417138	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	CN1CCN(c2ccc(Nc3ncc4cc(Oc5c(Cl)cccc5Cl)c(=O)n(C)c4n3)cc2)CC1		CHEMBL3747023	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	16417139	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NCCc3ccccn3)nc21		CHEMBL3746951	=	Inhibition	%	6.0	CHEMBL2634	Homo sapiens	INH	%	6.0
	16417140	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(Nc3ccc(N4CCCCC4)cc3)nc21		CHEMBL3746973	=	Inhibition	%	15.0	CHEMBL2634	Homo sapiens	INH	%	15.0
	16417141	CHEMBL3750645	Inhibition of CSK (unknown origin) at 10 uM	B	CN(C)CCNc1ncc2cc(Oc3ccc(F)cc3F)c(=O)n(C)c2n1		CHEMBL3745857	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	16421904	CHEMBL3750386	Inhibition of CSK (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	16425340	CHEMBL3751252	Inhibition of CSK (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	5.2	CHEMBL2634	Homo sapiens	INH	%	5.2
	16429052	CHEMBL3750790	Inhibition of CSK (unknown origin) at 1 uM	B	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCN(S(N)(=O)=O)CC3)nc21		CHEMBL3747489	=	Inhibition	%	22.0	CHEMBL2634	Homo sapiens	INH	%	22.0
	16431793	CHEMBL3748997	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	16450800	CHEMBL3762318	Inhibition of CSK (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	3.7	CHEMBL2634	Homo sapiens	INH	%	3.7
	16457645	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	12.0	CHEMBL2634	Homo sapiens	INH	%	12.0
	16457646	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	10.0	CHEMBL2634	Homo sapiens	INH	%	10.0
	16457647	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	13.0	CHEMBL2634	Homo sapiens	INH	%	13.0
	16457648	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	12.0	CHEMBL2634	Homo sapiens	INH	%	12.0
	16457649	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	16457650	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	7.0	CHEMBL2634	Homo sapiens	INH	%	7.0
	16457651	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	16457652	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	18.0	CHEMBL2634	Homo sapiens	INH	%	18.0
	16457653	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	16457654	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	15.0	CHEMBL2634	Homo sapiens	INH	%	15.0
	16457655	CHEMBL3761565	Inhibition of CSK (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	16495380	CHEMBL3778360	Inhibition of N-terminal His6-tagged recombinant human CSK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	16.0	CHEMBL2634	Homo sapiens	Activity	%	16.0
	16508149	CHEMBL3778360	Inhibition of N-terminal His6-tagged recombinant human CSK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	4.0	CHEMBL2634	Homo sapiens	Activity	%	4.0
	16509126	CHEMBL3778360	Inhibition of N-terminal His6-tagged recombinant human CSK expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	6.0	CHEMBL2634	Homo sapiens	Activity	%	6.0
	16540761	CHEMBL3789979	Inhibition of CSK (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	16540762	CHEMBL3789979	Inhibition of CSK (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	16559585	CHEMBL3794762	Inhibition of full length human N-terminal GST-tagged CSK (1 to 450 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-4.3	CHEMBL2634	Homo sapiens	INH	%	-4.3
	16559586	CHEMBL3794762	Inhibition of full length human N-terminal GST-tagged CSK (1 to 450 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-5.0	CHEMBL2634	Homo sapiens	INH	%	-5.0
	16559587	CHEMBL3794762	Inhibition of full length human N-terminal GST-tagged CSK (1 to 450 residues) expressed in baculovirus expression system using fluorescence labelled srctide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	-0.5	CHEMBL2634	Homo sapiens	INH	%	-0.5
	16593539	CHEMBL3811542	Inhibition of His-tagged full length human recombinant CSK expressed in Escherichia coli using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2634	Homo sapiens	INH	%	40.0
	16611878	CHEMBL3816740	Inhibition of human CSK (1 to 450 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-24.0	CHEMBL2634	Homo sapiens	Activity	%	-24.0
	16611879	CHEMBL3816740	Inhibition of human CSK (1 to 450 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	6.0	CHEMBL2634	Homo sapiens	Activity	%	6.0
	16611880	CHEMBL3816740	Inhibition of human CSK (1 to 450 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-5.0	CHEMBL2634	Homo sapiens	Activity	%	-5.0
	16611881	CHEMBL3816740	Inhibition of human CSK (1 to 450 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	0.0	CHEMBL2634	Homo sapiens	Activity	%	0.0
	16614442	CHEMBL3817308	Inhibition of human CSK at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	16618251	CHEMBL3817073	Inhibition of full length recombinant human His-tagged CSK expressed in Escherichia coli at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	16627502	CHEMBL3820220	Inhibition of full length recombinant human N-terminal GST-tagged CSK expressed in Escherichia coli BL21(DE3) cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	9.0	CHEMBL2634	Homo sapiens	INH	%	9.0
	16627503	CHEMBL3820220	Inhibition of full length recombinant human N-terminal GST-tagged CSK expressed in Escherichia coli BL21(DE3) cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	-5.0	CHEMBL2634	Homo sapiens	INH	%	-5.0
	16628480	CHEMBL3820183	Inhibition of human recombinant full-length CSK at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2634	Homo sapiens	INH	%	80.0
	16654239	CHEMBL3829773	Inhibition of human CSK (1 to 450 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	79.0	CHEMBL2634	Homo sapiens	Activity	%	79.0
	16739468	CHEMBL3857041	Inhibition of His tagged recombinant full length human CSK expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	16739469	CHEMBL3857041	Inhibition of His tagged recombinant full length human CSK expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	16739470	CHEMBL3857041	Inhibition of His tagged recombinant full length human CSK expressed in Escherichia coli at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	12.0	CHEMBL2634	Homo sapiens	INH	%	12.0
342618	17720009	CHEMBL3887546	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.2	CHEMBL2634	Homo sapiens	IC50	nM	2.2
342639	17720030	CHEMBL3887546	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	2.4	CHEMBL2634	Homo sapiens	IC50	nM	2.4
385010	17758432	CHEMBL3888252	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.2	CHEMBL2634	Homo sapiens	IC50	nM	2.2
385031	17758453	CHEMBL3888252	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	2.4	CHEMBL2634	Homo sapiens	IC50	nM	2.4
412014	17776729	CHEMBL3888658	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
Inactive	17893091	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893092	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	2154.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	2154.0
Inactive	17893093	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893094	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893095	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893096	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893097	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893098	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893099	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893100	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893101	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893102	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893103	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893104	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893105	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893106	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893107	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893108	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893109	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893110	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893111	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893112	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893113	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893114	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893115	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893116	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893117	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893118	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893119	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893120	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893121	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893122	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893123	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893124	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893125	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	313.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	313.0
Inactive	17893126	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893127	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893128	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893129	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893130	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893131	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893132	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893133	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893134	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893135	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893136	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893137	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893138	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893139	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893140	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893141	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893142	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893143	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893144	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893145	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893146	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893147	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893148	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893149	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893150	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	39553.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	39553.0
Inactive	17893151	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893152	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893153	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893154	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893155	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893156	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893157	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893158	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893159	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893160	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17893161	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	7.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	7.0
Inactive	17893162	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893163	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893164	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893165	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893166	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893167	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893168	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893169	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893170	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893171	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893172	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893173	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893174	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893175	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893176	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893177	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893178	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893179	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893180	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893181	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893182	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893183	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893184	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893185	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893186	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893187	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893188	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893189	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893190	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893191	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893192	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893193	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893194	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893195	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893196	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893197	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893198	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893199	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893200	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893201	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893202	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893203	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893204	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893205	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893206	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893207	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893208	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893209	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893210	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893211	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893212	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893213	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893214	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893215	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893216	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893217	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893218	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893219	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893220	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893221	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	195.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	195.0
Inactive	17893222	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893223	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893224	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893225	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893226	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893227	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893228	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893229	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893230	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893231	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893232	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893233	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	1473.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	1473.0
Inactive	17893234	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893235	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893236	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893237	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893238	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893239	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893240	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893241	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893242	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893243	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893244	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893245	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893246	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893247	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893248	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893249	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893250	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893251	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893252	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893253	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893254	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893255	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893256	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	399.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	399.0
Inactive	17893257	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893258	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893259	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893260	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893261	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	315.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	315.0
Inactive	17893262	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893263	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893264	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893265	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893266	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893267	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893268	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893269	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893270	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893271	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893272	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893273	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893274	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893275	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893276	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893277	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893278	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893279	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893280	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893281	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893282	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893283	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893284	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893285	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893286	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893287	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893288	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	=	Kd	nM	1717.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	1717.0
Inactive	17893289	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893290	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893291	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893292	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893293	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893294	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893295	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893296	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893297	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	22.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	22.0
Inactive	17893298	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893299	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893300	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893301	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893302	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893303	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893304	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893305	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893306	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	=	Kd	nM	410.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	410.0
Inactive	17893307	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893308	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893309	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Active	17893310	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	=	Kd	nM	851.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	851.0
Inactive	17893311	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893312	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893313	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893314	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893315	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893316	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893317	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893318	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893319	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893320	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893321	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893322	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893323	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893324	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893325	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893326	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893327	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893328	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893329	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893330	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893331	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893332	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17893333	CHEMBL3991673	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL2634	Homo sapiens	Kd apparent	nM	30000.0
	18114421	CHEMBL4025073	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	18147084	CHEMBL4032524	Inhibition of CSK (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	14.7	CHEMBL2634	Homo sapiens	INH	%	14.7
	18147085	CHEMBL4032524	Inhibition of CSK (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	6.9	CHEMBL2634	Homo sapiens	INH	%	6.9
	18147120	CHEMBL4032544	Inhibition of CSK (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	3.3	CHEMBL2634	Homo sapiens	INH	%	3.3
	18147121	CHEMBL4032544	Inhibition of CSK (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	-4.6	CHEMBL2634	Homo sapiens	INH	%	-4.6
	18153110	CHEMBL4034308	Inhibition of CSK Lysine 1 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	15.1	CHEMBL2634	Homo sapiens	INH	%	15.1
	18153326	CHEMBL4034307	Inhibition of CSK activation loop (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	10.6	CHEMBL2634	Homo sapiens	INH	%	10.6
	18156556	CHEMBL4035089	Inhibition of CSK (unknown origin)	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2c(Cl)cc(Cl)cc2Cl)nc2ccc(N)cc12		CHEMBL4090364	>	IC50	nM	100000.0	CHEMBL2634	Homo sapiens	IC50	uM	100.0
	18203597	CHEMBL4043884	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	18211667	CHEMBL4045668	Inhibition of CSK labeling at conserved Lys2 (VAVKCIK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-39.3	CHEMBL2634	Homo sapiens	INH	%	-39.3
	18211692	CHEMBL4045667	Inhibition of CSK labeling at conserved Lys2 (VSDFGLTKEASSTQDTGKLPVK) in human PBMC at 1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-34.1	CHEMBL2634	Homo sapiens	INH	%	-34.1
	18211814	CHEMBL4045910	Inhibition of CSK labeling at conserved Lys2 (VSDFGLTKEASSTQDTGKLPVK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1		CHEMBL3971067	=	Inhibition	%	-9.6	CHEMBL2634	Homo sapiens	INH	%	-9.6
	18211815	CHEMBL4045911	Inhibition of CSK labeling at conserved Lys2 (VAVKCIK) in human PBMC at 0.1 uM	B	CC(C)n1cc(-c2cc(-c3ccc(CN4CCOCC4)cc3)cnc2N)nn1	Outside typical range	CHEMBL3971067	=	Inhibition	%	-49.5	CHEMBL2634	Homo sapiens	INH	%	-49.5
	18232176	CHEMBL4050330	Inhibition of human CSK assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	18253779	CHEMBL4055174	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	18253780	CHEMBL4055174	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	18267999	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	1154.0	CHEMBL2634	Homo sapiens	IC50	nM	1154.0
	18268000	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	2145.0	CHEMBL2634	Homo sapiens	IC50	nM	2145.0
	18268001	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	261.0	CHEMBL2634	Homo sapiens	IC50	nM	261.0
	18268002	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	626.0	CHEMBL2634	Homo sapiens	IC50	nM	626.0
	18268003	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	455.0	CHEMBL2634	Homo sapiens	IC50	nM	455.0
	18268004	CHEMBL4057954	Inhibition of CSK (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	665.0	CHEMBL2634	Homo sapiens	IC50	nM	665.0
	18269011	CHEMBL4058142	Inhibition of recombinant human full length N-terminal GST-tagged CSK expressed in Escherichia coli BL21 (DE3) cells preincubated for 5 mins followed by biotinyl-beta Abeta Abeta AEEEPQYEEIPIYLELLP substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	2826.0	CHEMBL2634	Homo sapiens	IC50	nM	2826.0
	18274851	CHEMBL4118329	Inhibition of CSK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VSDFGLTKEASSTQDTGKLPVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1Cl		CHEMBL3883384	=	Inhibition	%	-0.8	CHEMBL2634	Homo sapiens	INH	%	-0.8
	18274852	CHEMBL4118329	Inhibition of CSK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VSDFGLTKEASSTQDTGKLPVK probe by mass-spectrometric analysis relative to control	B	C=CC(=O)Nc1ccccc1Oc1nc(Nc2cnn(CCOC)c2)ncc1Cl		CHEMBL3884839	=	Inhibition	%	5.2	CHEMBL2634	Homo sapiens	INH	%	5.2
	18274853	CHEMBL4118329	Inhibition of CSK in human SKCO1 cells at 1 uM after 4 hrs using biotin labeled VSDFGLTKEASSTQDTGKLPVK probe by mass-spectrometric analysis relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Inhibition	%	-1.8	CHEMBL2634	Homo sapiens	INH	%	-1.8
	18282011	CHEMBL4119966	Inhibition of full length recombinant His-tagged human CSK cytoplasmic domain expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	6.8	CHEMBL2634	Homo sapiens	INH	%	6.8
	18282330	CHEMBL4119966	Inhibition of full length recombinant His-tagged human CSK cytoplasmic domain expressed in Escherichia coli at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	14.8	CHEMBL2634	Homo sapiens	INH	%	14.8
	18440139	CHEMBL4156963	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	94.0	CHEMBL2634	Homo sapiens	Activity	%	94.0
	18449896	CHEMBL4178130	Inhibition of human CSK (1 to 450 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	99.0	CHEMBL2634	Homo sapiens	Activity	%	99.0
	18463740	CHEMBL4181156	Inhibition of recombinant human N-terminal GST-tagged CSK expressed in Escherichia coli BL21(DE3) cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21	Outside typical range	CHEMBL4212680	=	Inhibition	%	-12.0	CHEMBL2634	Homo sapiens	INH	%	-12.0
	18484579	CHEMBL4185742	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	93.0	CHEMBL2634	Homo sapiens	Activity	%	93.0
	18485042	CHEMBL4185742	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	84.0	CHEMBL2634	Homo sapiens	Activity	%	84.0
	18507830	CHEMBL4190932	Inhibition of recombinant full-length human CSK at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	18558658	CHEMBL4201060	Inhibition of human CSK at 1 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	Inhibition	%	98.9	CHEMBL2634	Homo sapiens	INH	%	98.9
	18653689	CHEMBL4230059	Inhibition of CSK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	93.0	CHEMBL2634	Homo sapiens	INH	%	93.0
	18653690	CHEMBL4230059	Inhibition of CSK (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	31.0	CHEMBL2634	Homo sapiens	INH	%	31.0
	18655593	CHEMBL4230642	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	92.0	CHEMBL2634	Homo sapiens	Activity	%	92.0
	18665543	CHEMBL4233309	Inhibition of CSK (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	18674616	CHEMBL4235339	Inhibition of CSK (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL2634	Homo sapiens	Ki	nM	2000.0
	18674617	CHEMBL4235339	Inhibition of CSK (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL2634	Homo sapiens	Ki	nM	2000.0
Not Determined	18674618	CHEMBL4235339	Inhibition of CSK (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL2634	Homo sapiens	Ki		
	18725379	CHEMBL4259076	Inhibition of CSK (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL2634	Homo sapiens	IC50	uM	100.0
	18751138	CHEMBL4263776	Inhibition of CSK (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	7.0	CHEMBL2634	Homo sapiens	INH	%	7.0
	18751672	CHEMBL4264231	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	95.0	CHEMBL2634	Homo sapiens	Activity	%	95.0
	18763082	CHEMBL4266879	Inhibition of CSK (unknown origin) at 1 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)N(C)C)cc2c1C(N)=O		CHEMBL4290876	=	Inhibition	%	19.54	CHEMBL2634	Homo sapiens	INH	%	19.54
	18763115	CHEMBL4266912	Inhibition of CSK (unknown origin) at 10 uM	B	CNC(=O)Nc1sc2c(C(C)C)cc(NS(=O)(=O)c3cccs3)cc2c1C(N)=O		CHEMBL4288081	=	Inhibition	%	17.27	CHEMBL2634	Homo sapiens	INH	%	17.27
	18764587	CHEMBL4267098	Inhibition of human CSK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2634	Homo sapiens	INH	%	70.0
	18764588	CHEMBL4267098	Inhibition of human CSK at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2634	Homo sapiens	INH	%	70.0
	18764589	CHEMBL4267098	Inhibition of human CSK at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2634	Homo sapiens	INH	%	70.0
	18857900	CHEMBL4307746	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	18861341	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CC(C)(C)NC(=O)N1CC(Cn2nc(C(=O)Nc3ccc(-c4ccc(=O)[nH]n4)c(Cl)c3)c3ccccc32)C1		CHEMBL4559531	=	IC50	nM	5600.0	CHEMBL2634	Homo sapiens	IC50	nM	5600.0
	18861342	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(-c4ccc(=O)[nH]n4)c(Cl)c3)c3ccccc32)CC1		CHEMBL4555519	=	IC50	nM	79.0	CHEMBL2634	Homo sapiens	IC50	nM	79.0
	18861343	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)cc1Cl		CHEMBL4518970	=	IC50	nM	80.0	CHEMBL2634	Homo sapiens	IC50	nM	80.0
	18861344	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CCc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1-c1n[nH]c(=O)cc1C		CHEMBL4591137	=	IC50	nM	70.0	CHEMBL2634	Homo sapiens	IC50	nM	70.0
	18861345	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CCc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1-c1cc(C)c(=O)[nH]n1		CHEMBL4588040	=	IC50	nM	430.0	CHEMBL2634	Homo sapiens	IC50	nM	430.0
	18861346	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CCc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1-c1n[nH]c(=O)c(C)c1C		CHEMBL4437906	=	IC50	nM	8.0	CHEMBL2634	Homo sapiens	IC50	nM	8.0
	18861347	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(NC(=O)c4cnn5ccccc45)c(Cl)c3)c3ccccc32)CC1		CHEMBL4443654	=	IC50	nM	5.0	CHEMBL2634	Homo sapiens	IC50	nM	5.0
	18861348	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1NC(=O)c1cnn2ccccc12		CHEMBL4577049	<	IC50	nM	3.0	CHEMBL2634	Homo sapiens	IC50	nM	3.0
	18861349	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(NC(=O)c4cnn5ccccc45)cc3)c3ccccc32)CC1		CHEMBL4483095	=	IC50	nM	26.0	CHEMBL2634	Homo sapiens	IC50	nM	26.0
	18861350	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccccc45)cc3C)cnn2c1		CHEMBL4582324	<	IC50	nM	3.0	CHEMBL2634	Homo sapiens	IC50	nM	3.0
	18861351	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C)c5ccccc45)cc3C)cnn2c1		CHEMBL4469360	=	IC50	nM	42.0	CHEMBL2634	Homo sapiens	IC50	nM	42.0
	18861352	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	Cc1cc(NC(=O)c2nn(C3CCN(C(=O)CC(C)(C)C#N)CC3)c3ccccc23)ccc1NC(=O)c1cnn2ccccc12		CHEMBL4545269	<	IC50	nM	3.0	CHEMBL2634	Homo sapiens	IC50	nM	3.0
	18861353	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)CC(C)(C)C#N)CC5)c5ccc(F)cc45)cc3Cl)cnn2c1		CHEMBL4445994	<	IC50	nM	3.0	CHEMBL2634	Homo sapiens	IC50	nM	3.0
	18861354	CHEMBL4308759	Inhibition of His-tagged/GST-tagged CSK (unknown origin) incubated for 1 hr by TR-FRET assay	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccc(F)cc45)cc3Cl)cnn2c1		CHEMBL4537527	=	IC50	nM	4.0	CHEMBL2634	Homo sapiens	IC50	nM	4.0
	18861424	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(NC(=O)c4cnn5ccccc45)c(Cl)c3)c3ccccc32)CC1		CHEMBL4443654	=	IC50	nM	4.0	CHEMBL2634	Homo sapiens	IC50	nM	4.0
	18861425	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	Cc1cc(NC(=O)c2nn(C3CCN(C(=O)NC(C)(C)C)CC3)c3ccccc23)ccc1NC(=O)c1cnn2ccccc12		CHEMBL4577049	=	IC50	nM	4.0	CHEMBL2634	Homo sapiens	IC50	nM	4.0
	18861426	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	CC(C)(C)NC(=O)N1CCC(n2nc(C(=O)Nc3ccc(NC(=O)c4cnn5ccccc45)cc3)c3ccccc32)CC1		CHEMBL4483095	=	IC50	nM	21.0	CHEMBL2634	Homo sapiens	IC50	nM	21.0
	18861427	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccccc45)cc3C)cnn2c1		CHEMBL4582324	=	IC50	nM	2.0	CHEMBL2634	Homo sapiens	IC50	nM	2.0
	18861428	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C)c5ccccc45)cc3C)cnn2c1		CHEMBL4469360	=	IC50	nM	13.0	CHEMBL2634	Homo sapiens	IC50	nM	13.0
	18861429	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	Cc1cc(NC(=O)c2nn(C3CCN(C(=O)CC(C)(C)C#N)CC3)c3ccccc23)ccc1NC(=O)c1cnn2ccccc12		CHEMBL4545269	=	IC50	nM	4.0	CHEMBL2634	Homo sapiens	IC50	nM	4.0
	18861430	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)CC(C)(C)C#N)CC5)c5ccc(F)cc45)cc3Cl)cnn2c1		CHEMBL4445994	=	IC50	nM	4.0	CHEMBL2634	Homo sapiens	IC50	nM	4.0
	18861431	CHEMBL4308764	Inhibition of CSK (unknown origin) using fluorescent labeled peptide as substrate in presence of ATP at Km concentration by caliper method	B	COc1ccc2c(C(=O)Nc3ccc(NC(=O)c4nn(C5CCN(C(=O)NC(C)(C)C)CC5)c5ccc(F)cc45)cc3Cl)cnn2c1		CHEMBL4537527	=	IC50	nM	6.0	CHEMBL2634	Homo sapiens	IC50	nM	6.0
	18892597	CHEMBL4314704	Inhibition of full-length recombinant human CSK assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.0	CHEMBL2634	Homo sapiens	Activity	%	98.0
	18919463	CHEMBL4322819	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged CSK (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	879.0	CHEMBL2634	Homo sapiens	Kd	nM	879.0
	18919651	CHEMBL4322819	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged CSK (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	1014.0	CHEMBL2634	Homo sapiens	Kd	nM	1014.0
	18937847	CHEMBL4327654	Inhibition of human CSK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	100.41	CHEMBL2634	Homo sapiens	Activity	%	100.41
	18937848	CHEMBL4327654	Inhibition of human CSK assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	104.35	CHEMBL2634	Homo sapiens	Activity	%	104.35
	18938494	CHEMBL4328014	Inhibition of human CSK assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL2634	Homo sapiens	Activity	%	65.0
	18938871	CHEMBL4328378	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	14.3	CHEMBL2634	Homo sapiens	IC50	10'-8M	1.43
	18953701	CHEMBL4331916	Inhibition of CSK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(NC3CCCCC3)c12		CHEMBL4440433	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	18953767	CHEMBL4331916	Inhibition of CSK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccccc3F)c12		CHEMBL4449552	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	18953830	CHEMBL4331916	Inhibition of CSK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(OC3CCCCC3)c12		CHEMBL4524629	=	Inhibition	%	20.0	CHEMBL2634	Homo sapiens	INH	%	20.0
	18953922	CHEMBL4331975	Inhibition of CSK (unknown origin) at 1 uM relative to control	B	CC(C)n1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cn1		CHEMBL4589022	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	18953986	CHEMBL4331975	Inhibition of CSK (unknown origin) at 1 uM relative to control	B	c1cc(-c2n[nH]c3ccnc(OC4CCOCC4)c23)cc(N2CCOCC2)n1		CHEMBL4460272	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	18954053	CHEMBL4331916	Inhibition of CSK (unknown origin) at 10 uM relative to control	B	Cc1n[nH]c2ccnc(Nc3ccc4ncsc4c3)c12		CHEMBL4588446	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	18958817	CHEMBL4333336	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	88.0	CHEMBL2634	Homo sapiens	Activity	%	88.0
	18964212	CHEMBL4335043	Inhibition of recombinant human CSK assessed as residual activity at 1 uM poly(Glu, Tyr) 4:1 as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	96.0	CHEMBL2634	Homo sapiens	Activity	%	96.0
	18964213	CHEMBL4335043	Inhibition of recombinant human CSK assessed as residual activity at 1 uM poly(Glu, Tyr) 4:1 as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	102.0	CHEMBL2634	Homo sapiens	Activity	%	102.0
	18971861	CHEMBL4336871	Inhibition of recombinant human CSK assessed as residual activity at 10 uM poly(Glu, Tyr) 4:1 as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	74.0	CHEMBL2634	Homo sapiens	Activity	%	74.0
	19035297	CHEMBL4350393	Inhibition of human CSK assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
Not Active	19039820	CHEMBL4351822	Inhibition of full-length recombinant human CSK at 10 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
Active	19041072	CHEMBL4352333	Inhibition of human CSK at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	19059519	CHEMBL4357820	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	1.3	CHEMBL2634	Homo sapiens	Activity	%	1.3
	19090090	CHEMBL4365664	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	94.0	CHEMBL2634	Homo sapiens	Activity	%	94.0
	19091887	CHEMBL4366361	Inhibition of human CSK at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	1.0	CHEMBL2634	Homo sapiens	INH	%	1.0
	19114501	CHEMBL4371419	Binding affinity to CSK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4cc(F)ccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4443828	=	Kd	nM	270.0	CHEMBL2634	Homo sapiens	Kd(free)	uM	0.27
Active	19114571	CHEMBL4371376	Inhibition of CSK (unknown origin) using biotinylated peptide as substrate at 10 uM by TR-FRET assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
Active	19114572	CHEMBL4371375	Inhibition of CSK (unknown origin) using fluorescence labeled peptide as substrate at 10 uM by IMAP assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4ccccc4C(F)(F)F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4587811		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	19114691	CHEMBL4371419	Binding affinity to CSK in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	=	Kd	nM	30.0	CHEMBL2634	Homo sapiens	Kd(free)	uM	0.03
	19140811	CHEMBL4376575	Inhibition of recombinant full length human His-tagged CSK at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	19144764	CHEMBL4377780	Inhibition of recombinant full-length human CSK at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	1.0	CHEMBL2634	Homo sapiens	INH	%	1.0
	19146900	CHEMBL4378892	Inhibition of recombinant full length human CSK at 10 uM using poly(Glu,Tyr) as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	-1.0	CHEMBL2634	Homo sapiens	INH	%	-1.0
	19147812	CHEMBL4379208	Inhibition of recombinant full length human CSK using poly(Glu, Tyr) 4:1 as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	uM	10.0
	19159347	CHEMBL4382451	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	69.0	CHEMBL2634	Homo sapiens	Activity	%	69.0
	19181003	CHEMBL4387214	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	19181229	CHEMBL4387214	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 0.1 uM using tyrosine-2 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	19191660	CHEMBL4389170	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	83.0	CHEMBL2634	Homo sapiens	INH	%	83.0
	19191833	CHEMBL4389647	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	65.0	CHEMBL2634	Homo sapiens	INH	%	65.0
	19199949	CHEMBL4391273	Binding affinity to wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	77.0	CHEMBL2634	Homo sapiens	Activity	%	77.0
	19266383	CHEMBL4405333	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2634	Homo sapiens	INH	%	50.0
	19275967	CHEMBL4407970	Inhibition of recombinant full length human CSK at 1 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294846	CHEMBL4412217	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CCN(CC)CCCC(C)Nc1nc(/C=C/c2cc(OC)c(OC)cc2Cl)nc2cc(Cl)ccc12		CHEMBL579353	=	IC50	nM	6850.0	CHEMBL2634	Homo sapiens	IC50	uM	6.85
	19294948	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4442304	=	Inhibition	%	14.0	CHEMBL2634	Homo sapiens	INH	%	14.0
	19294949	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL4453032	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294950	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c(OC(C)=O)c1		CHEMBL4517514	=	Inhibition	%	64.0	CHEMBL2634	Homo sapiens	INH	%	64.0
	19294951	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	Inhibition	%	44.0	CHEMBL2634	Homo sapiens	INH	%	44.0
	19294952	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1cccc(/C=C/c2nc3ccccc3c(=O)[nH]2)c1		CHEMBL1092204	=	Inhibition	%	5.0	CHEMBL2634	Homo sapiens	INH	%	5.0
	19294953	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL1092207	=	Inhibition	%	36.0	CHEMBL2634	Homo sapiens	INH	%	36.0
	19294954	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL4459848	=	Inhibition	%	16.0	CHEMBL2634	Homo sapiens	INH	%	16.0
	19294955	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4583163	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294956	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CCCCOc1ccc(/C=C/c2nc3ccccc3c(=O)[nH]2)cc1		CHEMBL4559299	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294957	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc3c2OCO3)nc2ccccc12		CHEMBL4468697	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294958	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc3c(c2)OCO3)nc2ccccc12		CHEMBL4470620	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294959	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2c(Br)ccc3c2OCO3)nc2ccccc12		CHEMBL4518551	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294960	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cc3c(cc2Br)OCO3)nc2ccccc12		CHEMBL4576121	=	Inhibition	%	37.0	CHEMBL2634	Homo sapiens	INH	%	37.0
	19294961	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2cccc([N+](=O)[O-])c2)nc2ccccc12		CHEMBL4445408	=	Inhibition	%	37.0	CHEMBL2634	Homo sapiens	INH	%	37.0
	19294962	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=c1[nH]c(/C=C/c2ccc([N+](=O)[O-])cc2)nc2ccccc12		CHEMBL4539405	=	Inhibition	%	34.0	CHEMBL2634	Homo sapiens	INH	%	34.0
	19294963	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CC(=O)Oc1ccccc1/C=C/c1nc(Nc2ccccc2I)c2ccccc2n1		CHEMBL4455338	=	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	19294964	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(OC)c(Nc2nc(/C=C/c3ccccc3OC(C)=O)nc3ccccc23)c1		CHEMBL4458986	=	Inhibition	%	64.0	CHEMBL2634	Homo sapiens	INH	%	64.0
	19294965	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccccc2Cl)c2ccccc2n1		CHEMBL4550950	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294966	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc(O)cc2)c2ccccc2n1		CHEMBL4472770	=	Inhibition	%	14.0	CHEMBL2634	Homo sapiens	INH	%	14.0
	19294967	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2cccc(O)c2)c2ccccc2n1		CHEMBL4459984	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294968	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	Inhibition	%	39.0	CHEMBL2634	Homo sapiens	INH	%	39.0
	19294969	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccccc1/C=C/c1nc(NCc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4470772	=	Inhibition	%	35.0	CHEMBL2634	Homo sapiens	INH	%	35.0
	19294970	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)cc1		CHEMBL4571210	=	Inhibition	%	31.0	CHEMBL2634	Homo sapiens	INH	%	31.0
	19294971	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	Inhibition	%	63.0	CHEMBL2634	Homo sapiens	INH	%	63.0
	19294972	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	Inhibition	%	61.0	CHEMBL2634	Homo sapiens	INH	%	61.0
	19294973	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1ccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)cc1		CHEMBL4553117	=	Inhibition	%	6.0	CHEMBL2634	Homo sapiens	INH	%	6.0
	19294974	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Oc1cccc(Nc2nc(/C=C/c3cccc(Cl)c3)nc3ccccc23)c1		CHEMBL4535076	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294975	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(/C=C/c2nc(NCCCN(C)C)c3ccccc3n2)cc1		CHEMBL186928	=	Inhibition	%	1.0	CHEMBL2634	Homo sapiens	INH	%	1.0
	19294976	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19294977	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Inhibition	%	94.0	CHEMBL2634	Homo sapiens	INH	%	94.0
	19294978	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Inhibition	%	11.0	CHEMBL2634	Homo sapiens	INH	%	11.0
	19294979	CHEMBL4412226	Inhibition of CSK (unknown origin) at 0.5 uM preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay relative to control	B	COc1ccc(Cl)c(Nc2ncnc3cc(OCC4CCN(C)CC4)c(OC)cc23)c1		CHEMBL426161	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	19295123	CHEMBL4412234	Inhibition of CSK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc2ccccc2c(=O)[nH]1		CHEMBL1090672	=	IC50	nM	704.0	CHEMBL2634	Homo sapiens	IC50	nM	704.0
	19295124	CHEMBL4412234	Inhibition of CSK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	COc1ccccc1/C=C/c1nc(Nc2ccc3c(c2)OCO3)c2ccccc2n1		CHEMBL4476482	=	IC50	nM	706.0	CHEMBL2634	Homo sapiens	IC50	nM	706.0
	19295125	CHEMBL4412234	Inhibition of CSK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Oc1cccc(Nc2nc(/C=C/c3cc4c(cc3Br)OCO4)nc3ccccc23)c1		CHEMBL4436086	=	IC50	nM	402.0	CHEMBL2634	Homo sapiens	IC50	nM	402.0
	19295126	CHEMBL4412234	Inhibition of CSK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	O=[N+]([O-])c1cccc(/C=C/c2nc(Nc3cccc(O)c3)c3ccccc3n2)c1		CHEMBL4437669	=	IC50	nM	473.0	CHEMBL2634	Homo sapiens	IC50	nM	473.0
	19295127	CHEMBL4412234	Inhibition of CSK (unknown origin) preincubated for 10 mins followed by substrate addition and measured after 1 hr by ADP-Glo luminescence assay	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	1.3	CHEMBL2634	Homo sapiens	IC50	nM	1.3
Not Active	19306168	CHEMBL4414992	Inhibition of human CSK at 1 uM using poly[Glu:Tyr] (4:1) as substrate preincubated for 15 to 20 mins followed by [gamma-33P]-ATP addition and measured after 120 mins by filter binding method	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761		Inhibition	%		CHEMBL2634	Homo sapiens	INH		
	19371121	CHEMBL4424878	Inhibition of human full length N-terminal GST-tagged CSK expressed in Escherichia coli BL21 (DE3) cells using Poly (Glu4Tyr) as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL2634	Homo sapiens	IC50	nM	1000.0
	19411476	CHEMBL4427689	Inhibition of CSK (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL2634	Homo sapiens	IC50	uM	5.0
	19411532	CHEMBL4427633	Inhibition of CSK (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL2634	Homo sapiens	INH	%	16.0
	19435833	CHEMBL4430393	Inhibition of human CSK at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	-5.0	CHEMBL2634	Homo sapiens	INH	%	-5.0
	19435834	CHEMBL4430393	Inhibition of human CSK at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	12.0	CHEMBL2634	Homo sapiens	INH	%	12.0
	19435835	CHEMBL4430393	Inhibition of human CSK at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	37.0	CHEMBL2634	Homo sapiens	INH	%	37.0
	20600493	CHEMBL4603445	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system using tyrosine-2 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2634	Homo sapiens	IC50	uM	100.0
	22391791	CHEMBL4667003	Inhibition of recombinant human GST-tagged full length CSK expressed in Escherichia coli expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc(Cl)ccc1OC(F)F)c1cnn2cccnc12		CHEMBL4744172	=	Inhibition	%	-2.0	CHEMBL2634	Homo sapiens	INH	%	-2.0
	22391792	CHEMBL4667003	Inhibition of recombinant human GST-tagged full length CSK expressed in Escherichia coli expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	Cn1cc(NC(=O)c2cnn3cccnc23)c(-c2cc(Cl)ccc2OC(F)F)n1		CHEMBL4777342	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	INH	%	2.0
	22391793	CHEMBL4667003	Inhibition of recombinant human GST-tagged full length CSK expressed in Escherichia coli expression system using Tyr 02 as substrate at 0.1 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	O=C(Nc1c[nH]nc1-c1cc2ccccc2cc1OC(F)F)c1cnn2cccnc12		CHEMBL4745474	=	Inhibition	%	3.0	CHEMBL2634	Homo sapiens	INH	%	3.0
	22392030	CHEMBL4667125	Inhibition of recombinant human GST-tagged full length CSK expressed in Escherichia coli expression system using Tyr 02 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	2.5	CHEMBL2634	Homo sapiens	INH	%	2.5
	22423697	CHEMBL4674424	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	88.98	CHEMBL2634	Homo sapiens	Activity	%	88.98
	22423698	CHEMBL4674424	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	88.95	CHEMBL2634	Homo sapiens	Activity	%	88.95
	22751943	CHEMBL4700050	Binding affinity to CSK in human K562 cells at 1 mM incubated for 2 hrs by LC-MS/MS analysis based pull down assay relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	FC		1115.0	CHEMBL2634	Homo sapiens	FC		1115.0
	22751959	CHEMBL4700063	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)cc1		CHEMBL4792853	=	Inhibition	%	0.65	CHEMBL2634	Homo sapiens	INH	%	0.65
	22751960	CHEMBL4700063	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccc(NCCCN)cc5nc43)cc2)cc1		CHEMBL4776609	=	Inhibition	%	0.9	CHEMBL2634	Homo sapiens	INH	%	0.9
	22809735	CHEMBL4713270	Inhibition of recombinant full length human CSK assessed as residual activity at 1 uM using poly[Glu:Tyr] as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	101.0	CHEMBL2634	Homo sapiens	Activity	%	101.0
	22820456	CHEMBL4716230	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	74.0	CHEMBL2634	Homo sapiens	Activity	%	74.0
	22820457	CHEMBL4716230	Inhibition of human CSK assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	54.0	CHEMBL2634	Homo sapiens	Activity	%	54.0
	22823729	CHEMBL4717039	Inhibition of human CSK	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	201.0	CHEMBL2634	Homo sapiens	IC50	nM	201.0
	22823730	CHEMBL4717039	Inhibition of human CSK	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	253.0	CHEMBL2634	Homo sapiens	IC50	nM	253.0
	22836168	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	8.0	CHEMBL2634	Homo sapiens	INH	%	8.0
	22836169	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	19.0	CHEMBL2634	Homo sapiens	INH	%	19.0
	22836170	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	17.0	CHEMBL2634	Homo sapiens	INH	%	17.0
	22836171	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	17.0	CHEMBL2634	Homo sapiens	INH	%	17.0
	22836172	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	6.0	CHEMBL2634	Homo sapiens	INH	%	6.0
	22836173	CHEMBL4718850	Inhibition of recombinant full length human His-tagged CSK expressed in Escherichia coli expression system at 500 nM using Tyr 02 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	9.0	CHEMBL2634	Homo sapiens	INH	%	9.0
	22843206	CHEMBL4720234	Inhibition of CSK (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL2634	Homo sapiens	IC50	nM	10000.0
	22843207	CHEMBL4720234	Inhibition of CSK (unknown origin)	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	2.3	CHEMBL2634	Homo sapiens	IC50	nM	2.3
	22843786	CHEMBL4720772	Inhibition of human CSK using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	7.12	CHEMBL2634	Homo sapiens	IC50	10^-9M	7.12
	22844138	CHEMBL4721124	Inhibition of human CSK assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.2	CHEMBL2634	Homo sapiens	Activity	%	97.2
	22844677	CHEMBL4721352	Inhibition of wild-type human full length CSK (M1 to L450 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	104.47	CHEMBL2634	Homo sapiens	Activity	%	104.47
	22845474	CHEMBL4721755	Binding affinity to Nluc-tagged CSK (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	3.45	CHEMBL2634	Homo sapiens	deltaTm	degrees C	3.45
	22845494	CHEMBL4721775	Binding affinity to human CSK using poly[Glu:Tyr] (4:1) as substrate by radiometric hotspot kinase assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	12.7	CHEMBL2634	Homo sapiens	IC50	nM	12.7
	22882828	CHEMBL4727420	Inhibition of CSK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	290.0	CHEMBL2634	Homo sapiens	IC50	nM	290.0
	22882829	CHEMBL4727420	Inhibition of CSK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	162.0	CHEMBL2634	Homo sapiens	IC50	nM	162.0
	22882830	CHEMBL4727420	Inhibition of CSK (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	350.0	CHEMBL2634	Homo sapiens	IC50	nM	350.0
	22882831	CHEMBL4727420	Inhibition of CSK (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	227.0	CHEMBL2634	Homo sapiens	IC50	nM	227.0
	22882832	CHEMBL4727420	Inhibition of CSK (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	717.0	CHEMBL2634	Homo sapiens	IC50	nM	717.0
	22950603	CHEMBL4766170	Inhibition of human full length recombinant CSK using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	9.0	CHEMBL2634	Homo sapiens	IC50	uM	0.009000000000000001
	22952805	CHEMBL4766742	Inhibition of recombinant human CSK assessed as residual activity at 10 uM poly(Glu, Tyr) 4:1 as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	65.0	CHEMBL2634	Homo sapiens	Activity	%	65.0
	23120338	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	4700.0	CHEMBL2634	Homo sapiens	IC50	uM	4.7
	23120339	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	3700.0	CHEMBL2634	Homo sapiens	IC50	uM	3.7
	23120340	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	IC50	nM	6300.0	CHEMBL2634	Homo sapiens	IC50	uM	6.3
	23120341	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	6900.0	CHEMBL2634	Homo sapiens	IC50	uM	6.9
	23120342	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	100.0	CHEMBL2634	Homo sapiens	IC50	uM	0.1
	23120343	CHEMBL4804372	Inhibition of CSK in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O	Outside typical range	CHEMBL4859660	=	IC50	nM	-4500.0	CHEMBL2634	Homo sapiens	IC50	uM	-4.5
	23121379	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23121380	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23121381	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23121382	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23121383	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23121384	CHEMBL4804554	Inhibition of CSK in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2634	Homo sapiens	INH	%	0.0
	23122505	CHEMBL4804856	Inhibition of human CSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	85.0	CHEMBL2634	Homo sapiens	Activity	%	85.0
	23123200	CHEMBL4805444	Inhibition of human CSK assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	98.0	CHEMBL2634	Homo sapiens	Activity	%	98.0
	23123691	CHEMBL4805935	Inhibition of DNA-tagged human CSK assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2634	Homo sapiens	Activity	%	100.0
	23124490	CHEMBL4806461	Inhibition of human CSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	86.0	CHEMBL2634	Homo sapiens	Activity	%	86.0
	23124491	CHEMBL4806461	Inhibition of human CSK assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	92.0	CHEMBL2634	Homo sapiens	Activity	%	92.0
	23127993	CHEMBL4807806	Inhibition of CSK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL2634	Homo sapiens	Activity	%	25.0
	23127994	CHEMBL4807806	Inhibition of CSK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL2634	Homo sapiens	Activity	%	25.0
	23127995	CHEMBL4807806	Inhibition of CSK (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL2634	Homo sapiens	Activity	%	25.0
	23291246	CHEMBL4839531	Inhibition of human full length recombinant CSK at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	22.0	CHEMBL2634	Homo sapiens	INH	%	22.0
	23291247	CHEMBL4839531	Inhibition of human full length recombinant CSK at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	2.0	CHEMBL2634	Homo sapiens	INH	%	2.0
	23291248	CHEMBL4839531	Inhibition of human full length recombinant CSK at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	22.0	CHEMBL2634	Homo sapiens	INH	%	22.0
	23291318	CHEMBL4839555	Inhibition of human full length recombinant CSK at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	28.0	CHEMBL2634	Homo sapiens	INH	%	28.0
	23291319	CHEMBL4839555	Inhibition of human full length recombinant CSK at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	4.0	CHEMBL2634	Homo sapiens	INH	%	4.0
	23291320	CHEMBL4839555	Inhibition of human full length recombinant CSK at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	34.0	CHEMBL2634	Homo sapiens	INH	%	34.0
	23291390	CHEMBL4839579	Inhibition of human full length recombinant CSK at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	39.0	CHEMBL2634	Homo sapiens	INH	%	39.0
	23291391	CHEMBL4839579	Inhibition of human full length recombinant CSK at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4850154	=	Inhibition	%	23.0	CHEMBL2634	Homo sapiens	INH	%	23.0
	23291392	CHEMBL4839579	Inhibition of human full length recombinant CSK at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	71.0	CHEMBL2634	Homo sapiens	INH	%	71.0
	23291460	CHEMBL4839605	Inhibition of human full length recombinant CSK by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	>	IC50	nM	1000.0	CHEMBL2634	Homo sapiens	IC50	nM	1000.0
	23291461	CHEMBL4839605	Inhibition of human full length recombinant CSK by radiometric scintillation counting analysis	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	IC50	nM	187.0	CHEMBL2634	Homo sapiens	IC50	nM	187.0
Not Active	23317340	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23317808	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	96.0	CHEMBL2634	Homo sapiens	% Control	%	96.0
Not Active	23318478	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	82.0	CHEMBL2634	Homo sapiens	% Control	%	82.0
Not Active	23318958	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23319597	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23320070	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23320748	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23321216	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23321846	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	80.0	CHEMBL2634	Homo sapiens	% Control	%	80.0
Not Active	23322314	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	91.0	CHEMBL2634	Homo sapiens	% Control	%	91.0
Not Active	23323003	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	87.0	CHEMBL2634	Homo sapiens	% Control	%	87.0
Not Active	23323471	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23323983	CHEMBL4880602	CSK (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1	Outside typical range	CHEMBL4593677		Inhibition	%	-14.0	CHEMBL2634	Homo sapiens	% inhibition	%	-14.0
Not Active	23324325	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23324960	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23325428	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	90.0	CHEMBL2634	Homo sapiens	% Control	%	90.0
Not Active	23326075	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23326543	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23327243	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	97.0	CHEMBL2634	Homo sapiens	% Control	%	97.0
Not Active	23327711	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	96.0	CHEMBL2634	Homo sapiens	% Control	%	96.0
Not Active	23328298	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23328766	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	94.0	CHEMBL2634	Homo sapiens	% Control	%	94.0
Not Active	23329309	CHEMBL4881016	CSK(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	102.0	CHEMBL2634	Homo sapiens	% residual kinase activity	%	102.0
Not Active	23329712	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23330180	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23330936	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23331404	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23331991	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	77.9	CHEMBL2634	Homo sapiens	% Control	%	77.9
Not Active	23332459	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23333175	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	90.0	CHEMBL2634	Homo sapiens	% Control	%	90.0
Not Active	23333814	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23334282	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23334886	CHEMBL4881510	CSK (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12	Outside typical range	CHEMBL1971943		Inhibition	%	-21.0	CHEMBL2634	Homo sapiens	% inhibition	%	-21.0
Not Active	23335261	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	87.0	CHEMBL2634	Homo sapiens	% Control	%	87.0
Not Active	23335729	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23336356	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL2634	Homo sapiens	% Control	%	96.0
Not Active	23336824	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	99.0	CHEMBL2634	Homo sapiens	% Control	%	99.0
Not Active	23337553	CHEMBL4881924	CSK Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.0	CHEMBL2634	Homo sapiens	% Ctrl	%	95.0
Not Active	23337905	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23338373	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23338985	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23339453	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	82.0	CHEMBL2634	Homo sapiens	% Control	%	82.0
Not Active	23340090	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	95.0	CHEMBL2634	Homo sapiens	% Control	%	95.0
Not Active	23340558	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	98.0	CHEMBL2634	Homo sapiens	% Control	%	98.0
Not Active	23341215	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23341683	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23342299	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23342767	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23343397	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	74.0	CHEMBL2634	Homo sapiens	% Control	%	74.0
Not Active	23343865	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	94.0	CHEMBL2634	Homo sapiens	% Control	%	94.0
Not Active	23344503	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23345076	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23345544	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	96.0	CHEMBL2634	Homo sapiens	% Control	%	96.0
Not Active	23346121	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23346590	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	82.3	CHEMBL2634	Homo sapiens	% Control	%	82.3
Not Active	23347198	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	77.1	CHEMBL2634	Homo sapiens	% Control	%	77.1
Not Active	23347681	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23348260	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23348728	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23349315	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23349933	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23350401	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23351006	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23351474	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	99.0	CHEMBL2634	Homo sapiens	% Control	%	99.0
Not Active	23352004	CHEMBL4882695	CSK Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	5.548	CHEMBL2634	Homo sapiens	% Inhibition	%	5.5476
Not Active	23352498	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23352966	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23353848	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23354316	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23355048	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23355516	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23356152	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23356620	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23357229	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23357876	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23358344	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23358930	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23359528	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23359996	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	97.0	CHEMBL2634	Homo sapiens	% Control	%	97.0
Not Active	23360581	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	93.0	CHEMBL2634	Homo sapiens	% Control	%	93.0
Not Active	23361049	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	99.0	CHEMBL2634	Homo sapiens	% Control	%	99.0
Not Active	23361622	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23362158	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	97.0	CHEMBL2634	Homo sapiens	% Control	%	97.0
Not Active	23362626	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	88.0	CHEMBL2634	Homo sapiens	% Control	%	88.0
Not Active	23364268	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	76.0	CHEMBL2634	Homo sapiens	% Control	%	76.0
Not Active	23364736	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	87.0	CHEMBL2634	Homo sapiens	% Control	%	87.0
Not Active	23365475	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	90.0	CHEMBL2634	Homo sapiens	% Control	%	90.0
Not Active	23366018	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	94.0	CHEMBL2634	Homo sapiens	% Control	%	94.0
Not Active	23366608	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23367076	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23367526	CHEMBL4883879	CSK ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	111.0	CHEMBL2634	Homo sapiens	% Residual activity with Skepinone-L	%	111.0
Not Active	23367954	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23368422	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23369021	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23369489	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	84.0	CHEMBL2634	Homo sapiens	% Control	%	84.0
Not Active	23370031	CHEMBL4884275	CSK(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	90.0	CHEMBL2634	Homo sapiens	% residual kinase activity	%	90.0
Not Active	23370457	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	98.0	CHEMBL2634	Homo sapiens	% Control	%	98.0
Not Active	23370925	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	85.0	CHEMBL2634	Homo sapiens	% Control	%	85.0
Not Active	23371734	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23372202	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	91.0	CHEMBL2634	Homo sapiens	% Control	%	91.0
	23372706	CHEMBL4884671	CSK(CSK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2634	Homo sapiens	pIC50		6.0
	23373115	CHEMBL4884962	CSK(CSK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2634	Homo sapiens	pIC50		6.0
	23373476	CHEMBL4885253	CSK(CSK1LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2634	Homo sapiens	pIC50		6.0
Not Active	23374949	CHEMBL4885943	CSK Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	22.0	CHEMBL2634	Homo sapiens	% Inhibition	%	22.0
Not Active	23375629	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	98.0	CHEMBL2634	Homo sapiens	% Control	%	98.0
Not Active	23376097	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	89.0	CHEMBL2634	Homo sapiens	% Control	%	89.0
Not Active	23376674	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23377144	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23378002	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23378470	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23379637	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23380105	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	91.0	CHEMBL2634	Homo sapiens	% Control	%	91.0
Not Active	23380799	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23381447	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23381915	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	98.0	CHEMBL2634	Homo sapiens	% Control	%	98.0
Not Active	23382539	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23383007	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	74.0	CHEMBL2634	Homo sapiens	% Control	%	74.0
Not Active	23383745	CHEMBL4887390	CSK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL2634	Homo sapiens	% Ctrl	%	96.0
Not Active	23383746	CHEMBL4887390	CSK Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	84.0	CHEMBL2634	Homo sapiens	% Ctrl	%	84.0
Not Active	23384035	CHEMBL4887633	CSK DUNDEE kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	78.3	CHEMBL2634	Homo sapiens	% Ctrl	%	78.3
Not Active	23384239	CHEMBL4887834	CSK(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	6.94	CHEMBL2634	Homo sapiens	% inhibition	%	6.94
Not Active	23384922	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
Not Active	23385389	CHEMBL4879646	KinomeScan assay: inhibition of CSK	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL2634	Homo sapiens	% Control	%	100.0
